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Oct4, a transcription factor belonging to the fifth class of POU proteins (POUV), 
plays essential roles in the maintenance of pluripotency, differentiation and the generation of 
induced pluripotent stem cells (iPSCs). Oct4 regulates two levels of pluripotency, which are 
distinguished by their gene expression profiles and epigenetic status, namely the naïve and 
primed state of pluripotency. Embryonic stem cells (ESCs) and embryonic germ cells 
(EGCs), which are isolated from inner cell mass and primordial germ cells in the embryo, 
respectively, are in vitro models in which the naïve state is propagated through self-renewal. 
Epiblast stem cells (EpiSCs) and traditional human ESCs have gene expression profiles that 
are closest to the post-implantation epiblast, which is closer to embryonic differentiation, and 
exhibit a primed state of pluripotency. As Oct4 is important for pluripotency in all these cell 
types, where it regulates different targets, it appears to have two distinct sets of functions, 
namely germ cell/naïve ESC-like activity and epiblast/primed pluripotency-like activity. 
Based on protein sequences and syntenic gene analysis, Oct4/POUV homologs of jawed 
vertebrates can be classified into two subfamilies: POU5F1 and POU5F3, which are thought 
to originate from a genome duplication event that occurred in a common ancestor. Most 
extant vertebrates have lost one of these paralogs, while a small fraction, including 
coelacanths, axolotls, turtles, and marsupials, retains both POUV forms.  
 
In my thesis, I investigated the gene duplication event that underlies divergence of 
POU5F1 and POU5F3 in both expression pattern and specialised function. In particular, I 
focused on species that have retained both genes and asked whether POUV functional 
divergence correlates with ancestral origin.  To test the function of POU5F1 and POU5F3, I 
substituted endogenous mouse Oct4/Pou5f1 with different POUV proteins using a cell line in 
which endogenous Oct4 expression can be silenced with tetracycline (ZHBTc4). Results 
showed that POU5F1 proteins had a greater capacity to support naïve ESC pluripotency and 
v
self-renewal than POU5F3 proteins. Global transcriptome analysis of the POUV-rescued 
ESC lines revealed that coelacanth POU5F1 protein regulates gene expression in a similar 
manner to mouse Oct4, in that genes involved in stem cell maintenance, reproduction and 
development are upregulated in ESCs rescued by POU5F1, but not POU5F3. Coelacanth 
POU5F3 rescued lines, however, expressed genes involved in various cell differentiation 
programs, including cell adhesion (e.g. E-cadherin and N-cadherin). This suggests that 
POU5F3 plays a role in primed pluripotency, while POU5F1 regulates naïve pluripotency. 
 
However, there is one POU5F3 factor that rescues ESCs like Oct4, the Xenopus 
gene Xlpou91 (Pou5f3.1). In Xenopus, a further duplication of POU5F3 gene enabled 
specialization, and Xlpou91 is expressed specifically in the primordial germ cells. Xlpou25 
(Pou5f3.2) exhibits epiblast-specific activities and lacks the capacity to maintain naïve ESC 
pluripotency, similar to other POU5F3 proteins. This functional distinction between the 
different Xenopus POUV paralogs enabled us to address how specific Oct4 functions (germ 
cell-like versus epiblast-like activity) are related to the induction of pluripotency. To address 
this question, mouse Oct4 was replaced by either Xlpou91 or Xlpou25 in murine cellular 
reprogramming using a Nanog-GFP reporter line to monitor iPSC generation. Results 
showed that Xlpou91 and mouse Oct4 were required at similar levels to reprogram somatic 
cells toward iPSCs and reprogrammed cells emerged with similar kinetics. Conversely, 
Xlpou25 was required at higher expression levels and the resulting iPSCs appeared at a later 
timepoint, while the pluripotent population in these cultures appeared to be less stable and 
more prone to differentiate. I found that this phenotype of enhanced differentiation in 
Xlpou25 reprogrammed cultures may be a product of a different set of immediate early 
genes induced at the first stages of differentiation. Global transcriptome analysis of the naïve 
ESC-like pluripotent subpopulation of these iPSC lines confirmed the capacity of all 
Xenopus POUVs to drive reprogramming towards the pluripotent state. However, the gene 
sets induced by both Xlpou91 and mouse Oct4, but not Xlpou25, were somewhat enriched 
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for genes involved in reproduction, emphasizing the segregated role of Xlpou91 as a germ 
cell specific POUV protein.  
 
Lastly, I explored the evolutionary origin of these two POUV paralogs and 
attempted to identify a POUV-related gene in jawless vertebrate (cyclostomes). Based on in 
silico analysis of genomic and transcriptome databases, my collaborators and I were able to 
identify a single POUV gene in the Japanese/arctic lamprey, thus providing the first insight 























Embryonic stem cells (ESCs) are pluripotent stem cells, which are capable of giving 
rise to all somatic cell types (e.g. neurons, blood cells, intestinal cells). This capacity is 
called pluripotency. Somatic cells can also be converted back to an ESC-like state through a 
technology called cellular reprogramming. These converted cells are called induced 
pluripotent stem cells (iPSCs). A particular protein called Oct4 is a transcription factor 
essential for the maintenance of ESC pluripotency and inducing cellular reprogramming. In 
mouse embryos, there are two tissues expressing Oct4, which are the epiblast, the origin of 
all cell types of the adult body, and the germ cells, the origin of sperm and oocytes. 
Interestingly, other vertebrates’ embryos, show a similar expression pattern of proteins with 
an amino acid composition similar to that of mouse Oct4. These proteins are called Oct4 
homologs. Here I explore whether these proteins from different vertebrates have the same 
functions as mouse Oct4 and ask how these proteins have become specialised in vertebrates 
carrying more than one Oct4 homolog.   
 
 In my thesis, I employed two approaches to address this question. First, I used 
genetically modified mouse ESCs, whose level of Oct4 protein can be artificially regulated. 
Thus, I can address the functional similarity/distinction of Oct4 homologs from other 
animals by just replacing Oct4 in ESC and observing whether the cells retain stem cell 
character. With this approach, I can address the question of how functionally similar or 
distinct Oct4 homologs from other animals are, compared to mouse Oct4. Secondly, I 
replaced mouse Oct4 with Oct4 homologs in mouse cellular reprogramming, which is 
generally induced by mouse Oct4 and three other transcription factors: Sox2, Klf4 and c-
Myc. By exploring these two functional tests for Oct4, I found that Oct4 homologs known to 
be expressed in germ cells were effective in both of these assays, suggesting that some 
viii
aspects of ESC pluriptoency has evolved from the gene expression program that evolved to 
control our reproduction. This study provides evidence that the mammalian stem cell 
network might be an ancient toolkit and originated as early as 400 million years ago before 
the emergence of mammalian lineages, and I present some computer based analysis that 
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CHAPTER 1 GENERAL INTRODUCTION 
 
 Oct4 or Oct43/4, a transcription factor encoded by the gene Pou5f1, is a central 
regulator of early embryonic development, differentiation potency and cellular 
reprogramming. Similar to other POU proteins, Oct4 contains a bipartite DNA binding 
domain including a POU-specific domain (POUs) and POU homeodomain (POUHD) that 
together classify Oct4 as a member of class V POU proteins (POUV proteins). In addition to 
its role in stem cells, Oct4 has important roles in at least three developmental stages: early 
pre-implantation, post-implantation epiblast and germ cells. Based on conserved POU 
domain sequences, several members of POUV proteins have been identified and their 
expression in early embryonic development is conserved among vertebrate species. In my 
thesis, I focus on understanding how the remarkable activity of Oct4 evolved, how different 
roles in development may explain its capacity to sustain and induce stem cell potency. 
 
To better understand the key findings of my thesis, this chapter will introduce you to 
early mouse embryonic development and transcriptional regulation of pre- and post-
implantation of mouse embryos (Section 1.1-1.2). Pluripotent stem cells from these early 
stages of mouse embryos can be isolated and maintained in vitro. In section 1.3, I describe 
the nature of pluripotent stem cells derived from different stages of development, and discuss 
current views on the extrinsic and intrinsic factors regulating pluripotency and 
differentiation. In section 1.4, I describe how cells can be reprogrammed from adult somatic 
cells to reactivate the pluripotency network by exogenous expression of the Yamanaka 
factors Oct4, Sox2, Klf4 and c-Myc. While recent work has suggested that other factors or 
combinations of Yamanaka factors can be used in reprograming, Oct4 is the most consistent 
requirement in most reprogramming protocols. In section 1.5-1.6, I provide an in-depth 
discussion of Oct4’s roles in mouse embryonic development and pluripotent stem cells. In 
section 1.7-1.8, I review the evolution of vertebrates and the evolution of Oct4-related 
3
proteins among different vertebrate taxa, Oct4/POUV expression profiles during early 


























Section 1.1 Introduction to murine embryonic development 
 
1.1.1 Morphological changes during pre-implantation development  
 
Figure 1.1A summarises early murine pre-implantation embryonic development.  
After fertilization, the zygote initiates mitotic cell division, giving rise to smaller individual 
cells called blastomeres. Once the blastomeres proliferate and reach the 8-cell stage, a 
phenomenon called compaction takes place. During compaction, the blastomeres become 
polarised, acquire a strong adhesion between each other and the embryo becomes a solid ball 
of cells. Compaction results in a 16-cell stage morula, which contains the first two distinct 
cell types: apolar cells, which are located inside the embryo (inside cells) and polarised cells, 
which are located on the outside facing the extracellular environment (outside cells). The 
inside cells of the 16-cell stage morula develop into the inner cell mass (ICM), which will 
eventually contribute to the embryo proper. The descendants of polarised outside cells 
become trophoblast cells, which will eventually give rise to the extra-embryonic lineages of 
the placenta (Boroviak and Nichols, 2014; Hirate et al., 2013). During transition from the 
morula to the blastula stage, a process called cavitation takes place, during which trophoblast 
cells secrete fluid into the intercellular cavity, pushing the ICM to one side of a monolayer 
trophoblast cells and generating a blastocoel. This mammalian-specific structure of cavitated 
blastula is called the blastocyst. Trophoblast cells that are directly overlying the ICM are 
called polar trophectoderm, while trophoblast cells at the bottom of the blastocoel are called 
mural trophectoderm, which later endoreplicates to form mononuclear polyploid trophoblast 




The cells in the ICM at the early blastocyst are composed of a heterogeneous mix of 
epiblast and primitive endoderm (PrEN) precursors (Chazaud et al., 2006). At the late 
blastocyst stage (E4.5), presumptive epiblast and PrEN physically segregate. PrEN forms a 
monolayer of cells on the surface of the epiblast (close to the blastocoel) and subsequently 
proliferates along the wall of the blastocoel. The PrEN adjacent to the mural trophectoderm 
will form parietal endoderm, while PrEN adjacent to the epiblast and polar trophectoderm 
will form visceral endoderm after implantation. The epiblast layer contains cells with the 
potential to become all somatic cell types and germ cells. The capability of ICM and epiblast 
to give rise to all embryonic germ layers including the germ line is called pluripotency, while 
the early cells of cleavage stages can give rise to both the embryo proper and the 
trophectoderm, this ability is called totipotency. Remarkably, ICM and epiblast cells can be 






















































































Figure 1.1 Schematic overview of early mouse embryonic development and germ cell development
A) Pre-implantation mouse embryonic development from embryonic day (E) 0.5 - 4 is illustrated. After fertilization, zygote proliferates and gives rise to smaller 
cells called blastomeres. The first lineage segregation takes place from compaction (8-cell stage) until early blastocyst when inner cell mass and trophectoderm 
are formed. The second lineage segregation takes place during blastocyst stage when epiblast and primitive endoderm are formed.
B) Early post-implantation mouse embryonic development before and during gastrulation is illustrated. Trophectoderm gives rise to extraembryonic ectoderm and 
ectoplacental cone while primitive endoderm gives rise to visceral endoderm and parietal endoderm. The epiblast undergoes rodent-specific morphogenesis and 
forms egg cyclinder-like structure. Complex transcriptional network happening during gastrulation determines lineage specification. Distal visceral endoderm and 
later anterior visceral endoderm help to specify embryonic axes: promixal-distal and anterior-posterior, respectively. During gastrulation, cells at the posterior side 
of the embryo undergoes changes in cell morphology and form a structure called primitive streak, where cells ingress and migrate underneath the epiblast layer to 
form mesoderm and intercalate with visceral endoderm to form endoderm. 
C) Germ cell development during primodial germ cells (PGC)’ migration towards genital ridge is illustrated.The PGCs are firstly found as a small cluster of 
approximately 40 cells at the base of the incipient allantois at E7.25. The PGCs then migrate to the developing hindgut endoderm, mesentery, and finally colonize 






1.1.2 Morphological changes during early post-implantation 
development  
 
Figure 1.1B summarises early post-implantation embryonic development in mouse. 
During implantation, the epiblast cells proliferate and undergo epithelial morphogenesis. The 
polar trophectodermal cells form the extraembryonic ectoderm (ExE) and ectoplacental 
cone, which will eventually form the placenta, an organ connecting the embryo to the 
mother’s uterus (Rossant and Cross, 2001). At the same time, the PrEN gives rise to the 
parietal endoderm that extends around the outside of the embryo forming Reichert’s 
membrane (Salamat et al., 1995), and the visceral endoderm (VE) that remains adjacent to 
the epiblast and extra-embryonic ectoderm. The epiblast layer is composed of pluripotent 
cells, which can give rise to all embryonic lineages including germ cells, and some 
extraembryonic tissues. From E6.5, there are a series of elaborate and co-ordinated cellular 
processes driving extensive morphological movements of the epiblast to form embryonic 
germ layers. This process is called gastrulation. However, before the onset of gastrulation, a 
number of important patterning events occur in the visceral endoderm layer that results in the 
establishment of the embryonic axes. At the distal end of the embryo, distal visceral 
endoderm (DVE) start to express a large number of Wnt and Nodal antagonists, shielding the 
distal epiblast from signals produced on the proximal side of the embryo. This creates the 
first embryonic axis: promixal-distal (P-D) axis at E5.5. The DVE then migrates to the 
anterior site of the embryo to form anterior visceral endoderm (AVE), which then ensures 
that the forebrain is formed, providing the first indication of the anterior-posterior axis 




Gastrulation begins with high levels of Wnt and Nodal signaling in the proximal 
posterior epiblast leading to the formation of a structure known as the primitive streak (PS), 
through which epiblast cells will migrate to form mesoderm (future bone, muscle, blood and 
cartilage), endoderm (furure gut and visceral organs) and the posterior neural tube. At the 
anterior most point of the PS is the node, the mammalian equivalent of the Spemann-
Mangold organiser, an important embryonic signaling centre that is responsible for 
patterning of the emerging central nervous system (Arnold and Robertson, 2009; Grubb, 
2006).  
 
To commence migration through the PS, epiblast cells undergo a morphological 
change called epithelial-mesenchymal transition (EMT). EMT involves a number of 
molecular and cellular changes including loosening of epithelial adherens junctions, loss of 
association with the basement membrane and rearrangement of the cytoskeleton (Nakaya 
and Sheng, 2008; Nakaya et al., 2013; Williams et al., 2012). EMT allows gastrulating 
epiblast cells to delaminate and migrate out through the streak, enabling them to form 
mesoderm or to intercalate with the underlying visceral endoderm to form the future 
definitive endoderm (Viotti et al., 2014). Different parts of the primitive streak receive 
different intensities of signals, which result in different allocations of future cell fates along 
the anterior-posterior axis. The cells ingressing at the early PS stage (posterior PS) will form 
associated with extra-embryonic structures like the chorion, visceral yolk sac mesoderm and 
blood islands. Cells from the intermediate and anterior part of the PS form lateral plate 
mesoderm, paraxial mesoderm and cardiac mesoderm. The cells from the most anterior tip of 
the PS (late PS) form midline axial mesendoderm including prechordal plate, notochord, 





1.1.3 Germ cell development in mice  
  
Figure 1.1C summarises key events of germ cell development in mouse embryo. 
Germ cells are the source of gametes, both oocytes and sperms. In the animal kingdom, germ 
cell lineages can be specified either by maternally inherited determinants (preformation) or 
by inductive signals (epigenesis) (Extavour, 2003). The evolution of modes of germ cell 
specification in different vertebrates is described in section 1.4.3. In murine development, 
the most proximal posterior epiblast at gastrulation is induced to switch on the primodial 
germ cell (PGC)-specific program in the response to localised signaling (described in section 
1.2.3). The PGCs are firstly found as a small cluster of approximately 40 cells at the base of 
the incipient allantois at E7.25. The PGCs then migrate to the developing hindgut endoderm, 
mesentery, and finally colonise at the genital ridges (figure 1.3a) (Hayashi et al., 2011; 
Saitou and Yamaji, 2012). During the early stages of PGC development, prior to their 
colonization at the genital ridges, PGCs undergo epigenetic reprogramming, including a 
genome-wide DNA de-methylation and re-acquisition of pluripotency (Saitou and Yamaji, 
2012). Later, in the gonads, the PGCs begin sex-specific differentiation programs: either 










Section 1.2 Transcriptional network regulating early mouse embryonic 
patterning  
 
1.2.1 Transcriptional regulation in the pre-implantation embryo  
 
Transcriptional regulation of early murine pre-implantation embryo is summarised 
in figure 1.2. Position-dependent Hippo signaling is an essential component of the first 
lineage segregation event, in which the inner ICM cells become distinct from the outside TE 
cells.  In the inside cells, Nf2/Merlin-Angiomotin (Amot) can form a complex with 
basolateral adherens junctions, and recruit Lat1/2 that results in the activation of Hippo 
signaling and priming the cell towards an ICM fate allowing the expression of core 
pluripotency genes, Oct4, Sox2, Klf4 and Nanog (Hirate et al., 2013). On the other hand, the 
outside cells become polarised and cell polarity/Par-aPKC signaling sequesters Amot away 
from basolateral adherens junctions to the apical membrane, that leads to the inactivation of 
Lat1/2 inhibiting Hippo signaling. Thus, Yap1 can be localised to the nucleus to act as a co-
activator of Tead4 to induce the expression of the trophectoderm program (e.g. Cdx2 and 
Gata3). 
 
 ICM cells rapidly show mosaic gene and protein expression of two distinct 
populations. The lineage determining transcritpion factors Nanog (epiblast) and Gata6 
(PrEN) become mutually exclusive as the blastocyst develops, with the presumptive epiblast 
becoming Nanog+Gata6- and presumptive PrEN becoming Gata6+ Nanog- (Chazaud et al., 
2006). This progressive process of lineage segregation appears to be mediated by Fgf 
signaling (Cheng et al., 1998). Based on a number of experiments with culturing embryos in 
the presence and absence of Fgf signaling, it has become apparent that Fgf4 promotes a 
PrEN cell fate and the Fgf4 mutant embryos lack PrEN layer and comprise only epiblast 
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cells at the time of implantation (Kang, 2013). Presumptive PrEN cells initally express 
slightly higher levels of Fgfr2, making them more receptive to Fgf signaling, while 
presumptive epiblast cells express higher levels of secreted Fgf4 to stimulate PrEN identity 
in the neighbouring FgfR2 expressing cells (Arman et al., 1998). The transcription factors 
Nanog and Gata6 reinforce this loop by cross-regulating Fgf components and themselves 
leading to an amplification of an initially small distinction in their expressions. The final 
result of the antagonistic effect of these transcription factors is to create a salt and pepper 
distribution of epiblast (Nanog and Sox2 positive cells) and PrEN (Gata6, Gata4, Sox17 and 
Pdgfrα positive cells) in the ICM (Chazaud et al., 2006; Frum et al., 2013; Plusa et al., 
2008). During blastocyst maturation, these cells segregate based on differential adhesion, 
resulting in the localization of PrEN cells at the surface of the blastocoel. The rearrangement 
of PrEN involves actin-dependent cell movements, retention of positional information, 
epithelialization and apoptosis (Gerbe et al., 2008; Meilhac et al., 2009; Plusa et al., 2008). 
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Figure 1.2 Transcriptional regulation of pre-implantation mouse embryo 
A) The first lineage segregation of inner cell mass (ICM) and trophectoderm (TE) is specified by position-dependent Hippo signaling, 
The Nf2/Merlin-Angiomotin (Amot)-Lat1/2 complex links Hippo signaling to basolateral adherens junctions (E-cadherin-β-catenin-α-cat-
enin). The Nf2/Amot/Lat1/2 complex phosphorylates Yap1 and blocks its nuclear localization. Yap is an essential co-activator of TEAD4 
to turn on trophectodermal (TE) gene expression. In outside cells, Amot is sequestered to the apical membrane, thus Yap1 is unphos-
phorylated and can localize to the nucleus and activate TE programs (expression of Cdx2, Gata3 etc). Whereas, in the inside cells 
Yap1 is phosphorylated and is unable to translocate to the nucleus, thus TE circuitry is blocked and inner cell mass programs 
(expression of Oct4, Nanog etc) is instead switched on. 
B) The second lineage segregation of epiblast and primitve endoderm (PrEN) is specified by FGF signaling. Nanog and Oct4 upregu-
lates the expression of secretory Fgf4, which in turn induces PrEN gene expression (e.g. Sox17, Sox7, Gata4, Gata6) of the neighbor-
ing cells mediated by Erk/MAPK signaling and Oct4. This creates mosaic/salt and pepper pattern of presumptive epiblast (Nanog+) and 





1.2.2 Transcriptional regulation in the early post-implantation embryo  
 
Transcriptional regulation of early murine post-implantation embryo is summarised 
in figure 1.3. Once the blastocyst implants into the uterus, Nodal-Smad2 signaling begins to 
pattern the embryo leading to gastrulation. Epiblast cells release Nodal ligands which are 
maturated by the ExE-secreted enzymes Spc1 and Spc4. The VE receives Nodal signal from 
the epiblast and in turn produces more Nodal at the distal tip, where the initial levels of 
Nodal signaling are the highest and Nodal induces inhibitors of its own signaling including 
Cer1, Lefty1 and Dkk1. The production of these inhibitors in the so called distal VE (DVE) 
shields the distal end of the expanding epiblast from the effects of Nodal signaling distinct 
domains. Following its induction, the DVE migrates toward what will be the future anterior 
side of the embryo to become the anterior VE (AVE), where it will shield the prospective 
forebrain from Nodal and Wnt signaling, establishing the beginning of the A-P axis. 
Relocation of DVE to the anterior side of the embryo therefore generates a gradient of 
Nodal/Wnt signaling along the anterior-posterior axis. This combination of localised high 
levels of Nodal-Smad, canonical Wnt, and BMP (from ExE) signaling at the posterior site is 
required for primitive streak (PS) formation and the beginning of further lineage 
specification (Arnold and Robertson, 2009). 
 
 In the promixal posterior epiblast, closest to the extraembryonic ectoderm, where 
cells in the pre-gastrula epiblast receive the highest level of Nodal/Wnt signaling, PS 
formation is initiated. The PS extends dorsally, and cell lineages are specified based on the 
proximity of cells to the PS and where they enter it. Graded Nodal signaling, which is 
highest around the PS, induces differentiation in a dose-dependent manner. High levels of 
Nodal/Smad2/3/Wnt signaling initially specify axial derivatives at the very anterior of the PS 
(Vincent et al., 2003). These cells will migrate forward along the midline and differentiate 
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into the anterior definitive endoderm (ADE) and prechordal plate. The ADE will eventually 
displace the AVE and form the ventral foregut. Initially it produces the same antagonists as 
the AVE, but also has a role in patterning the anterior neural plate. The more posterior 
definitive endoderm is also produced by relatively high levels of Nodal/Wnt signaling and 
these cells will undergo an EMT and intercalate with the VE, to make the remainder of the 
embryonic gut. Slightly lower levels of Nodal signaling induce the formation of node and the 
axial cells migrating forward from the node will form the notochord and the floor plate of the 
neural tube. Low levels of Nodal/Smad2/Smad3 specify paraxial and laterial plate mesoderm 
(Chu, 2004; Dunn, 2004). Epiblast cells on the future anterior side of the embryo do not 
ingress through the PS and differentiate to make neuroectoderm (Lawson, 1999). 
 
  Before epiblast cells begin ingressing through the PS, these cells are linked via 
adherens junctions mediated by E-cadherin. E-cadherin is essential for the epithelial integrity 
throughout early mammalian development, but its downregulation is essential for the 
majority of movements associated with gastrulation. The downregulation of E-cadherin is 
mediated by a number of gastrulation stage signaling pathways including Fgf8, Nodal and 
Wnt signaling. In particular, Fgf8 is released from the visceral endoderm (VE) and 
stimulates Fgfr1 in the region of the PS resulting in the induction of Snai1, which in turn 
downregulates Cdh1 (E-cadherin) transcription (Arnold and Robertson, 2009). Gastrulating 
cells downregulate E-cadherin and upregulate a N-cadherin. In the mesoderm, gastrulating 
cells remain N-cadherin postive, but in the endoderm this is not the case. Gastrulating 
endoderm is identified by the expression of the transcription factor Sox17, and after these 
cells intercalated into the VE, they form the definitive endoderm and re-express E-cadherin 




Figure 1.3 Transcriptional regulation of gastrulation and inductive germ cell specification of mouse embryo 
(described in section 1.2.2) In gray boxes under the cartoon of mouse gastrulation indicate the gradient of some important cytokines required for 




















































































































































































































Gene upregulated in epiblast, not in EpiSC
Rpl14, Rpl6, Eif4g1, Sall4, Cdx2, Evx1, Ing5, Smarca4, Dnmt3b, 
Eomes, Hopx, Cdh1 (E-cadherin), Myh1, Lin28, Msx1, Otx etc
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1.2.3 Transcriptional network of murine germ cell specification  
Transcriptional regulation of murine germ cell specification is summarised in figure 
1.3. Following the initiation of gastrulation, the positioning of the AVE and its production of 
signaling antagonists ensures that the region of the embryo experiencing the highest levels of 
BMP signaling is the proximal posterior epiblast. BMP cytokines are released from 
extraembryonic ectoderm (Bmp4 and Bmp8B) and visceral endoderm (Bmp2) adjacent to 
this region and high level of BMP signaling leads to the induction of the PGC program. 
BMPs, like Nodals are members of the TGF-β super family, except they signal through 
different cell signaling transducers (Smad1 and 5 instead of 2 and 3, see section 1.3.5).  In 
this context, BMP signaling induces the expression of Prdm1 or Blimp1, PR domain-
containing protein that is a master regulator of the germ cell lineage. Initially Prdm1 positive 
cells also express a number of mesoderm-related genes, including the Hox cluster, Snai1, 
Tbx3, Tbx6, Mesp1, Sp5, Mixl1, Sall3, Ccnd1, Cdx1, Ets1, Foxf1, Plxna2, and Smad7 
(Magnúsdóttir et al., 2013; Saitou and Yamaji, 2010), leading to speculation about a 
common origin of hematopoietic stem cells and PGCs. During this early stage, pluripotency 
markers including Sox2, Nanog and Zic are not expressed, supporting the notion that the 
epiblast must be reprogrammed to a pluripotent state during PGC induction. Later, the 
pluripotency genes are upregulated again alongside with primodial germ cell (PGC)-related 
markers, while mesoderm specific genes are downregulated.  
Prdm14 is another PR domain-containing protein that plays essential roles in the 
birth of the germ cell lineage (Yamaji et al., 2008). At early stages, Prdm14 is induced 
independently of Prdm1 although later the maintenance of Prmd14 depends on Prdm1 
expression. Interestingly, Prdm14 is also expressed in ICM, from which ESCs can be 
isolated. It is also highly expressed in pluripotent cells and appears specific to naïve 
pluripotency (Assou et al., 2007; Saitou and Yamaji, 2010). From the perspective of this 
thesis, Prdm14 appears specifically expressed in naïve pluripotent cells and in particular in 
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the PGCs or ICM derivatives. This makes it a very good marker for a PGC-like pluripotent 
state, whereas Prdm1 is expressed broadly in other tissues. 
In addition, Tcfap2c (also known as AP2y) plays key roles together with Prdm1 and 
Prdm14 in germ cell specification (Weber et al., 2009).  These three regulators form a 
tripartite early germ cell network that is essential for downstream expression of the 
following PGC specific transcripts: Nanos3, Dnd1, Rhox9, Kit, Dppa3, Dazl, Ifitm3, E-
cadherin (Cdh1), Nanog, Sox2, Oct4 (Pou5f1), Sox3, Elf3, Elk1, Isl2, Mycn, Klf2, Ddx4, 
Fiat, Sp8, Smad3, Zic3, Tcfe3, Epc1, Six4, Eya3, Ccne1, Ccnd1, Cdc25a (Magnúsdóttir et 
al., 2013; Saitou and Yamaji, 2010). As mentioned above, the reinduction of pluripotent 
gene expression suggests that PGC induction involves some form of reprogramming. This 
also includes a number of other global chromatin and epigenetic changes including genome-
wide DNA de-methylation, erasure of parental imprints, and re-activation of the inactive X-
chromosome. These changes may be regulated by a set of chromatin modifiers and DNA 
demethylases that are upregulated during PGC specification, e.g. de novo DNA 
methyltransferases 3a and b (Dnmt3a, Dnmt3b) (Saitou and Yamaji, 2010).  
While reprogramming event appears to occur during PGC specification, several of 
these pluripotent/PGC factors are maintained in spermatogonia in testis, for example, c-kit, 
Vasa (MvH), Dazl, Stra8, Epcam, Oct4 (Pou5f1), Nanos2, Nanos3, Ngn3, Sox-3, Taf4b, 
Bcl6b, Numb, Lrp4, Ret, Cdh1, UTF1 and Lin28 (Phillips et al., 2010). Spermatogenesis 
involves a classical adult stem cell-dependent process. The stem cells in the adult testis are 
called spermatogonia stem cells (SSCs). Several regulators e.g. Gdnf, Bcl6b, Etv5, Ihx1, Plzf 
and Taf4b have been shown to play a role in SSC maintenance (Oatley and Brinster, 2008). 
Interestingly, it has also been shown that the Oct4+c-Kit+ subpopulation shows less capacity 
in repopulation than the Oct4+c-Kit- subpopulation. This suggests that Oct4 has roles in 
maintenance of the stem cell population in spermatogenesis process (Phillips et al., 2010).  
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Section 1.3 Pluripotent stem cells 
 
Pluripotency refers to the potential of cells to differentiate toward cell lineages of all 
three embryonic germ layers (ectoderm, mesoderm and endoderm) as well as germ cells. 
However, it does not include the ability of cells to differentiate to the extra-embryonic 
lineages TE and PrEN. Cells harboring pluripotency are called pluripotent cells. In the 
embryo, pluripotent cells exist only transiently, but cell lines such as ESCs can be 
established in vitro. These cells have the ability to indefinitely propagate in vitro and exhibit 
self-renewal, meaning that their pluripotent character is passed through successive rounds of 
cell division. Pluripotency can be assessed by in vitro and in vivo differentiation. In vivo 
differentiation assay includes both teratoma formation and chimera generation. During 
teratoma formation, pluripotent cells are able to form teratomas, tumors containing all the 
lineages of an embryo, at ectopic sites in the adult. Pluripotent cells can also be introduced 
into the blastocyst stage embryo and undergo normal embryonic differentiation and 
contribute to all lineages (chimera formation). A brief introduction to the in vitro derivation 
and differentiation of pluripotent stem cells is illustrated in figure 1.4. 
 
1.3.1 Mouse embryonic stem cells  
 
Pluripotent cells exist transiently in the ICM of the pre-implantation embryo. Under 
certain conditions, these cells can be expanded in vitro to generate immortal, karyotypically 
normal cell lines known as ESCs.  Based on the early stage of development from which 
these cells are derived, they are referred to as naïve, pluripotent cells. While traditionally 
these lines have only been generated in mouse, naïve ESCs have recently been derived in 
human (Ware et al., 2014). Originally, mouse ESCs were cultured in fetal bovine serum 
(FBS) and on feeder cell lines, but they can now also be cultured in the presence of LIF (the 
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cytokine produced by the feeders) and Bmp4 (component in FBS).  For convenience, ESCs 
are frequently grown in the serum and LIF. More recently, completely defined conditions 
employing LIF and two small molecules inhibitors of MEK (mitogen-activated protein or 
extracellular signal-regulated kinase) and GSK3β (glycogen synthase kinase 3β) (conditions 
referred to as 2i/LIF) have been used extensively (Ying et al., 2008). Naïve ESCs exhibit the 
capacity to give rise to all cell lineages including germ cells and, importantly, they 
demonstrate high chimera contribution. In addition, naïve ESCs display active X 
chromosomes and differentiate under the activation by Fgf/Erk signaling. The addition of 2i 
helps to prevent ESCs from differentiation (Nichols and Smith, 2009). Interestingly, it has 
been recently demonstrated that 2i+LIF indeed maintains ESCs at a similar to totipotent 
state, and that they have potential to give rise to both embryonic and extraembryonic 
lineages (Morgani et al., 2013).  In addition, ESCs are heterogeneous and this heterogeneity 
appears to reflect the cell states found in the blastocyst from which they are derived 
(Boroviak et al., 2014).  As a result, a number of the factors expressed in the early epiblast 
progenitors in the blastocyst are expressed heterogeneously in ESCs (Canham et al., 2010; 
Hayashi et al., 2008; Niwa et al., 2009; Toyooka et al., 2008; van den Berg et al., 2008). 
ESC culture also contains a fraction of cells primed toward PrEN differentiation (Price et al., 
2013). 
 
1.3.2 Mouse epiblast stem cells 
 
Pluripotent cells can also be generated from the post-implantation epiblast. These 
cells are known as Epiblast Stem cells (EpiSCs) (Tesar et al., 2007). As these cells are 
derived from a later developmental stage, they are closer to differentiating and express some 
germ layer as well as pluripotency markers and therefore they are referred to as “primed.” 
EpiSCs can be generated from pre-gastrulation (E5.5) to late-bud (E8.25) stages (Kojima et 
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al., 2014; Nichols and Smith, 2009). EpiSCs have capacity to give rise to all functional soma 
and germ cells including teratoma formation but the chimera contribution is limited to a 
specific subpopulation, in particular Oct4 high subpopulation of the EpiSCs (Han et al., 
2010). Unlike naïve ESC or blastocysts, one of the X chromosomes in female embryos is 
randomly inactivated in primed epiblast and EpiSCs (Guo et al., 2009; Heard, 2004). 
 
 In addition, EpiSCs require bFgf and Activin for the self-renewal maintenance, and 
the inhibition of the JAK/STAT and/or the Rho-associated kinase signaling pathway helps to 
increase the survival of EpiSCs (Chenoweth et al., 2010). Moreover, EpiSCs can be derived 
from ESCs under EpiSC culture condition, while the reversion of this primed to naïve state 
requires genetic manipulation (e.g. exogenous expression of Klf4) (Guo et al., 2009). Recent 
findings of Kojima and colleagues reveal that EpiSCs derived from different stages of post-
implantation have similar transcriptomes (Kojima et al., 2014). This suggests that specific 
populations of epiblast are selected to expand under the EpiSC culture (activin+bFgf). Like 
ESCs, EpiSCs are heterogeneous and contain populations with different differentiation 
biases or potency. Thus EpiSCs are not merely epiblast/ectoderm, but exhibit high levels of 
activity in genes associated with Fgf/MAPK, TGF-β and Wnt signaling. EpiSCs express 
genes related to anterior mesendoderm/AME and definitive endoderm/DE (Lefty1, Cited2, 
Cer1, Lbh, and Sox17) and anterior primitive streak (Sfrp1, Foxa2, Chrd, Acvr1b and Frd8) 
than the epiblast/ectoderm (Kojima et al., 2014). Based on in-depth proteomic analysis, 
Rugg-Gunn et al., 2012 reveals the unique and common surface protein of ESCs and 
EpiSCs, and found 60 cell-surface proteins unique to ESCs and 256 to EpiSCs. They also 
confirmed the expression of these genes by immunofluorescent staining of Pecam1, Pvrl2 
and Cd81 specific in ESC, while Notch3, Cd40, Cdh10, Sirpa, Cd47 and Cdh2 specific to 
EpiSCs. Some of these markers are used in this thesis to help distinguish different aspects of 
pluripotency.   
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Hayashi et al., 2011 and Kojima et al., 2014 have compared the global transcriptome 
of gastrulation stage epiblast to epiblast-derived EpiSCs and ESCs using microarray. The list 
of genes upregulated in these cells are shown in figure 1.3D. Core pluripotency gene like 
Oct4, Sox2 and Nanog are expressed in these cells, while ICM-related genes (e.g. Dppa2, 
Dppa4) are downregulated. In addition, epiblast and EpiSCs express many genes related to 
lineage commitment e.g. Id2, Foxb1, Meis2, Tbx3, T-brachyury, Irx2, Gbx2, Fgfr2, Sp5, 
Cdx2, Wnt3a, Wnt5a.  
 
While recent work suggests that naïve cells can be generated from human embryos 
(Ware et al., 2014), the majority of existing human ESC lines resemble mouse EpiSCs in 
both cell culture requirements and gene expression profiles (Brons et al., 2007; Rossant, 
2008; Tesar et al., 2007). Hence, despite derivation from human blastocysts, these embryos 
have a tendency to progress to the primed epiblast state when cultured in vitro.  
 
1.3.3 Mouse embryonic germ cells 
 
Murine germ cells originate during gastrulation before all germ layers are set. The 
early cells specified with germ cell programs are called primodial germ cells (PGCs), which 
during development migrate through several parts of the embryo to the genital ridge. During 
this route of germ cell specification and migration, pluripotent stem cells called embryonic 
germ cells (EGCs) can be derived. The successful derivation of EGCs depends on the 
supplement of Stem Cell Factor (SCF) and LIF. Oncostatin M, interleukin-6 and ciliary 
neurotrophic factor also help to increase the self-renewal capacity of EGCs (Durcovahills 
and Mclaren, 2004). Interestingly, EGCs have a similar gene expression as naïve state ESCs. 
Recently, Leitch and colleagues found that ESCs and EGCs have a similar global DNA 
methylation status. Both pluripotent cells can be cultured in 2i/LIF (MEK and Gsk3b 
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inhibitor) and show a similar induction of naïve pluripotency markers. Based on whole 
genome expression analysis of ESCs and EGCs, their gene expression was found to cluster 
based on culture conditions rather than cell types, suggesting that EGCs and ESCs were 
indeed very similar (Leitch et al., 2013).   As mentioned above the ICM cells of the 
blastocyst and PGCs express a similar set of transcription factors, so that it is possible that 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.3.4 Intrinsic factors regulating embryonic stem cell identity 
 
The maintenance of pluripotency is controlled by both extrinsic regulators and 
complex network of transcription factors. While the list of key regulators is rapidly 
expanding, I will focus on the historical core of Oct4, Sox2 and Nanog (OSN) as the 
literature about their function is the most extensive. OSN together bind extensively to both 
pluripotency-related/ differentiation-related genes. These core factors form protein 
complexes with other transcription factors on enhancers of genes, leading to activation of 
pluripotency genes or repression of lineage specific genes. Autoregulatory loops formed by 
OSN balance their own expressions at appropriate levels.  
 
 Oct4 plays essential roles during early embryonic development and early lineage 
decisions. Oct4 mutant embryos exhibit a degenerated inner cell mass and a defect in the 
formation of embryonic epiblast and extraembryonic endoderm. ESCs cannot be derived 
from Oct4 mutant embryos (Nichols et al., 1998).  In addition, a precise level of Oct4 is 
required to maintain the ESC state. Reduction or overexpression of Oct4 in ESCs leads to the 
differentiation toward trophectoderamal cells and primitive endoderm/mesoderm, 
respectively (Niwa et al., 2000; Radzisheuskaya et al., 2013; Yeom et al., 1996). Oct4 is also 
required for PGC specification and differentiation (Kehler et al., 2004; Scholer et al., 1990).  
Oct4 is described in more detail in section 1.8. 
 
Octamer binding proteins like Oct4 are known to bind cooperatively with HMG 
proteins of the SRY-related HMG box family, and in the case of Oct4, its partner in the 
regulation of pluripotency is Sox2. Sox2 is expressed in all pluripotent cell types and then 
later in neural progenitors. Sox2 mutant embryos exhibit epiblast defects and die at peri-
implantation stages, although Sox2 mutants also exhibit abnormalities in the placental 
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lineages, especially in the chorion. Moreover, like the phenotype of Oct4-/-, ESCs cannot be 
derived from Sox2 mutant embryos (Avilion et al., 2003). Sox2 and Oct4 form heterodimer 
that binds to a cognate Oct/Sox element at many important downstream regulators of 
pluripotency alongside genes repressing lineage differentiation in ESCs. In addition, the dose 
of Sox2 is critical for naïve pluripotency maintenance. The reduction and overexpression of 
Sox2 also induce rapid ESC differentiation, similar to Oct4 (Kopp et al., 2008; Li et al., 
2007b; Masui et al., 2007). As mentioned above, Sox2 is expressed in various progenitors of 
the central nervous system, including retinal progenitor cells, and neural stem cells (NSC), 
suggesting additional roles in lineage specific self-renewal and multipotency (Miyagi et al., 
2008; Taranova et al., 2006). 
 
Nanog is a homeobox transcription factor and an essential mediator of the choice 
between epiblast and PrEN (Mitsui et al., 2003; Ralston and Rossant, 2009). In the early 
epiblast, Nanog inhibits the induction of the PrEN program. Nanog is expressed in epiblast 
progentors from morula stages, but its expression is shut down around the time of 
implantation.  Later, Nanog is expressed in the posterior proximal epiblast around the PS, 
and then during the differentiation of PGCs. Nanog is essential for the formation of germ 
cells, both the maturation and migration of PGCs toward genital ridges. Nanog-null ESCs 
retain their self-renewal ability and can contribute to all lineages in chimeras except the germ 
cells (Chambers et al., 2007; Mitsui et al., 2003). In addition, ESCs express Nanog 
heterogeneously similar to what is seen in the blastocyst. The knockout of Nanog makes 
ESCs more likely to differentiate; whereas, its overexpression enables ESCs to self-renew in 
the absence of LIF (Chambers et al., 2007; Hatano et al., 2005). While Nanog expression is 
more homogeneous in 2i culture than it is in serum and LIF, ESCs in 2i culture also contain 




The three factors discussed above are the three most well known members of the 
ESC gene regulatory network; however, a number of high-throughput screens have revealed 
a more exhaustive list of ESC regulators. Additional factors known to be important for 
supporting pluripotency include (1) transcription factors (Smad1, Stat3, Tcf3, c-Myc, Esrrb, 
Sall4, Tbx3, Zfx, Ronin, Klf4, Prdm14), (2) transcriptional co-factors (cohesion, PAf1 
complex, Dax1, Cnot3, Trim28), (3) chromatin regulators (polycomb group, SetDB1/ESET, 
esBAF, Chd1, Chd7, Tip60-p400) and (4) non-coding RNAs (miRNAs, GC-rich ncRNAs) 
(Young, 2011). Remarkably, Smad1, Stat3 and Tcf3, downstream effectors of BMP, LIF and 
Wnt signaling respectively, co-occupy many genes coordinately with OSN to directly link 


























































































Esrrb, C-Myc, Sall4, Tbx3, Zfx, Ronin, 
Klf4, Prdm14 etc
Targets: Non-coding RNA regulator
miRNAs, GC-rich ncRNAs
Targets: Co-factors
Cohesion,PAF1 complex, Dax1, Chd7, 
Trim28
Targets: Chromatin regulators
Polycomb group, SetDB1/ESET, esRAF
Figure 1.5 Extrinsic and intrinsic factors regulating pluripotency
Oct4, Sox2 and Nanog (OSN) together bind extensively to both pluripotency-related/ differentiation-related genes. These core factors form protein 
complexes with other transcription factors on enhancers of genes, leading to activation of pluripotency genes or repression of lineage specific 
genes. Downstream effectors of BMP, LIF and WNT signaling co-occupy many genes coordinately with OSN to directly link extracellular signals to 
the regulation of the pluripotency circuitry. Details of how each extrinsic signaling is linked to core pluripotent circuitry are described in section 1.3.5.
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1.3.5 Extrinsic factor regulating embryonic stem cell identity 
a) LIF-STAT pathway 
 
Leukemia inhibitory factor or LIF is a member of the IL6 cytokine family. LIF was 
identified as the factor produced by feeders required to support ESC expansion. LIF is 
required for the maintenance of an undifferentiated state of naïve ESCs. However, there are a 
number of conditions such as Nanog or Klf4 overexpression, or the combination of Erk and 
Gsk3β  inhibition (2i), where LIF is not absolutely required to maintain self-renewal 
(Chambers et al., 2007; Ying et al., 2008). In a number of these cases, the inclusion of LIF in 
the culture medium still augments ESC expansion. LIF induces three downstream signaling 
pathways: (1) Jak/Stat3 (2) PI3K/Akt (3) Grb2/MAPK (Niwa et al., 2009). ESC self-renewal 
has been shown to be regulated by Jak/Stat3 signaling, and Stat3 has been shown to be 
required for ICM survival (Do et al., 2013). The LIF receptor gp130 is also required for the 
maintenance of pluripotency during diapause. Diapause is a process in certain mammals, in 
which the mother can suspend embryonic development at the blastocyst stage when in the 
process of weaning or nutrient starvation. When conditions improve, the pluripotent cells of 
the blastocyst can resume development. Interestingly, induced diapause has been used to 
improve ESC derivation (Brook and Gardner, 1997; Evans and Kaufman, 1981). 
 
In Jak/Stat3 signaling, phosphorylated Stat1/3 proteins localise to the nucleus and 
act as a transcription factor, and together with other pluripotency regulatory complexes, they 
induce genes involved in self-renewal and pluripotency (Chen et al., 2008a). Several Stat3 
target genes are identified, including Klf5, Klf4, Smad7, Gbx2, Icam1, Sall4, Stat3 itself 
(Bourillot et al., 2009). In particular, LIF has been shown to induce the expression of Klf4, 
which appears to be essential for murine cellular reprogramming (Stuart et al., 2014).  
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b) BMP/Nodal-Smad pathway 
 
BMPs (Bone morphogenetic proteins) and Nodal are both members of the TGF-   
superfamily of secreted growth factors. TGF-β binds to transmembrane type I and type II 
serine/threonine kinase receptor complexes, in which the type II receptor is specific for 
different classes of cytokines. Binding of the cytokines cause phosphorylation of the type I 
receptor through the kinase activity on the type II receptor, which leads to the recruitment of 
specific R-Smads to transduce signals to the nucleus. BMP signaling involves Smad1, 
Smad5, and Smad8, while the interaction of Nodal with its receptor leads to the activation of 
Smad 2 and 3. These phosphorylated R-Smads form a heteromeric complex with Smad4 
(Co-Smad). The R-Smad/C-Smad complex translocates to the nucleus and regulates target 
gene expression in conjunction with different sequence specific DNA binding proteins. The 
signaling mediated by R-Smad is also negatively regulated by I-Smads (Smad6 and Smad7).  
 
In mouse ESCs, Bmp4 together with LIF maintains ESC pluripotency and self-
renewal. BMP signaling induces the expression of bHLH proteins known as ID proteins, that 
bind to, and suppress, the activity of differentiation-promoting transcription factors. 
However, BMP/Smad signaling is dispensable for self-renewal when cells are cultured in 2i 
(Ying et al., 2008). Several BMP-Smad1/5 target genes are enriched in neural differentiation, 
which are silenced in naïve ESCs. Nodal, another member of the TGF-β family also has a 
role in early epiblast expansion. However, it is also a dose-dependent inducer of mesoderm 
and endoderm.  Another TGF-β signaling molecule called activin can substitute Nodal and 




c) Wnt-β-catenin signaling 
 
Wnt ligands can transduce the signaling through several pathways, but here I focus 
solely on the canonical pathway because it has been implicated in the maintenance of 
pluripotency. Canonical Wnt/β-catenin signaling is regulated through post-translational 
modification of β-catenin. In the absence of Wnt ligands, β-catenin is bound to a destruction 
complex, composed of the APC and Axin scaffolding proteins and the glycogen synthase 
and casein kinases (GSK3β and CK1). Gsk-3β activation leads to a ubiquintin-mediated 
proteolytic degradation of β-catenin. Upon stimulation of the Wnt pathway through the 
Frizzled receptor, Gsk-3β activity is inhibited through the activity of Dishevelled (Dsh or 
Dvl) and the expression of β-catenin is stabilised, enabling it to translocate to the nucleus. In 
the nucleus, β-catenin interacts with the HMG-domain, containing repressors of the Tcf 
family, and converts them to be activators by displacing Groucho family co-repressors. In 
mouse ESCs, canonical Wnt signaling supports self-renewal primarily through blocking 
differentiation towards-neuroectodermal lineages. Tcf3 is a major component of the OSN 
network, and it acts to shut down the pluripotency network in the absence of Wnt signaling 
(Atlasi et al., 2013). In the case of Tcf3, Wnt stimulation does not appear to convert it to an 
activator, but rather induces Tcf1 to bind with β-catenin and compete Tcf3 away from its 
targets. In this way, the complex of Tcf1-β-catenin supports ESC self-renewal (Yi et al., 
2011).  
        






Section 1.4 Induced pluripotent stem cell and mechanism of cellular 
reprogramming 
 
ESC are remarkable cell lines derived from the mammalian embryo with the 
capacity to both expand indefinitely in culture and differentiate into all adult cell types, a 
property known as pluripotency. A major goal of regenerative medicine has been to develop 
the capacity to transform somatic cells to an ESC like state, enabling the generation of 
patient specific stem cells. Initial efforts to reprogram differentiated, mature somatic cells to 
a pluripotent embryonic state, was driven by the nuclear reprogramming. Nuclear 
reprogramming involves the transfer of embryonic factors from an oocyte or ESC to enable 
the reprogramming of a differentiated somatic nucleus. This was achieved by either 
transferring the somatic nucleus to an oocyte or ESC, or through cell fusion and the 
generation of heterokaryons (Gurdon et al., 1958; Hochedlinger and Jaenisch, 2006; Wilmut 
et al., 1997). A more targeted alternative was developed by Shinya Yamanaka and 
colleagues and involves the overexpression of specific transcription factors in somatic cells. 
They identified candidate transcription factors normally expressed in ESCs and used 
retrovirus to force their expression in differentiated mouse embryonic fibroblasts. Starting 
with 24 ESC specific transcription factors, they were able to induce an ESC like pluripotent 
state through the prolonged culture of these infected MEFs under conditions that normally 
support ESC growth.  Of these original twenty-four factors, they found that Oct4, Sox2, Klf4 
and C-myc (also called together as “Yamanaka factors”) were sufficient to reprogram mouse 
embryonic fibroblasts to pluripotent cells, which they termed induced pluripotent stem cell 
(iPSCs). These iPSCs expressed ESC markers such as SSEA-1 and alkaline phosphatase and 
exhibited comparable level of pluripotency genes such as Oct4, Sox2, Nanog and etc 
(Takahashi and Yamanaka, 2006). With time, this protocol was improved, such that iPSCs 
were shown to be able to contribute to the germ line and generate cloned animals. Human 
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iPSCs have also been generated with either the original set of Yamanaka factors or a 
combination of Oct4, Sox2, Nanog, and Lin28. Human iPSCs express the same set of 
transcription factors as human ESCs, exhibit a similar methylation status and differentiation 
potential (Takahashi et al., 2007; Yu et al., 2007). While initially developed in mouse and 
human, the protocol with original four factors has been shown to partially induce the 
fibroblasts into induced pluripotent stem cell like states also in other vertebrates (chicken, 
quail, zebra finch, zebrafish) and invertebrate (fruit fly) (Rossello et al., 2013). This suggests 
the conservation of stem-cell like phenotypes and the reprogramming gene network in 
animal kingdom. 
 
Reprogramming occurs as a result of the progressive acquisition of new cell 
identities, culminating in the stable establishment of the network of transcription factors 
normally expressed in pluripotent cells, the pluripotency network. Following viral induction, 
the four factors induce a mesenchymal-epithelial transition (MET) that is essential for 
successful reprograming and produces a pre-iPS state, in which some components of the 
pluripotency network are expressed, although not stably. This is followed by the 
establishment of a stable state with the capacity to differentiate in chimeras or fully 
reprogrammed iPSCs that have established naïve pluripotency.  Fully reprogrammed iPSCs 
can both produce germ line transmission and yield iPSC-derived embryos in tetraploid 
complementation. Moreover at fully state of cellular reprogramming, retrovirally expressed 
reprogramming factors are efficiently silenced by the induced ESC-like transcriptome, and 
this enables the faithful testing of these cell lines in a variety of differentiation assays. Full 
reprogramming is generally associated with the activation of Dio1-Dlk3 locus (Stadtfeld et 
al., 2010). 
 
 In the initial phase of reprogramming, Oct4, Klf4 and Sox2 act as pioneer factors 
and bind to distal regulatory elements on genes with in DNase resistant closed chromatin. 
33
With time, this binding needs to be converted to recognition of the proximal promoter 
regions of these genes and this will require co-factors such as the cohesin complex (Taberlay 
et al., 2011). C-Myc acts as an amplifier and requires OSK binding for its recruitment to 
specific promoters on active chromatin for transcriptional induction of its target genes. Early 
targets include many genes associated with promoting reprogramming such as GLISI, mir-
302/367, MET promoting factors and apoptosis regulators. Interestingly, although OSK 
induce abundance of genes at this early state of cellular reprogramming, they do not 
recognise the gene targets normally expressed in the naïve ESC state. The time taken to 
convert these immediate early genes from silent to transcribed may be reflected in the 
observation that the early phase of the reprogramming is thought to be stochastic process 
(Buganim et al., 2012). In addition, the early upregulation of apoptosis regulators by OSK 
also explains the high levels of apoptosis known to occur during this early phase of 
reprogramming and this is consistent with the finding that mutant apoptotic regulator (e.g. 
p53) increase the chance of successful iPSC generation (Kawamura et al., 2009). 
 
All four reprogramming factors facilitate the induction of MET (figure 1.6). As 
TGF-  signaling is known to promote EMT (or suppress MET) and TGF-β inhibitors can 
replace either Sox2 or C-myc. Oct4 and Sox2 appear to inhibit the expression of TGFβR3 
and TGFβ3 while stimulating the expression of miR-200, a specific inhibitor of the EMT 
regulator, Zeb2. Klf4 also inhibits TGFβ3 and stimulates the expression of E-cadherin. C-
myc both inhibits TGFβ1 and TGFβR2 expression and induces expression of additional 
miRNA that target TGFβR2 (Li et al., 2010). Interestingly, overexpression of the MET 
regulator E-cadherin can replace Oct4 in the reprogramming cocktail (Redmer et al., 2011). 
 
The establishment of the endogenous pluripotency network is a long process, which 
involves the initial activity of OSK as pioneer factors, binding their targets in silent 
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chromatin and their slow activation. However, despite the pioneer activity of OSK, they are 
unable to recognise their endogenous ESC targets in differentiated cells, where large 
segments of the genome are inaccessible to OSK (e.g. regions containing pluripotency genes 
Nanog, Sox2, PRDM14) as they are marked with the H3K9me3 histone modification. In 
somatic cells, these inaccessible targets are marked by H3K9me3. The H3K9 methyl 
transferase SUV39H1/2 is required for maintenance of these domains and its inhibition in 
reprogramming increases the access of OSKM to sites within these H3K9me domains. The 
loss of this mark appears to be an inefficient process that is influenced by culture conditions 
including response to the reprogramming block induced by Bmp4 (Chen et al., 2013) and 
these regions include nearly all the hotspots of aberrant DNA methylation that appear, when 
iPSCs are compared to ESCs. The H3K9 demethylases Kdm3/4 are also essential for the 
transition from pre-iPSCs to iPSCs. Moreover, Oct4 itself is a potent activator of two 
additional H3K9 demethylases: Jmjd1a and Jmjd2c.   
 
The transition between pre-iPSCs and fully reprogrammed iPSCs is not rapid, and a 
combination of single cell analysis and the identification of specific precursor populations 
suggest a degree of heterogeneity in reprogramming in the favor of stochastic processes. The 
pluripotency network itself is activated in stages with the transcription of endogenous Sox2 
and Esrrb coming very late in the process.  The expression of late pluripotency genes marks 
cells as close as possible to being fully reprogramming state (Buganim et al., 2012; 
O’Malley et al., 2013). 
 
One of the current views of reprogramming and the establishment of pluripotency 
involves a conflict between distinct lineage specific transcription factors in the same cell. 
Pluripotent cells are also maintained or induced by conflicts between transcription factors 
specifying different lineages and this implies that a number of early lineage specifiers should 
be able to induce pluripotency, as it was recently shown. In addition, this model suggests that 
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the reprogramming factors (O, S, K) are also acting on their normal developmental 
programs. For example, Oct4 is believed to induce mesendodermal (ME) and inhibit 
ectodermal (ECT) genes, while Sox2 induce ECT and inhibit ME genes. The balance 
between ME versus ECT genes leads to a “seesaw model ”, in which the contrasting 
activities of these factors creates a road that leads to the acquisition of pluripotency. 
Interestingly, ME-specific transcription factors (Gata6, Gata3, Sox7, Pax1, Gata4, CEBPa, 
HNF4a, and GRB2) can replace exogenous Oct4 in the iPSC induction; whereas ECT-
specific transcription factors (Sox1, Sox3, and GMNN) can replace exogenous Sox2 (Shu et 
al., 2013). 
 
There have been several efforts to identify both transcription factors and surface 
markers to follow the process of reprogramming in a stepwise manner. Oct4, SSEA1 and 
alkaline phosphatase (AP) staining are commonly used to determine the acquisition of 
pluripotency. However, these markers, in particular Oct4, are upregulated early during the 
emergence of the network and the expression of these markers does not indicate the 
acquisition of fully reprogrammed state (Buganim et al., 2012). James O’Malley and 
colleagues have identified two additional surface markers ICAM1 and CD44 that enable the 
sorting of cell populations during the reprogramming process (O’Malley et al., 2013). In 
addition to the previously established Nanog-GFP reporter, these markers enable a better 
characterization of the reprogramming mechanism. They found a series of changes in these 
markers, that could be used to plot the trajectory of reprogramming to a final iPSC state that 
was ICAM1+CD44-, similar to ESCs. This ICAM1+CD44- population contains both a Nanog 
positive and a Nanog negative population, reflecting the heterogeneity in iPSC clonal lines. 
In addition, they followed the reprogramming behavior based on these two markers and 
found that reprogramming occurs via an ICAM-CD44+, ICAM-CD44- and finally to 
ICAM+CD44- and that gene expression changes could be tracked in these populations. These 
changes commence with the downregulation of mesenchymal gene expression (e.g. N-
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cadherin (Cdh2), Snail, Slug, Zeb1, and Zeb2), transient upregulation of epidermal genes 
(e.g. Krt6a, Ngfr, Evpl), upregulation of early pluripotency genes (e.g. Oct4, Sall1, Sall4), 
and culminate with the upregulation of late pluripotency genes (e.g. Nanog, Dppa4, Sox2, 
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Figure 1.6 Mechanism of murine cellular reprogramming 
A) Somatic cells (e.g. mouse fibroblast cells) can be reprogrammed toward induced pluripotent stem cells by overexpression of Yamanaka 
factor Oct4, Sox2, Klf4 and c-Myc.  In the initial phase of reprogramming, Oct4, Klf4 and Sox2 act as pioneer factors and bind to distal 
regulatory elements on genes with closed chromatin. The four factors also induce a mesenchymal-epithelial transition (MET) that is 
essential for successful reprograming and produces a pre-iPS state. One of the current views of reprogramming and the establishment of 
pluripotency involves a conflict between distinct lineage specific transcription factors in the same cell, called “seesaw model”. Oct4 is 
believed to induce mesendodermal (ME) and inhibit ectodermal (ECT) genes, while Sox2 induce ECT and inhibit ME genes. The balance of 
ECT versus ME gene network requires for pluripotency acquisition and interestingly the Oct4 and Sox2 can be substituted by ME and ECT 
genes respectievly to induce reprogramming. Some reprogrammed cells later upregulate early pluripotency genes and only a small fraction 
of cells culminate with the upregulation of late pluripotency genes and become fully reprogrammed cells. 
B) James O’Malley and colleagues have identified two additional surface markers ICAM1 and CD44 that enable the sorting of cell popula-
tions during the reprogramming process. The fully reprogrammed iPSC cells exhibit ICAM1+CD44-, similar to ESCs. This ICAM1+CD44- 
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Oct4, Sall1, Sall4, Zfp296, Tcfcp2l1, Etv5
Nanog, Dppa4, Dppa5a, Sox2, Esrrb, Klf2
eGFP- refers to Nanog negative cell population 
eGFP+ refers to Nanog positive cell population 
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Section 1.5 Roles of Oct4 in the early mouse embryonic development 
 
 Neither maternal nor zygotic Oct4 is required for the initiation of zygotic 
transcription, early cleavage or the initiation of the expression of early embryonic gene 
expression relevant to pluripotency (e.g. Nanog and Sox2) (Wu et al., 2013). One of the first 
requirements for Oct4 involves the specification of ICM and TE at the 16-cell stage. At this 
point, Oct4 expression in the ICM inhibits Cdx2, whereas Cdx2 expression in the TE inhibits 
Oct4. Both Oct4-mutant ICM cells and ESCs differentiate to trophoblasts (Nichols et al., 
1998). Oct4 also regulates the specification of PrEN, both by inducing the transcription of 
Fgf4 and potentially acting cell-intrinsically within the PrEN cells to potentiate ERK 
signaling (Frum et al., 2013). Oct4 also reinforces PrEN fate by feed-forward mechanism via 
partnership with its own downstream target, Sox17 (Aksoy et al., 2013).  
 
 Oct4 is expressed throughout the post-implantation epiblast prior to the onset of 
gastrulation and is successively confined to proximal posterior epiblast during gastrulation 
(Fuhrmann et al., 1999; Pelton et al., 2002). Deletion of Oct4 from post-implantation epiblast 
during gastrulation leads to severe phenotypes including craniorachischisis, random heart 
tube orientation, failed turning, defective somitogenesis and posterior truncation. In addition, 
Oct4 is required for cell viability and proper cell proliferation within the primitive streak 
(DeVeale et al., 2013). Moreover, based on studies in Xenopus and EpiSCs, Oct4 appears 
essential to maintain intact adherens junctions in the epiblast (Livigni et al., 2013).  Oct4 
expression is repressed in the epiblast during the late gastrulation and by E7.5 it emerges 
again and is restricted to only PGCs (Sabour et al., 2010; Stebler et al., 2004). The 
expression of Oct4 is maintained in PGCs migrating towards genital ridges (Scholer et al., 
1990; Stebler et al., 2004; Yeom et al., 1996). Conditional ablation of Oct4 in the PGCs 
results in premature apoptosis prior to the completion of migration to genital ridges. Thus, 
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Oct4 might not be required for PGC specification but is crucial for the survival of PGCs and 
differentiation (Kehler et al., 2004). The role of Oct4 in PGC survival might be regulated by 
an oxygen-regulated transcription factor HIF-2  as it has been shown that HIF-2  mutant 
embryo severely decreased the number of PGCs (Covello, 2006). However, once germ cells 
are allocated to genital ridges, the deletion of Oct4 from oocytes does not impair the 






















Section 1.6 Oct4 roles and its regulation in embryonic stem cells  
 
The level of Oct4 in ESCs is essential for both maintaining the pluripotency network 
and to support efficient differentiation. Loss of Oct4 expression results in ESC 
differentiation to trophoblast (Nichols et al., 1998). However, iPSC and ESCs expressing 
lower levels of Oct4 have an enhanced capacity to self-renew and cell lines can be isolated 
with as low 15% of normal Oct4 expression (Karwacki-Neisius et al., 2013; Radzisheuskaya 
et al., 2013). Moreover, in experiments where Oct4 mutations are rescued by expression of 
mutant gain and loss of function proteins expressed from a transgene, the level of Oct4 
expressed in different clonal lines supported by these transgenes is remarkable similar and 
depends on the activity of the Oct4 transgene (Hammachi et al., 2012; Morrison and 
Brickman, 2006). This observation suggests that ESC growth selects for a precise level of 
Oct4 expression and activity. These observations are also consistent with the observations 
that ESCs with elevated Oct4 levels are prone to differentiate to primitive endoderm and 
mesoderm (Niwa et al., 2000; Radzisheuskaya et al., 2013). 
 
Oct4 is predominantly a transcriptional activator and under standard ESC conditions 
it is predominantly involved in supporting the pluripotency network (Hammachi et al., 
2012). There are currently several ChIP-seq datasets and this has enabled us to compile an 
annotated list of gene targets from several studies (Livigni et al., 2013; Loh et al., 2006; 
Matoba et al., 2006; Sharov et al., 2008). Some of these targets are listed in Figure 1.7 These 
include chromatin modifiers; for example Jmjd1a and Jmjd2c, encoding histone H3 lysine 9 
demethylases and Jarid2 and Mtf2, the components of polycomb repressive complex 2 
(PRC2) (Chen et al., 2008b; Kim et al., 2008; Loh et al., 2006). In addition, this Oct4 
network is linked to non-coding RNA network. For example, Oct4, synergistically acting 
with Nanog and Sox2, represses X chromosome inactivation. Oct4 binds to Tsix and Xite 
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(noncoding RNA genes) and enhances their transcriptions, in turn leading to repression of 
non-protein coding gene Xist, which coats and inactivates the X chromosome. Hence, Oct4 
prevents X chromosome inactivation through indirectly repressing Xist (Baker, 2009; 
Navarro et al., 2008). Oct4 also induces the expression of large intergenic noncoding RNAs 
(lincRNAs, e.g. lincRoR) and miRNA network regulating the maintenance and establishment 
of pluripotency and cell cycle (Greer Card et al., 2008; Lichner et al., 2011; Loewer et al., 
2010; Wang et al., 2013a). Part of this non-coding RNA network (e.g. miR-296, miR470 and 
miR134 in mouse; Lin28 and miR-145 in human) is involved in Oct4 autoregulation as they 
post-transcriptionally regulate Oct4 expression through direct binding to the Oct4 mRNA 
(Qiu et al., 2010; Tay et al., 2008; Xu et al., 2009).  
 
There have also been some ChIP-seq studies done on Oct4 targets in mouse EpiSC 
or transient epiblast like cells (EpiLCs) and human ESCs. These targets in human ESCs 
include OCT4, SOX2, NANOG, LEFTY2/EBAF, CDX2, HAND1, DPPA4, FOXO1A, 
CRIPTO/TDGF1, ZIC3, ESX1l, HOXB1, MEIS1, PAX6, LHX5, LBX1, MYF5 etc. Some of 
these genes are important for differentiation into three germ layers (Boyer et al., 2005). 
Some of this gene list is also found specifically in EpiLCs but not in the naïve ESCs, 
suggesting human ESCs are more similar to mouse EpiSCs than the naïve ESCs. In addition, 
Oct4 occupancy are substantial around the genes associated with post-implantation epiblast 
e.g. Fgf5, Oct6 and Wnt8, in mouse EpiLCs. Interestingly, most of the occupancy sites of 
Oct4 are distal and far from the transcriptional start site (TSS), suggesting Oct4 acts on the 
enhancers of these genes to regulate their expressions (Buecker et al., 2014). 
 
 Oct4 protein has been shown to be associated with a number of other pluripotency 
regulators and that also recognise overlapping sets of targets. However, the Oct4 protein 
complex also includes a number of molecules associated with other cellular processes. While 
the significance of these has yet to be demonstrated, the Oct4 core protein interactome 
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includes transcriptional coactivators and repressors, cell cycle associated proteins, metabolic 
processing proteins, ribonucleoprotein complexes, RNA and factors involving protein 
transport and localization, signal transduction mediators, and translational regulators 
(Campbell et al., 2007). Recently, it was also shown that Oct4 forms a complex with 
cyclinB-Cdk1, which inhibits Cdk1 activation. Oct4-mediated Cdk1 inhibition ensures 
normal G2 progression and prevents premature mitotic entry (Zhao et al., 2014). 
 
Oct4 expression is regulated by a TATA less minimal promoter driven by two 
upstream regulatory elements: proximal enhancer (PE) and distal enhancer (DE). These 
enhancers are essential drivers of Oct4 expression at distinct embryonic stages. The Oct4 
proximal enhancer plays a role in the epiblast and EpiSC, while the distal enhancer regulates 
Oct4 expression in the morula, the ICM, ESCs and PGCs (Okazawa et al., 1991; Yeom et al., 
1996). The distal enhancer of Oct4 is bound by many transcription factors already associated 
with the pluripotency network, including Oct4 itself, Sox2, Nanog, Sall4, Tcf3, Smad1, 
Stat3, Esrrb, Klf4, Klf2, Klf5, E2f1, n-Myc, and Zfx (Chen et al., 2008a; Chew et al., 2005; 
Ng and Surani, 2011). Those regulatory elements are hypomethylated in ESCs and highly 
methylated in trophoblast and other differentiated cell types. Given its ability to reprogram 
somatic cells, it is essential that it remains off in differentiated cell types and it is therefore 
usually found sequestered away in heterochromatin (Deshpande et al., 2008; Feldman et al., 
2006; Li et al., 2007a).   
 
Oct4 is also post-translationally modified, although the significance of these 
modifications has yet to be shown. Post–translational regulation of Oct4 protein is mediated 
by phosphorylation, the addition of monosaccharide O-linked -N-acetylglucosamine (O-
GlcNAc), ubiquitination and sumoylation (Jang et al., 2012; Saxe et al., 2009; Wei et al., 
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Figure 1.7 Transcriptional network of Oct4 and regulation of Oct4
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Section 1.7 Introduction to vertebrate evolution: relevance to gene 
regulatory network, pluripotency and germ cell specification 
  
1.7.1 Introduction to vertebrate evolution (Figure 1.8) 
 
 All chordates possess shared characters that include a hollow neural tube dorsal to a 
notochord, pharyngeal gill slits, an endostyle, and a post-anal tail. While these features may 
not be ubitquitous, they are all present at some point in the organisms’ life cycle. The 
presence of these characteristics is requisite for the membership of the groups. Animals in 
phylum Chordata include tunicate (salps, sea squirts), cephalochordate (lancelets or 
amphioxus) and vertebrates. Vertebrates have also evolved a complicated gene regulation 
that enables them to produce complex and novel morphologies including neural crest and 
their derivatives, neurogenic placodes, elaborated segmented brain, and endoskeleton 
(Shimeld and Holland, 2000). The phylum Vertebrata includes several evolutionary clades 
that mostly diverged by the Precambrian and Paleozoic Eras (600-360 Mya), see figure 1.8 
(Hedges and Kumar, 2009). The vertebrates can be broadly divided into (1) the organisms 
lacking a hinged jaw, termed as agnathans (cyclostomes) including lamprey and hagfish, and 
(2) the organisms with hinged jaw, termed as gnathostomes including cartilaginous fish 
(chondrichthyes), and bony vertebrates (osteichthyes). Below are listed the different 








(1) Cyclostomota: jawless fish (agnathans) including lamprey and hagfish,  
(2) Gnathostomata: 
(2.1) Chondrichthyes: cartilaginous fish including sharks, rays and chimaeras,  
        (2.2) Osteichthyes: 
 (2.2.1) Actinopterygii: ray-finned fish including bichirs, sturgeons,  
paddlefish, gars, bowfins, and teleost fish  
(2.2.2) Sarcopterygii 
(2.2.2a) Actinistia: coelacanths  
(2.2.2b) Dipnoan: lungfish  
(2.2.2c) Tetrapoda 
(a) Lissamphibia: frogs, toads, salamanders, and caecilians  
(b) Amniota: mammals, tuataras, squamates (lizards,  
snakes, and amphisbaenians), turtles, crocodilians, and birds. 
 
Here I summarise the detail of each clade that are relevant to this thesis and the classification 
and timescale are based on the review of (Hedges and Kumar, 2009). 
 
(1) CYCLOSTOMATA: jawless vertebrate 
  
 Cyclostomata comprises the two extant jawless fish orders: (1) Myxinidae: hagfish 
and (2) Petromyzonidae: lampreys, representing the most basal lineage of vertebrates. Both 
lampreys and hagfish belong to this group because the presence of a jawless mouth armed 
with retractable horny teeth and the lack of numerous key traits of gnathostomes, including 
the paired fins/limbs and a mineralised skeleton. Unlike lamprey, the adult form of hagfish 
lack some phenotypic traits of vertebrates including vertebrae, heart innervation and eye 
lens, suggesting jawed vertebrates are more closely related to lampreys than to hagfish. 
However, recent studies on the craniofacial development of hagfish and lamprey embryos 
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confirms that there are pan-cyclostome patterns of development that are not shared by jawed 
vertebrates (Oisi et al., 2013). This embryological data combined with other morphological 
and molecular evidence strongly support the monophyly of these cyclostome’s orders and 
suggest that the deviated traits of hagfish are just secondary losses in this lineage (Oisi et al., 
2013; Shimeld and Donoghue, 2012). 
 
 Lamprey and hagfish have been studied in order to understand the origins of 
vertebrate patterning in evolution and in particular the origin of gnathostomes. The 
developmental biology of lampreys has been studied in two lamprey species including sea 
lamprey and Japanese lamprey, which account for the majority of lamprey studies. In 
addition, both have complete genome assemblies. Hagfish eggs are more difficult to find and 
until now there has been no available hagfish genome assembly. As a result, the embryo 
studies in this basal group of vertebrate are limited to mostly lamprey (Shimeld and 
Donoghue, 2012). The genome assemblies of lampreys reveal some interestingly uncommon 
events called programmed genome rearrangement (PGR). PGR is the irreversible process of 
elimination of portions of chromosomes (chromosome diminution) or the loss of entire 
chromosomes (chromosome elimination) during embryonic development. PGR events 
happen only in somatic cells; thus the somatic genome is different from the germline genome 
in species that have PGR. In lampreys, PGR occurs at mid-blastula stage (MBT), which is 
the beginning of zygotic transcription. Hence, cells in early cleavage and blastula stages are 
the only somatic cells that have the same genome to that of the germline. This PGR is also 
found in hagfish, leading to the idea that this event is conserved in cyclostomes (Sémon et 






(2) GNATHOSTOMES: jawed vertebrates 
 
Features distinguishing gnathostomes from cyclostomes include (1) the presence of 
pair appendages (pelvin fins and pectoral fins in fish, limbs in terapods) and (2) extensive 
neural crest-derived and mineralised dermal skeleton, and (3) immunoglobin-based adaptive 
immunity (Shimeld and Donoghue, 2012; Venkatesh et al., 2014). Gnathostomes are 
comprised of two major clades: Chondrichthyes (cartilaginous fish) and Osteichthyes (bony 
vertebrates). 
 
(2.1) CHONDRICHTHYES: cartilaginous fish 
 
Extant Chondrichthyes or cartilaginous fish comprises two subclasses; (1) 
Holocephalii: ratfish, rabbitfish, and elephantfish and (2) Elasmobranchii: sharks, rays, 
skates, sawfish, and guitarfish. Unique characteristics of cartilaginous fish that differ from 
Osteichthyes are (a) the possession of a skeleton of cartilage, (b) internal fertilization via 
modified male pelvic fins (claspers), (c) possession of placoid (tooth like) scales, and (d) 
heterocercal tail fin in many lineages. Based on evidence from morphological and molecular 
analysis, the monophyly of Holocephalii and Elasmobranchii is well supported (Arnason et 
al., 2001; Mallatt and Winchell, 2007).  
 
(2.2) OSTEICHTHYES: Bony vertebrate  
 
After splitting from the chondrichthyan lineage, the osteichthyan ancestor evolved to 
have a highly complex process of endochondral ossification. This is likely the result of a 
tandem gene duplication of genes in the secretory calcium binding phosphoprotein (SCPP) 
family (Venkatesh et al., 2014). Osteichthyes are comprised of five clades: Actinopterygii, 
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Actinistia, Dipnoi, Lissamphibia, and Amniota. The first three are bony fish and the latter 




Extant Actinopterygii or ray-finned fish diversified in the lower Denovian (416-397 
Mya) and consist of five major clades that had diversified by the end of the Carboniferous 
(300 Mya). These five clades include: (1) Polypteriformes: bichirs, (2) Acipenseriformes: 
sturgeons and paddlefish, (3) Lepisosteiformes: gars, (4) Amiiformes: bowfin, (5) Teleostei: 
zebrafish, medaka, puffer. Based on molecular and morphological data, the relationship 
between these five fish clades is controversial, in particular whether (1), (2), (3), and (4) 
form an ancient fish clade or the monophyletic Holostei of gars and bowfin (Broughton et 
al., 2013; Hurley et al., 2007).  
 
Teleostei are the most species rich and diversified group of all vertebrates. Teleostei 
is typically grouped together with Lepisosteiformes and Amiiformes to form the subclass 
Neopterygii. There are four subdivisions of extant teleosts: (1) Osteoglossomorpha (e.g. 
mooneyes and bonytongues) (2) Elopomorpha (e.g. eels, tarpons and bonefish) (3) 
Otacephala (e.g. ostariophysan and clupeomorph teleosts) (4) Euteleostei, the remaining 











 (2.2.2a) Actinistia  
 
Actinistia is a subclass of mostly lobe-finned fish identified in the fossil record. 
There are only two extant species of this subclass including West Indian Ocean coelacanth 
(Latimeria chalumnae) and the Indonesian coelacanth (Latimeria menadoensis). These fish 
are closer relatives of lungfish and tetrapods than actinopterygians (Amemiya et al., 2013; 
2014). It has been held for long time that the most exciting feature of this fish is its 
prehistoric appearance, which resembles fossils of their ancestors that date back at least to 
the early Denovian period around 400 Mya (Johanson et al., 2006). This leads to the idea 
that coelacanth is a very slowly evolving vertebrate lineage and is commonly mentioned as a 
potential “living fossil.” However, the concept of “living fossil”, “basal lineage” and 
“primitive extant species” has been challenged in the field of evolution. Didier Casane and 
Patrick Laurenti recently reviewed numerous coelacanth studies and concluded that 
coelacanth should not be mentioned as a living fossil, based on some growing controversial 
points e.g. low intra-specific molecular diversity, low substitution rates and morphological 
stability of coelacanth (Casane and Laurenti, 2013). The studies of Chris Amemiya and 
colleagues provide some insight into how coelacanth protein coding genes might evolve. 
They examined 251 protein coding genes of coelacanth compared to their orthologs in 22 
vertebrates including cartilaginous fish, teleosts, amphibians, birds, reptiles and mammals, 
and found that coelacanth has a relatively slow rate of protein evolution, compared to other 
vertebrates (Amemiya et al., 2013). This leads to the idea that coelacanth might be a good 
reference point for studying the evolution of protein structure. In addition, genome-wide 
analysis of coelacanth (Latimeria chalumnae) provides insight into the genes and regulatory 
elements that changed during the transition from water to land in the tetrapod ancestor. 
Coelacanth gene classes absent in tetrapods include fin development, otolith, ear 
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development, kidney development, trunk and tail development. However, a significant 
number of homeobox genes (e.g. LIM, POU, TALE, ZF, HNF) responsible for the body plan 
show only minor variation when coelacanth is compared to ray-finned fish and tetrapods, but 
the number of these genes is approximately doubled when compared to amphioxus. Thus, 
during this transition, genes unnecessary for land survival were deleted, while tetrapods 
retained the key early developmental programs (Amemiya et al., 2013).  
 
(2.2.2b) Dipnoi  
 
Lungfish are living representatives of the Subclass Dipnoi, which belongs to one of 
extant Sarcopterygii, along with tetrapods and coelacanths. Lungfish are further subdivided 
in to three families: (1) Lepidosirenidae: South American lungfish, (2) Protoperidae: African 




Tetrapods are composed of two major groups: amphibians (frogs, axolotl and 
caecilians) and amniote (reptiles, birds and mammals). Non-amniote tetrapods lay eggs into 
aquatic environments, similar to teleost fish. Their early embryonic body plans develop 
quickly after fertilization and the embryo’s nutritional source is from intracellular yolk. The 
successful transition to a completely terrestrial environment in amniotes is part of a 
revolution in embryonic development that involved the development of extraembryonic 
tissues and the presence of an egg shell (reptiles, birds and monotremes). In particular, 
hypoblast/primitive endoderm is one of the amniote innovations although some of the gene 
regulatory network specifying PrEN is found in deep anterior endoderm of frog embryos and 





Amphibia are subdivided into three subclasses: Labyrinthodontia, Lepospondyli and 
Lissamphibia. Only the latter subclass comprises all modern amphibians. Lissamphibians 
can be further divided into three distinct orders: (1) Caudata/Urodela: salamanders and 
newts, (2) Anura: frogs and toads, and  (3) Gymnophiona/Apoda: caecilians. Based on 
phylogenetic analyses, Caudata and Anura are grouped in the clade Batrachia, which is 




 The Amniota comprises six terminal taxa: (1) Testudines: turtles, (2) Sphenodontia: 
tuatara, (3) Squamata: lizards and snakes, (4) Crocodylia: alligators and crocodiles, (5) Aves: 
birds, and (6) Mammalia: mammals. The relationships between these taxa are not entirely 
clear, several conflicting lines of evidence influence the nature of Amniota phylogeny.  In 
particular Testudines complicate things. Based on early examinations of the mammalian and 
reptile skull, these taxa were classified based on holes or openings near the temples, termed 
temporal fenestra. The skull of turtles appeared to lack these fenestra (animals with this trait 
were referred to as Anapsids) and as a result were classed as a more primitive taxa. Other 
species appeared to have evolved to have one temporal fenestra in Synapsids (or theropsids, 
mammals) and two fenestra in Diapsids (crocodiles, lizards, snakes, tuatara and birds). Thus, 
this morphology of skull had originally placed turtle as paraphyletic group to mammals and 
birds (Gauthier et al., 1988; Lee, 1993; Lyson et al., 2010). However, there is now growing 
evidence based on in-depth molecular data that has prompted a re-evaluation of classification 
based on the skull morphology of reptiles. This alternative view places turtles closer to birds 
and crocodiles and suggests that turtles underwent a secondary loss of skull fenestration or a 
reversal to an ancestral condition in turtles (Chiari et al., 2012; Crawford et al., 2012; Wang 
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et al., 2013b). The study of Hugall et al., 2007 based on phylogenetic analysis of long 
nuclear gene RAG-1 provides additional evidence to place turtles closer to a monophyletic 
Archosauria (groups of Aves and Crocodylia, including extinct dinosaurs) (Hugall et al., 
2007). Based on a combination of fossil calibration together with molecular data, the 
molecular time estimates predict that turtles diverged from archosauria in the early Triassic 
around 230 Mya and crocodylia later split from birds around 220 Mya (Kumar and Hedges, 
1998; Paton et al., 2002). Squamates and tuatara diverged earlier around 270 Mya (Hugall et 
al., 2007). 
 
The mammalian ancestor probably diverged from reptiles some 320-350 Mya 
(Carboniferous period) (Blair and Hedges, 2005; Pereira, 2006). Mammals would have 
evolved alongside dinosaurs during the Mesozoic era and continued to evolve following the 
mass extinction that wiped out the dinosaurs in the Cretaceous-Paleocene mass extinction 
some 65 Mya, that opened new ecological opportunities.  Mammal species radiation has 
expanded ever since, making this lineage one of most successful vertebrates showing great 
eco-morphological specialization (Luo, 2007). Mammals consist of three major clades: 
Monotremes (Prototherian mammals, e.g. platypus), Marsupials (e.g. tammar wallaby, 
Tasmanian devil, koala, opossums, wombats), and Eutherian (e.g. mouse, human). 
Marsupials and Eutherians together form a clade called Therian. All mammals have the 
following features: the presence of homeothermy, lactation and hair. The key characteristics 
of monotremes are the presence of venom, electroreception, meroblastic cleavage, oviparity 
and a unique reproductive system with combined reptile/bird and therian features, while 
those of therians are the presence of holoblastic cleavage, placentation, viviparity, testicular 
descent and trophectoderm (Frankenberg et al., 2013; Warren et al., 2008). Key features of 
Marsupials are the presence of pouch, short gestation and prolonged lactation. The placenta 
of marsupials does not support much fetal growth as it does in eutherians. Marsupial infants, 
called joey, are born in fetal state and have to make their own way to mothers pouch to 
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receive nutrient via a teat. Eutherians have prolonged gestation, in which embryos develop 
inside their mother’s for longer periods of time. The novel traits of the eutherian lineage 
include the emergence of novel structures in pre-implantation development including an 
inner cell mass (Warren et al., 2008) and probably better supportive trophectoderm. The 
combination of these novel mechanisms might have facilitated the extremely successful 
radiation of eutherian lineages on Earth.  
  
 Living eutherians or placental mammals consist of four major groups of orders: 
Afrotheria, Xenathra, Euarchontoglires, and Laurasiatheria. The former two are Gondwanan 
origin and form a clade called Atlantogenata. The latter two are Laurasian origin and form a 
clade called Boreoeutheria. Fossil records reveal that eutherian mammals originated in the 
early Cretaceous around 125 Mya (David Archibald, 2003; Ji et al., 2002). Four major clades 
of eutherians form a monophyletic group and each clade contains subdivisions into several 
orders as follows: 
 
 (a) Afrotheria can be further subdivided into 6 orders: Macroscelidea (e.g. cape 
elephant shrew), Afrosoricida (e.g. tenrec, golden moles), Tubulidentata (e.g. aardvark), 
Proboscidea (e.g. elephant), Hyracoidea (e.g. hyrax or shrewmouse or dassy), and Sirenia 
(e.g. manatee or sea cow). 
 
 (b) Xenathra consists of extant placental mammals including anteater, tree sloths, 
and armadillos. Based on divergence time estimates, it has been found Xenathra have 
diverged from Afrotheria around 100 Mya which is coincident with the separation of Africa 
and the South American continent (David Archibald, 2003; Murphy et al., 2007). It is still 
debated whether Afrotheria or Xenathra is the basal placental lineage. Many traits of 
Xenathra are not found in other eutherians e.g. extra articulations in vertebral joints, 
ischiosacral fusion, and internal testicles. 
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 (c) Euarchontoglires consists of five orders: Rodentia (e.g. mouse, deermouse, 
jerboa, hamster, squirrel, mole rat), Lagomorpha (e.g. rabbit, pika), Primates (e.g. human, 
monkey), Dermoptera (e.g. colugos or flying lemur), and Scandentia (e.g. treeshrew).  
 
 (d) Laurasiatheria consists of six orders: Carnivora (e.g. ferret, cat, tiger, dog, 
walrus, seal), Pholidota (e.g. pangolin), Perissodactyla (e.g. horse, rhinoceros), Chiroptera 
(e.g. bats), Cetartiodactyla, and Eulipotyphla. Cetartiodactyla can be further divided into two 
clades: Artiodactyla (e.g. antelope, alpaca, sheep, pig, buffalo, goat, cow, wild yak) and 
Cetacea (e.g. whale, dolphin). Eulipotyphla is composed of four further families: 
Solenodontidae (e.g solenodons), Erinaceidae (e.g. hedgehogs, gymnures), Talpidae (e.g. 
desmans, moles, shrew moles) and Soricidae (e.g. true shrews). Both Talpidae and Soricidae 
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(adapted from Hedges and Kumar 2009)
Figure 1.8 Evolution of vertebrates The figure is adapted from Hedges and Kamar 2009. The numbers in each node are refered to 
divergence time in table 3.1  Abbreviations: C (Carboniferous), Cm (Cambrian), CZ (Cenozoic), D (Devonian), J (Jurassic), K (Cretaceous), Np 











1.7.2 Origin of vertebrates 
 
The origin of vertebrates has been associated with elemental embryological 
innovation and genome duplication (Donoghue and Keating, 2014). According to recent 
models, two ancient whole genome duplications (WGD) are responsible for the expansion of 
the regulatory gene repertoire in vertebrates (e.g. HOX cluster, TGF-β signaling, FGF 
signaling, insulin receptors, nuclear receptors, neural crest genes etc). In other areas of 
evolution WGDs have also been suggested to drive the emergence of rich transcription factor 
repertoires in some plants, fungi and protozoa (de Mendoza et al., 2013). The increase in 
gene complexity driven by WGDs facilitates species diversification and faster adaptation to 
novel conditions, increased biological complexity and provides an origin for evolutionary 
novelties (Van de Peer et al., 2009). Following WGD, the fate of individual genes is not 
always clear. According to Ohno’s classical view, one member of a pair of duplicated genes 
sustains the original function while its paralog loses function (non-functionalization) or 
acquires new functions (neo-functionalization). In the DDC (Duplication, Degeneration, 
Complementation) model, a third possible outcome is suggested, that the ancestral structural 
and regulatory subfunctions of a parental single-copy gene are partitioned into two duplicate 
genes (subfunctionalization), leading to the subsequent preservation of both paralogs 
(Cañestro et al., 2007).  
 
 Based on the identification of genomic-wide sets of putative regulatory regions for 
five vertebrates (human, mouse, cow, stickleback and medaka), three broad trends of 
regulatory innovation were found that provide a stepwise account of vertebrate evolution. 
The first period involved the innovation of novel regulatory networks, interfacing and 
modifying the regulatory elements of transcription factors and key developmental genes and 
this likely occurred during the evolution of early vertebrate ancestors and continued until the 
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divergence of the mammal lineage from birds and reptiles (around 300 MYA). A second 
stage began between 300-100 MYA and involved perturbations of receptor and extracellular 
signaling interactions to gain novel signaling networks, although the changes to 
transcriptional regulation had begun to decline during this period. The third period is found 
in placental mammals, when regulatory innovation for genes implicated in post-translational 
protein modification increases while the first two trends in innovation (signaling and 
transcription) decrease to the background levels (Lowe et al., 2011).  
 
1.7.3 Evolution of core pluripotency in vertebrates 
 
 Oct4, Sox2, and Nanog (OSN) and the other transcription factors regulating 
pluripotency have evolved based on their roles in development. Thus OSN have different 
roles in different compartments of the vertebrate embryo, following the principles of 
“Mosaic pleiotropy” and “Heterotopy”. Mosaic pleiotropy means that the same proteins 
contribute to different developmental processes and body structures, while Heterotopy 
means that changes in spatial regulation are associated with morphological divergence. 
Conserved domains such as the HMG-box (in Sox2) and POU domain (in Oct4) are found 
across metazoans, but thought to have originated deep in unicellular eukaryotic evolution (de 
Mendoza et al., 2013). The interaction of POU-SOX proteins is also ancient and a part of 
ancestral genetic complexity involved in bilaterian development (e.g. Hydractinia, planaria, 
fruit flies and vertebrates). In Hydractinia, its POU protein is called Polynem (Pln) and it 
functions as a block to differentiation in the i-cells, the progenitor population capable of 
differentiation into somatic and germ cells. Interestingly, Pln has the capacity to re-establish 
a “stem cell-like,” state when reintroduced into differentiated epithelial cells (Millane et al., 
2011; Plickert et al., 2012). This could reflect the conserved roles of POU proteins in the 
maintenance and establishment of progenitor cell phenotypes in the animal kingdom. In this 
thesis, evolution of POU proteins, in particular POUV/Oct4 is described in more detail 
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(section 1.8, chapter 3 and chapter 4). Moreover, Nanog might also be a vertebrate 
innovation, originating with the Bsx gene family at early vertebrate evolution. Surprisingly, 
Cephalochordate Bsx is incapable of replacing mouse Nanog in murine cellular 
reprogramming, indicating that the gene regulatory network that supports naïve pluripotency 
might come from developmental innovations that originate at the beginning of vertebrate 
evolution (Theunissen et al., 2011). Identification of a naïve pluripotency toolkit in jawless 
vertebrates (e.g. lamprey and hagfish) might help provide an understanding of why the gene 
regulatory network supporting naïve pluripotency first emerged and why.  
 
1.7.4 The evolution of germ cell specification 
 
Germ cells give rise to both the sperm and oocyte, which enable the transfer of 
genetic information from one generation to the next and as a result germ cells themselves 
have significant roles in evolution. In the animal kingdom, a review of 28 taxa (Extavour, 
2003) of both invertebrates and vertebrates, indicate that their germ cells have a lot of gene 
expression in common. For example, two key germ cell determinants, Nanos and Vasa, are 
conserved in flies, worms, frogs, fish, chicken, and mammals. This suggests that all 
organisms in the animal kingdom retain the ancestral machinery for germ cell specification. 
There are two distinct modes for germ cell development: preformation or the predetermined 
mode and epigenesis or the inductive mode.  Predetermined modes of germ cell specification 
rely on the localization of maternally inherited determinants as germ plasma to drive germ 
cell specification. Inductive modes for germ cell specification employ integrative signaling 
from surrounding tissues for the specification of PGCs during gastrulation. While less 
common, it appears that the inductive mode is ancestral trait, while preformation is a 
secondary derived trait. There is little evidence of reversion of performation to epigenesis in 
any of the branches of the animal kingdom (Extavour, 2003). In this thesis, I explore the 
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activity of POUV proteins in vertebrates and how that activity might be related to germ cell 
specification; hence, here I summarise the recent findings regarding the mode of germ cell 
specification observed amongst several vertebrate taxa below: 
 
a) Inductive mode of germ cell specification 
 Cyclostomata (lampreys and hagfish), Dipnoi (lungfish), Urodeles (axolotl), 
Testudines (turtles), Monotremes (platypus), Marsupials (tammar wallaby), Eutherians 
(mouse and human)  
 
b) Predetermined mode of germ cell specification 
 Actinopterygians (sturgeon, zebrafish, medaka), Anura (frogs), Archosauria (birds 
and crocodiles) 
 
Germ cell specification in some vertebrate taxa is still controversial, including 
cartilaginous fish and other reptiles. Andrew Johnson and colleagues (Bachvarova et al., 
2009) suggest that the PGCs of snake are observed at the onset of gastrulation in the lower 
hypoblast layer similar to chicken, thus snake might have a predetermined mode. While 
lacertoids exhibit localization of their PGCs similar to that observed in turtle, suggesting an 
inductive mode. But these inferences are based only on the location of PGCs at later stages 
and implies that future work needs to be done to resolve the different stages of PGC 







Section 1.8 Evolution of Oct4 homologs in vertebrates 
 
1.8.1 Identification and the origin of vertebrate Oct4 homologs (Figure 1.9) 
 
Available genome assemblies across several classes of vertebrate species enable a 
comparison of class V POU proteins in different species, as there are not many members of 
this category of POU domain protein, it is relatively straight forward to assign orthologous 
and syntenic relationships. Two types of orthologous families of POUV genes have been 
identified, namely POU5F1 and POU5F3 (Frankenberg and Renfree, 2013). Both genes are 
believed to have originated as a result of a single genome duplication; hence POU5F1 is 
paralogous to POU5F3 and vice versa. The flanking genes of all vertebrate POU5F3 are 
NPDC1 and FUT7. In the coelacanth and turtle genomes, their POU5F1 genes are flanked 
by the paralog of NPDC1, namely NPDC1L (NPDC1-like), indicating that the original 
duplication giving rise to POU5F1 and POU5F3 was multigenic and presumable occurred 
sometime in early vertebrate evolution. Frankenberg et al 2013 examined the conservation of 
NPDC1 and NPDC1L to locate POUV genes in the available vertebrate genomes. They 
found that some vertebrates including coelacanth, turtle, axolotl, monotremes, and 
marsupials retain both POU5F1 and POU5F3 genes. Birds and crocodiles have lost the 
POU5F1 gene, indicating the extinction of POU5F1 might be common in all archosaurians 
(including dinosaurs).  Frogs, but not axolotl, lost pou5f1, but in this case, pou5f3 has 
undergone further tandem gene duplication, giving rise to three paralogs: xlpou91 
(pou5f3.1), xlpou25 (pou5f3.2) and xlpou60 (pou5f3.3). The absence of POU5F3 in both the 
genomes from various lizards and snakes also indicates a single extinction event in a 
common ancestor of squamate reptiles. During early mammal evolution, NPDC1L was 
deleted and POU5F1 was instead flanked by DDX39B. This pattern persists in monotremes 
while the therian ancestor underwent further addition of H2 major histocompatibility 
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complex between POU5F1 and DDX39B. Finally, the POU5F3 gene was eliminated from 
the eutherian ancestor. 
 
 The presence of both POUV paralogs in the coelacanth genome led to the previous 
view that POU5F1 originated from genome duplication in a sarcopterygian ancestor; 
however, putative chondricthyan POU5F1 and POU5F3 were recently identified using the 
genomic location and conservation of NPDC1 and NPDC1L genes. Partial sequence for both 
POUV genes was found in the little skate genome while only the POU5F3 gene is found in 
the elephantfish genome. This suggests that the origin of POU5F1 occurred at least as early 
as a gnathostome ancestor. Recent views of vertebrate evolution support this, as the current 
2R hypothesis argues that two rounds of whole genome duplication occurred during early 
vertebrate evolution and this may explain the origin and duplication of POUV genes. It is 
well accepted that urochordates, not cephalochordates, are sister group to vertebrates or 
closest living relatives to vertebrates (Delsuc et al., 2006). The first round of genome 
duplication probably occurred after the split between urochordates and vertebrates and the 
second appears to occur prior to gnathostome radiation (osteichthyan-chondrichthyan split) 
or after the split between gnathostomes and cyclostomes. However, the accurate timing of 
second duplication relative to the gnathostome-cyclostome split remains ambiguous 
(Holland et al., 2008; Kuraku, 2008; Kuraku et al., 2009). It is unclear which of the ancient 
whole genome duplications was responsible for the birth of POU5F1 and POU5F3.  
Identification of POUV-like genes among jawless vertebrates (e.g. lamprey and hagfish) 
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1.8.2 Comparative early vertebrate embryogenesis and relevance to 
expression of Oct4 homologs  
 
a) Medaka fish versus zebrafish (Figure 1.10A) 
 
Medaka fish and zebrafish belong to the families Cypriniformes and Beloniformes, 
which diverged during early teleost fish evolution about 250-300 MYA (Yamanoue et al., 
2006). Both fish have similar early embryonic development. Their oocytes have a large 
amount of yolk and after fertilization the blastomeres divide on the top of the yolk, so called 
meroblastic cleavage. The large yolk region is formed based on cytoplasmic segregation of 
yolk and as a result of early meroblastic cleavages producing a single yolk cell with 
embryonic blastomeres on top. The first embryonic movements begin at the blastula stage.  
At this point the embryo contains three distinct cell types, an epithelial monolayer on top of 
the embryo known as the enveloping layer (EVL), deep cells of the blastoderm (DEL) are 
located underneath these and then a large multinucleated yolk known as the yolk syncytial 
layer (YSL). Radial intercalation of the DEL leads to epibody movements and production of 
the embryonic epiblast. At the same time (512 cells) zygotic transcription is initiated. These 
epiboly movements eventually result in the embryonic cells completely surrounding the yolk 
cell. The descendants of the DEL cells will make up all the germ layers and the EVL only 
periderm. Gastrulation occurs at 50% epiboly with the formation of a marginal region 
referred to as the marginal ring that is the equivalent to the PS. DEL cells involute through 
this region to make the mesoderm and endoderm, and shortly after the onset of these 
movements, a thickening at one side of the embryo produces the embryonic shield, the fish 
equivalent of the node in mouse (Grubb, 2006). Neurulation, and organogenesis of both fish 
are also well conserved and are quite well conserved with other vertebrates. Germ cell 
specification in both zebrafish and medaka fish is based on a predetermined mode of 
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specification (presence of germ plasm), similar to other actinopterygian fish (Ijiri et al., 
1996; Iwamatsu, 2004). 
 
Zebrafish Pou5f3 (Spg2/Pou2, here I referred to as Drpou5f3) and medaka fish 
Pou5f3 (Medaka Oct4, here I referred it as Olpou5f3) are true orthologs of other vertebrate 
POU5F3 (Frankenberg and Renfree, 2013). Both fish POUV proteins localise to all cells of 
blastomeres at cleavage stage and are later restricted to the epiblast and marginal ring during 
gastrulation. Both fish Pou5f3 proteins are later restricted to the posterior tip of the 
embryonic body (Belting et al., 2001; Sánchez-Sánchez et al., 2009; Takeda et al., 1994). 
However, there are also some different features of the Pou5f3 expression and function in 
PGC biology and brain development between zebrafish and medaka fish. In zebrafish, 
Drpou5f3 is expressed at the midbrain-hindbrain boundary (MHB) where it is required for 
the establishment and maintenance of progenitors in this region, regulating their competence 
to respond to Fgf8 (Belting et al., 2001; Reim and Brand, 2002). It is also expressed in the 
anterior neural plate early during neural induction (Belting et al., 2001). Similar expression 
patterns of POU5F3 during MHB formation have been shown in Xenopus (Xlpou25), axolotl 
(AmPOU5F3) chick (GgPOU5F3) embryos (Cao, 2004; Lavial et al., 2007; Tapia et al., 
2012).  Unlike zebrafish, Olpou5f3 is expressed in PGCs, undifferentiated spermatogonia 
and germ plasm of the oocyte, but not detected at MHB (Belting et al., 2001; Sánchez-
Sánchez et al., 2009; Takeda et al., 1994). Zebrafish Pou5f3 has also been shown to be 
important for the initiation of zygotic transcription and this is unlikely to be conserved in 
mammals, as Oct4 is not expressed at the 2C stage, the point at which the zygotic genome is 
activated in mouse. 
 
It’s noteworthy that bichir (Polypterus) and sturgeon (Acipenser) undergo 
holoblastic cleavage, similar to Xenopus. Thus these fish exhibit complete cleavage of the 
early blastomere segregating yolk and animal cytoplasm at the same time until the first 
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horizontal cleavage events. These fish lineages diverged from teleost fish prior to a teleost 
specific WGD (Takeuchi et al., 2009), suggesting that the expression and function of 
different POUV proteins in these species might resemble that found in frogs and axolotl.  In 
addition, transitional species on the way to teleosts, but still prior to the WGD like gar 
(Lepisosterus) and bowfin (Amia) display the transitional forms of cleavage from a 
holoblastic to meroblastic type. Perhaps these species could shed light on the evolution of 
the teleost Pou5f3 activity that has lost some functional activity when it is tested for its 
capacity to support murine ESCs in place of Oct4 (described in detail below). 
 
b) Axolotl versus frog (Figure 1.10B, C) 
 
Most frogs and salamanders undergo holoblastic cleavage, which is the primitive 
form of cleavage (also found in lamprey and echinoderm) (Takeuchi et al., 2009). The 
fertilised egg already contains yolk localised to what is referred to as the vegetal hemisphere. 
Cells in the upper, non-yolky, animal hemisphere will produce the ectoderm and mesoderm. 
As amphibians possess large amounts of yolk which is an impediment to the cleavage, 
cleavage occurs asymmetrically (so called unequal holoblastic cleavage), producing a 
morula with small animal cells and larger yolky vegetal cells. The cells on the future dorsal 
side are smaller and also tend to cleave faster. By the 128-cell stage the amphibian embryo 
starts to form a blastocoel in the centre of the animal hemisphere and zygotic transcription 
initiates around the 10-12th cleavages at the mid-blastula transition. Gastrulation begins as a 
result of the marginal zone (analogous to the PS in the mouse) involuting through the dorsal 
blastopore and migrating up and inside the blastocoel. The structure formed at the beginning 
of gastrulation at the edge of where the dorsal blastopore will form, is the organiser, and can 
induce secondary axis formation in heterotropic grafting experiments (Hamburger, 1988).  
This structure is the equivalent to the node in amniotes and shield in fish. As in zebrafish, 
involution expands from the initial site on the dorsal side to involute the entire marginal zone 
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or the circumference of the embryo. In Xenopus, the lineage fate is determined very early 
and fates can be mapped at either the 32-cell stage or the blastula (Moody, 1987). As in 
mouse, the first cells to involute will form the anterior endoderm and prechordal plate, then 
notochord.  The location of cells relative to the site of involution prior to gastrulation will 
determine their fate (Grubb, 2006; Zorn and Wells, 2009).  
 
Axolotl has two Oct4 homologs and here I refer to them as AmPOU5F1 and 
AmPOU5F3. Both proteins localise to animal and marginal zones of the gastrulating 
embryo, which is thought to be an equivalent structure to post-implantation epiblast and PS 
in the mouse embryo. Interestingly, both homologs are also found in the gonad. Only 
AmPOU5F3 protein was expressed in the MHB during brain regionalization, similar to 
zebrafish Pou5f3 (Tapia et al., 2012).  
 
In Xenopus, the frog ancestor lost pou5f1 and retained only pou5f3. However, 
pou5f3 underwent further tandem gene duplication, giving rise to three paralogs in the same 
genomic region: xlpou25 (pou5f3.2), xlpou91 (pou5f3.1) and xlpou60 (pou5f3.3).  
 
Xlpou60 is expressed maternally and its transcript is localised to the animal 
hemisphere in unfertilised oocytes and during early cleavage stages up to MBT. Its 
expression remains in the animal hemisphere and marginal zone of the embryo until early 
gastrulation (Morrison and Brickman, 2006).  
 
Xlpou25 is expressed and peaks during gastrulation. Like Xlpou60 it is localised to 
the animal and marginal zones of the embryo. Later Xlpou25 is found in MHB during brain 
regionalization and the posterior tip of the neural tube, similar to zebrafish Pou5f3 (Cao, 
2004; Hinkley et al., 1992). Xlpou25 is also expressed in the anterior neural plate during the 
early phase of neural induction.  
67
 
Xlpou91 is first activated in the animal and marginal zones during mid-blastula stage 
(onset of zygotic transcription), but not as highly as Xlpou25. Interestingly, only Xlpou91 is 
strongly expressed in PGCs at neurula stage when PGCs initiate zygotic transcription, 
suggesting the role of Xlpou91 in PGC biology equivalent to other PGC-specific POUV 
homologs (Venkatarama et al., 2010). Otherwise its expression is identical to Xlpou25. 
Either Xlpou25 or Xlpou91 is required to maintain the MHB region and to sustain the 
expansion of the forebrain region (Morrison and Brickman, 2006). 
 
c) Chicken (Figure 1.10D) 
 
Chicken embryos develop from a disc of cytoplasm sitting on top of a massive yolk.  
From fertilization to laying takes approximately 20 hours during which a lot of 
developmental changes take place.  Early meroblastic incomplete cleavages produce cells 
that remain open to the yolk. By the end of cleavage generating a disc of cells, the 
blastoderm, is generated sitting on top of the yolk. In the centre, this disc is thick with up to 
six layers of cells and these deeper cells are shed into the subgerminal cavity (that separates 
the blastoderm from the yolk) leaving a single layer known as the area pellucida, that will 
make the majority of the embryo. At the edge of the area pellucida, where cells were not 
shed, is the area opaca and the cells between the two regions of the blastoderm are known as 
the marginal zone. Cells at the posterior edge of the blastoderm in the region of a structure 
known as Koller’s sickle grown under the blastoderm at the same time as isolated epiblast 
cells delaminate from the area pellucida, and these two populations will join to make the 
hypoblast (chick equivalent of VE). There are now two layers, an upper layer, from which 
most of the embryo will be derived, referred to as epiblast and lower extra-embryonic 
endoderm layer, the hypoblast. The area between these layers is the blastocoel and they are 
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joined at their edges by the area opaca. Thus while the geometry of the embryo is different 
the principles are the same as other vertebrates. 
 
Gastrulation in the chick begins with the formation of the PS just anterior of Koller’s 
sickle.  Epiblast cells migrate towards the PS, undergo EMT and migrate along the underside 
of the epiblast, initially mixing with the hypoblast, but later sorting out, so that the ingressing 
endoderm forms the embryo and the hypoblast forms the yolk sac.  At the anterior end of the 
PS, a structure known as the Hensen’s node forms. It has the same function as the node in 
mouse and is similar to the organiser in amphibian, or shield in fish. Similar to teleost fish 
and frogs, chicken germ cell specification is based on maternally deposited germ plasma that 
dictates the site of germ cell specification.  
 
Chicken has only POU5F3 gene, also known as cPOUV (here I called it Gallus 
gallus POU5F3 or GgPOU5F3). GgPOU5F3 is expressed initially in all blastomeres of the 
area pellucida and area opaca, as well as in a speckled pattern in the hypoblast. Prior to 
gastrulation GgPOU5F3 expression is localised to the epiblast region of the area pellucida, 
During gastrulation, it is expressed around the PS and in the presumptive ectoderm, 
mesoderm but not endoderm. Similar to other POU5F3 orthologs, GgPOU5F3 is also 
expressed in neuroectoderm in the MHB region. In addition, GgPOU5F3 is co-expressed 









d) Marsupials versus eutherians (Figure 1.10E, F)  
 
Marsupials (e.g. tammar wallaby, koala, Tasmanian devil) and eutherians (e.g. 
human, elephant, mouse) belong to the superclass Therian, placental mammals. Therian eggs 
with no/little yolk undergo holoblastic cleavage while monotremes (e.g. platypus) eggs 
possessed large amount of yolk undergo meroblastic cleavage similar to other birds and 
reptiles (Leon Hughes and Hall, 1998). Marsupials and eutherians both have a unique 
blastula structure called the “blastocyst”, which can implant into the mother’s uterus through 
a novel cell type called trophectoderm. Unlike mouse, tammar wallaby has a unilaminar 
blastocyst that is formed by association of cells into a hemisphere, initially supported by 
adherence to the zona pellucida.  Thus the blastocyst consists of a hemisphere of cells with 
pluriblast (future embryo) at the centre flanked by trophoblast at the periphery. The 
pluriblast is defined as the population that will eventually give rise to epiblast (equivalent to 
4.5 dpc epiblast in mouse) and hypoblast (equivalent to PrEN). In some species this 
distinction is apparent morphologically (opossum) whereas others, the unilaminar 
hemisphere appears homogenous (wallaby) and the pluriblast cells do not become apparent 
until epiblast formation. The hypoblast will form from the pluriblast and it has been 
suggested that it may follow the pattern in the chicken, a population of posterior cells 
adjacent to the trophoblast combine with delaminating islands to form a coherent epithelium 
beneath the epiblast (Frankenberg et al., 2013). Following hypoblast formation, the 
remaining disc of pluriblast is referred to as epiblast. All cells in the unilaminar blastocyst 
express NANOG, POU5F1, POU5F3, CDX2, and SOX2 proteins, suggesting these cells 
remain totipotent, and equivalent to mouse morula. Like mice, marsupials can be induced 
into diapause at the unilaminar blastocyst stage when the mother has not finished the 




 During the early blastocyst stage, tammar wallaby POU5F1 is found in all cell 
lineages. However, tammar POU5F3 is expressed in a more restricted fashion, only in 
NANOG+ cells committed to epiblast, and not in either the GATA6+ and CDX2+ cells that 
mark hypoblast and trophectoderm, respectively (Frankenberg et al., 2013). During 
gastrulation, both tammar POU5F1 and POU5F3 can be found in the epiblast. Interestingly, 
during gastrulation, POU5F3 protein is localised to the nucleus while POU5F1 localised 
mainly to the cytoplasm of the epiblast cells. At later stages, only tammar POU5F1 is 
expressed in the PGCs and adult gonads, similar to mouse Oct4 (Frankenberg et al., 2010). 
This expression segregation of tammar POUV proteins suggests that tammar POU5F1 
activity might be equivalent to the mouse Oct4 activity in the ICM and PGCs, while tammar 

















Figure 1.10 Comparative POUV expression among vertebrates A) Zebrafish (Danio rerio, Dr) and medaka fish (Oryzias 
latipes, Ol) have only single POUV protein called Drpou5f3 and Olpou5f3, respectively. Both POUV are expressed similarly in blastomeres 
around animal hemisphere and epiblast cells during epiboly process of gastrulation. Later Olpou5f3 is specifically expressed in the primodial 
germ cells (PGC) while Drpou5f3 is specifically expressed in the midbrain-hindbrain boundary (MHB) and posterior tip. B) African clawed frog 
(Xenopus lavis, Xl) has three POUV homologues; Xlpou25, Xlpou60 and Xlpou91. Xlpou60 is abundantly expressed from oocyte to cleavage. 
Later Xlpou25 and Xlpou91 are expressed in the ectoderm (epiblast-equivalent structure) during gastrulation. Xlpou91 is then specifically 
expressed in PGCs. Mexican axolotl (Ambystoma mexicanum, Am) has both POU5F1 and POU5F3, called here AmPOU5F1 and AmPOU5F3. 
Both are expressed in cleavage, gastrulation and PGCs. AmPOU5F3 is also expressed in MHB. C) Chicken/Gallus gallus POUV is a POU5F3 
(called here GgPOU5F3). GgPOU5F3 is expressed in the epiblast of area pellucida , and less in area opaca and hypoblast layer. GgPOU5F3 is 
later expressed in the gastrulation stage epiblast, neuroectoderm and germ cells at later stage of development. D) Tammar wallaby (Macropus 
eugenii, Me) has both POU5F1 and POU5F3. Both are expressed in all blastomeres at cleavage and in presumptive pluriblasts and trophoblasts 
of the unilaminar blastocyst stage. Specified epiblast at blastocyst stage later expresses only MePOU5F3. After implantation, MePOU5F3 
localizes to the nucleus while MePOU5F1 localizes to the cytoplasm of the epiblast. Only MePOU5F1 is later expressed in the PGCs. E) Oct4 or 
Pou5f1 in mouse (Mus musculus) embryo is expressed in all blastomeres at cleavage and morula stages, and later is restricted to the epiblast 
and primitive endoderm (PrEN) at the late blastocyst stage. During gastrulation, Oct4 is expressed in the epiblast, and later is restricted to only 



















































































1.8.3 Conserved network of Oct4 homologs in regulating pluripotency 
and differentiation 
 
Several studies have shown that POUV proteins across vertebrate evolution have the 
capacity to support and induce pluripotency in murine ESCs in place of Oct4. We have 
previously shown that Xenopus Pou91 (Pou5f3.1) could replace mouse Oct4 efficiently 
while zebrafish Pou5f3 (Drpou5f3/Pou2) had no such activity. Other laboratories also 
examined the ability of other vertebrate POUV proteins, including chick POUV 
(GgPOU5F3/cPOUV), platypus POU5F1, opossum POU5F3, axolotl POU5F1 and axolotl 
POU5F3, to rescue mouse Oct4-null ESCs (commonly used ZHBTc4 ESC cell lines). 
Different POUV proteins show different abilities to rescue Oct4-null phenotypes and in this 
thesis I examine the quantitative difference between POUV paralogs.  It has also been shown 
that mouse Oct4 can rescue POUV-deleted Xenopus embryos, further emphasizing the 
conservation of POUV activities (Morrison and Brickman 2006). 
 
In addition to its role in maintaining ESC self-renewal, Oct4 is one of the key 
reprogramming factors.  Natalia Tapia and colleagues have investigated the substitution of 
mOct4 in murine cellular reprogramming with other vertebrate POUVs, including medaka 
Pou5f3, zebrafish Pou5f3, axolotl POU5F1, axolotl POU5F3, and Xlpou91. These POUVs 
have the ability to reprogram mouse embryonic fibroblasts into an ESC-like state with varied 
degrees of success (Tapia et al., 2012). Zebrafish Pou5f3 lacks the capacity to induce 
reprogramming, fitting well with the rescue assay shown in Morrison and Brickman, 2006 
whereas medaka Pou5f3 had some activity, although it exhibited less than 10% of the 
activity normally demonstrated by Oct4. Interestingly, Xlpou91 was almost as effective as 
Oct4 (approximately 80% Oct4 activity) at reprogramming human fibroblasts, which is 
consistent with its ability to support Oct4 null murine ESCs. However, this study did not 
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point to any logical pattern for the evolution of the capacity of these proteins to reprogram 
human cells, e.g. both axolotl POU5F3 and POU5F1 were not able to induce iPSCs, but 
Xenopus Pou5f3 (Xlpou91) was. In an attempt to explain the differences in these proteins I 
examine their activity in both ESCs (chapter 3) and reprogramming (chapter 4) and attempt 
to try and shed some light on the evolutionary basis for the capacity of some of these 
proteins to support pluripotency in mammals.  
 
A number of developmental phenotypes observed in different species in response to 
gain and loss of function of POU5F1 and POU5F3 appear similar. The lack of Oct4 in the 
post-implantation mouse embryo results in a failure to support continued axis extension 
(DeVeale et al., 2013) and this may be because of a loss of PS progenitor populations. 
Similarly, in Xenopus gastrulation, partial depletion of all three POU5F3 homologs leads to a 
failure in axis extension as a result of the immediate early differentiation of marginal zone 
progenitors to endoderm (Morrison and Brickman, 2006). In addition, zebrafish mutants 
lacking both maternal and zygotic Pou5f3 proteins (MZspg mutant) and more efficient knock 
down of Xenopus Pou5f3 proteins exhibit gastrulation failures (Lachnit et al., 2008; Lunde et 
al., 2004; Reim et al., 2004). Thus, the phenotypes of XlpouV deletion and MZspg mutant 
have some commonalities. Moreover, comparisons between Xenopus and mouse POUV 
target genes suggest that Oct4 and its homologs regulate cell adhesion and this may be 
linked to blocking differentiation in progenitor cells. Interestingly, some of these conserved 
Oct4/POUV targets (Xenopus Xlim5, Xcad2 and Xsal1) and direct regulators of adhesion, 
such as E-cadherin, can rescue XlpouV depleted embryos (Livigni et al., 2013).  
 
Oct4 regulatory networks are likely to be conserved. In addition to the regulation of 
adhesion mentioned above there are two examples of potential conserved networks that are 
worth introducing; the link between Oct4 and Cdx, and a role for Oct4 homologs in neural 
development. Oct4 is an essential regulator of early lineage choices in mammalian 
74
development. While these choices involve extra-embryonic development and as such are 
unique to mammals, how are they linked to conserved networks in other vertebrates? When 
Oct4 inhibits trophoblast fate in favor of ICM, its acts through inhibiting Cdx2 expression. 
Interestingly, this regulatory relationship is also found in Xenopus, despite the absence of 
trophoblast. The homolog of Cdx2 in X.laevis is Xcad3, which is expressed in posterior 
neural tube at larval stages. XlPouV depletion in Xenopus leads to the expansion of Xcad3 
expression (Morrison and Brickman, 2006), indicating that a POUV-CDX network is likely 
conserved among vertebrates.  
 
 POU5F3 proteins have also been shown to have roles in both forebrain specification 
and supporting a progenitor population at the MHB in both fish and frog (Morrison and 
Brickman, 2006; Reim and Brand, 2002). How conserved is this function? Based on 
expression it appears that POU5F3 homologs are also expressed in these regions in both 
chick and axolotl embryos (Lavial et al., 2007; Tapia et al., 2012). There is no evidence for 
mouse Oct4 expression in the MHB region and epiblast depletion of Oct4 via conditional 
mutagenesis does not appear to create a MHB phenotype (DeVeale et al., 2013) although 
overexpression of an activator form of Oct4 in ESCs induces neural and MHB gene 
expression (Hammachi et al., 2012). Hence, while this regulatory loop may still be encoded 
in the mammalian genome, Oct4 itself could have been replaced by another octamer protein 
that acts to sustain both forebrain and MHB development. 
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Section 1.9 Aims of this study 
 
Oct4 homologs are conserved among vertebrates in their activities to maintain and 
establish pluripotency. In this thesis, I explore the links between a pattern of evolution of 
these proteins and their functional properties. As there are two clear assays for function, I 
employ them both and explore different aspects of POUV conservation.   
 
The specific aims of this thesis include: 
1. Better define the evolutionary relationships of POUV proteins.  In chapter 
3, I explore the evolutionary relationships between the genes encoding 
different POU5F1 and POU5F3 proteins. I attempt to better describe their 
divergence and evolutionary origins. I also assess the functional activity 
of these proteins in ESCs and compare their activity to their evolutionary 
relationships, what is known about their expression pattern and whether 
they are derived from a species with POU5F1, 3 or both. 
2. To better understand the diversification of POU5F3 activity that occurred 
in Xenopus as a result of tandem duplication using a reprogramming assay 











CHAPTER 2 Material and Methods 
 
Section 2.1 Reagents-Materials, Plasmids, Antibodies, and Primers 
 
2.1.1 Reagents and materials used in this study 
 
1. Dulbecco’s Modified Eagle Medium (DMEM)-High Glucose, Invitrogen, 41965-039 
2. 100X MEM Non-essential Amino Acids solution (NEAA), Sigma-Aldrich, M7145 
3. 200 mM L-Glutamine, Invitrogen, 25030024 
4. Fetal Bovine Serum (FBS), Invitrogen, 10270-106 
5. Knockout Serum Replacement (KOSR), Invitrogen, 10828-028 
6. Leukemia Inhibitory Factor (LIF)-Homemade LIF produced by COS cells (Dora Papp) 
7. Glasgow Minimum Essential Medium (GMEM), Sigma-Aldrich, G5154-6X500 ML 
8. β-mercaptoethanol, Sigma-Aldrich, M6250 
9. Sodium pyruvate, Invitrogen, 11360039 
10. Penicillin-Streptomycin, Invitrogen, 15140-122 
11. 2.5% Trypsin (10X), Invitrogen, 15090-046, 5 mL of 2.5% Trypsin was dissolved in 500 
mL of PBS with 0.186 gram of EDTA and 5 mL of chicken serum to obtain 1X Trypsin-
EDTA for ESC/iPSC culture. 
12. Dimethyl sulfoxide (DMSO), Merck Millipore, 102952 
13. Dulbecco’s Phosphate Buffered Saline (PBS), Sigma-Aldrich, D8537-100 ML  
14. Lipofectamine ® 2000 transfection reagent, Invitrogen, 11668019 
15. Restriction enzymes and buffers, New England Biolab (NEB) 
16. T4 ligase, New England Biolab (NEB), M0202S 
17. Phusion® High-Fidelity PCR Master Mix with HF Buffer, New England Biolab (NEB), 
M0531L 
18. UltraPureTM Agarose, Invitrogen, 16500-500 
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19. Tris-acetate EDTA (TAE), Homemade 
20. ZymocleanTM Gel DNA Recovery Kit, Zymo Research, D4008 
21. QIAquick® PCR Purification Kit, Qiagen, 28104 
22. Qiagen Plasmid Mini/Maxi Kit, Qiagen, 12125/12362  
23. IllustraTM PlasmidPrep Mini Spin Kit, GE Healthcare, 28-9042-70 
24. SyBr  ® Safe DNA Gel Stain, Invitrogen, S33102 
25. 1 kb Plus DNA Ladder, Invitrogen, 10787018 
26. Carbenicillin, GE Healthcare, P31-020 
27. Kanamycin, Sigma-Aldrich, K4000-25G 
28. LB broth, SUND core facility 
29. LB agar, SUND core facility 
30. Retro-XTM Concentrator, Clontech, 631453 
31. Retro-XTM qRT-PCR Titration Kit, Clontech, 631456 
32. Tetracycline Hydrochloride, Sigma-Aldrich, T-7660, Dissolved in 70% ethanol to obtain 
10 mg/mL  
33. Nuclease-free water, Ambion, AM9937 
34. Puromycin dihydrochloride from Streptomyces alboniger, Sigma-Aldrich, P8833 
35. Triton® X-100, AppliChem, A13388-0500 
36. Donkey serum for immunofluorescence, Sigma-Aldrich, D9663-10ML 
37. Leukocyte Alkaline Phosphatase Kit, based on napththol AS-BI and fast red violet LB, 
Sigma-Aldrich, 86R-1KT 
38. RNA extraction kit: RNeasy® Mini Kit, Qiagen, 74106 
39. Trizol® Reagent, Invitrogen, 15596018 
40. DirectPCR (Tail) Lysis Reagent for Genotyping Using Crude Lysates, Viagen, 102-T 
41. GeneArt® Seamless PLUS Cloning and Assembly Kit, Invitrogen, A13288 
42. Agilent’s microarray kit, Agilent Technologies 
 42.1 SurePrint G3 Mouse GE 8X60K Kit, G4852A 
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 42.2 LowInput QuickAmp Labeling Kit One-Colour, 5190-2305 
 42.3 RNA Spike In Kit-One Colour, 5188-5282 
 42.4 Gene Expression Hybridization Kit, 5188-5242 
 42.5 Pack 5 Backings 8 arrays per slide, G2534-60014 
 42.6 Gene Expression Wash Pack, 5188-532 
43. DNA Clean & ConcentratorTM, Zymo Research, D4029 
44. RNase-Free DNase set, Qiagen, 79254 
45. Hexadimethrine bromide (polybrene), Sigma-Aldrich, H9268-10G 
46. SuperScript® III Reverse Transcriptase (200 U/µL), Invitrogen, 18080-044 
47. TOPO TA Cloning® Kit for Sequencing, Invitrogen, 45-0030 
48. NucleoSpin® RNA Virus, Macherey-Nagel, 740956-50 
49. Mitomycin C from Streptomyces caespitosus, Sigma-Aldrich, M4287 
50. L-Ascorbic acid, Sigma-Aldrich, A4403-100MG, Dissolved in water to obtain 10 mg/mL 
stock solution 
51. Alk5 inhibitor (Alk5i), Tocris, A83-01, Dissolved in DMSO to obtain 10 mM stock 
solution 
52. Accutase® solution, Sigma, A6964-100 mL 
53. 25/75/150 cm2 cell culture flask, Corning Incorporated 
54. Cryotube, Thermo Scientific 
56. 100 mm X 20 mm style cell culture dish, Corning Incorporated 
57. 6, 12, 24, 96 (flat/V bottom) well cell culture plate, Corning Incorporated 
58. 25 mL disposable, Pre-sterile, polystyrene reservoir 
59. Universal, Thermo Scientific 
60.BD FalconTM 15 mL high clarity polypropylene conical tube, BD Bioscience 
61. 5 mL polystyrene round-bottom tube with cell strainer cap, Corning Incorporated 
62. Serological pipettes, VWR 
63. 15 µ-Slide 8 well, Ibidi, 80826 
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64. WhatmanTM FP30/0.45 CA-5 Filter unit (0.45 µm), GE Healthcare, 10462100 
65. BBD6220 CO2 incubator, Thermo Scientific 


























2.1.2 Plasmids used in this study 
 
For chapter 3: Rescue experiment 
 
Expression vectors carrying POUV genes were generated from pPCAG575-SiP 
(called shortly pCAG in this thesis). The expression of POUV gene is driven by CAG 
promoter (murine pDR10, Rathjen et al., 1990).  
 
1. pCAG-3xflag mOct4, Generated by Fella Hammachi, Source of cDNA: Mus musculus 
(house mouse)/ mOct4 (Genbank: MGI:101893; ENSMUSG00000024406), referred to here 
as mouse Oct4, mouse Pou5f1 or mOct4 
2. pCAG-3xflag Xlpou91, Generated by Fella Hammachi, Source of cDNA: Xenopus laevis 
(African clawed frog)/Xlpou91 or Pou5f3.1 or Oct91, Genbank: M60077; NP_001081342.1, 
referred to here as Xlpou91,  Pou5f3.1 or X91 
3. pCAG-3xflag Xlpou25, Generated by Fella Hammachi, Source of cDNA: Xenopus laevis 
(African clawed frog)/Xlpou25 or Pou5f3.1 or Oct25, Genbank: ABH07383, referred to here 
as Xlpou25, Pou5f3.2 or X25 
4. pCAG-3xflag MePOU5F1, Generated in this study, Source of cDNA: Macropus eugenii 
(tammar wallaby)/POU5F1, Genbank: FJ998419, cDNA was obtained from Stephen 
Frankenberg, referred to here as tammar POU5F1 or tammar P1 
5. pCAG-3xflag MePOU5F3, Generated in this study, Source of cDNA: Macropus eugenii 
(tammar wallaby)/POU5F3, Genbank: FJ998420, cDNA was obtained from Stephen 
Frankenberg, referred to here as tammar POU5F3 or tammar P3 
6. pCAG-3xflag CpPOU5F1, Generated in this study, Source of cDNA: Chrysemys picta 
bellii (painted turtle)/POU5F1, cDNA sequence was obtained from Stephen Frankenberg and 
synthesised by Invitrogen, referred to here as turtle POU5F1 or turtle P1 
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7. pCAG-3xflag CpPOU5F3, Generated in this study, Source of cDNA: Chrysemys picta 
bellii (painted turtle)/POU5F3, cDNA sequence was obtained from Stephen Frankenberg and 
synthesised by Invitrogen, referred to here as turtle POU5F3 or turtle P3 
8. pCAG-3xflag AmPOU5F1, Generated in this study, Source of cDNA: Ambystoma 
mexicanum (axolotl; Mexican salamander)/AxOCT4, Genbank: AY542376, cDNA sequence 
was obtained from Elly Tanaka, referred to here as axolotl POU5F1 or axolotl P1 
9. pCAG-3xflag AmPOU5F3, Generated in this study, Source of cDNA: Ambystoma 
mexicanum (axolotl; Mexican salamander)/AxPOU2, Genbank: KF020689, cDNA sequence 
was obtained from Elly Tanaka, referred here as axolotl POU5F3 or axolotl P3 
10. pCAG-3xflag LcPOU5F1, Generated in this study, Source of cDNA: Latimeria 
chalumna  (coelacanth)/POU5F1, cDNA sequence was obtained from Stephen Frankenberg 
and synthesised by Invitrogen, referred here as coelacanth POU5F1 or coelacanth P1 
11. pCAG-3xflag LcPOU5F3, Generated in this study, Source of cDNA: Latimeria 
chalumnae (coelacanth)/POU5F3, cDNA sequence was obtained from Stephen Frankenberg 
and synthesised by Invitrogen, referred here as coelacanth POU5F3 or coelacanth P3 
 
For chapter 4: iPSC experiment 
 
Retroviral expression vectors carrying POUV genes were generated from pMXs-gw 
(Kitamura et al., 2003). POUV coding sequences were firstly subcloned into pENTR-2B2 
(Invitrogen).  POUV gene in pENTR-2B2 was then subcloned into pMXs-gw vector through 
Gateway ® cloning LR recombination reaction (Invitrogen).  
 
1. pMXs-mOct4, Generated by Shinya Yamanaka laboratory (provider: Addgene), Source 
of cDNA: Mus musculus (house mouse)/ mOct4, Genbank: MGI:101893; 
ENSMUSG00000024406, referred to here as mouse Oct4, mouse Pou5f1 or mOct4 
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2. pMXs-Sox2, Generated by Shinya Yamanaka laboratory (provider: Addgene), Source of 
cDNA: Mus musculus (house mouse)/ Sox2, Genbank: AL606746.1, referred to here as Sox2 
or S 
3. pMXs-Klf4, Generated by Shinya Yamanaka laboratory (provider: Addgene), Source of 
cDNA: Mus musculus (house mouse)/ Klf4, Genbank: RP23-322L22.2, referred to here as 
Klf4 or K 
4. pMXs-c-Myc, Generated by Shinya Yamanaka laboratory (provider: Addgene), Source of 
cDNA: Mus musculus (house mouse)/ c-Myc, Genbank: AU016757, referred to here as c-
Myc or M 
5. pMXs-dsRED, Generated by Shinya Yamanaka laboratory (provider: Addgene), Source 
of cDNA: Discosoma sp. (sea anemone)/ dsRED, referred to here as dsRED or R 
6. pMXs-3xflag Xlpou91, Generated by this study, Source of cDNA: Xenopus laevis 
(African clawed frog)/Xlpou91 or Pou5f3.1 or Oct91, Genbank: M60077; NP_001081342.1, 
referred to here as Xlpou91, Pou5f3.1 or X91 
7. pMXs-3xflag Xlpou25, Generated by this study, Source of cDNA: Xenopus laevis 
(African clawed frog)/Xlpou25 or Pou5f3.1 or Oct25, Genbank: ABH07383, referred to here 












2.1.3 Antibodies used in this study 
 
For flow cytometry analysis and FACS sorting 
 
1. Mouse CD54 (ICAM-1) conjugated with Biotin, eBioscience, 13-0541-81, Dilution 1:200 
2. Human/Mouse CD44 conjugated with APC-eFluor® 780, eBioscience, 47-0441-82, 
Dilution 1:200 
3. Alexa Fluor® 647 Streptavidin (used together with ICAM-1), BioLegend, 405237, 
Dilution 1:1000 
4. Mouse CD31 (PECAM-1) conjugated with APC, BD Pharmingen, 551262, Dilution 1:100 
5. Mouse SSEA1 conjugated with Alexa Fluor® 647, BD Pharmingen, 560120,  
Dilution 1:1000 
6. Mouse CD324 (E-cadherin) conjugated with eFluor® 660, eBioscience, 50-3249,  
Dilution 1:400 






1. Mouse Oct3/4 (Host: mouse), Santa Cruz, sc-5279, Dilution 1:200 
2. Mouse Sox2 (Host: goat), Santa Cruz, sc-17320, Dilution 1:200 
3. Mouse Klf4 (Host: goat), R&D, AF3158, Dilution 1:200 
4. Mouse C-myc (Host: rabbit), Abcam, ab32072, Dilution 1:200 
5. Flag (Host: mouse), Sigma, F3165, Dilution 1:1000 
6. Mouse SSEA1 conjugated with Alexa Fluor® 647, BD Pharmingen, 560120,  
Dilution 1:50 
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7. Mouse Nanog (Host: rat), eBioscience/14-5761, Dilution 1:400 
8. Mouse p120 catenin (Host: mouse), BD Pharmingen, 610134, 1:250 
9. Human Gata6 (Host: Goat), R&D, AF1700, Dilution 1:200 
10. Mouse Cdx2 (Host: mouse), BioGenex, MU392A-UC, Dilution 1:100 




1. Donkey anti goat Alexa 488 (IgG), Molecular Probes, A121055, Dilution 1:800 
2. Donkey anti goat Alexa 568 (IgG), Molecular Probes, A11057, Dilution 1:800 
3. Donkey anti goat Alexa 647 (IgG), Molecular Probes, A11057, Dilution 1:800 
4. Donkey anti rabbit Alexa 568 (IgG), Molecular Probes, A10042, Dilution 1:800 
5. Donkey anti rabbit Alexa 647 (IgG), Molecular Probes, A31573, Dilution 1:800 
6. Donkey anti mouse Alex 488 (IgG), Molecular Probes, A21202, Dilution 1:800 



















2.1.4 Primers used in this study 




Cdh1 18 ATCCTCGCCCTGCTGATT ACCACCGTTCTCCTCCGTA 
Cdh2 67 GGTGGAGGAGAAGAAGACCAG GGCATCAGGCTCCACAGTAT 
Cdx2 34 CACCATCAGGAGGAAAAGTGA CTGCGGTTCTGAAACCAAAT 
Dlx3  18 GCAAGTCGAAAGAGGGATGT CTCCTTCACTTCCCACGAAA 
Esrrb 93 AACTGGGCCAAGCACATC ATCTCCATCCAGGCACTCTG 
Fgf5 95 GCGAAACTTCAGTCTGTACTTCACT ACCGGTGAAACCAAAGGTG 
Gata6 40 GGTCTCTACAGCAAGATGAATGG TGGCACAGGACAGTCCAAG 
IRES-PAC 41 TGGCTCTCCTCAAGCGTATT CCCCAGATCAGATCCCATAC 
Klf4 62 CGGGAAGGGAGAAGACACT GAGTTCCTCACGCCAACG 
Lhx5  55 TGTGCAATAAGCAGCTATCCA TTGCACACAAACTTGTTCTCG 
Nanog 25 CCTCCAGCAGATGCAAGAA GCTTGCACTTCATCCTTTGG 
Oct4 95 GTTGGAGAAGGTGGAACCAA CTCCTTCTGCAGGGCTTTC 
Prdm14 73 GGCCATACCAGTGCGTGTA TGCTGTCTGATGTGTGTTCG 
Sox7 97 GCGGAGCTCAGCAAGATG GGGTCTCTTCTGGGACAGTG 
Utx 25 CTGATGCAAGTCTATGACCAATTT CAAGATGAGGCGGATGGT 
TBP 97 GGGGAGCTGTGATGTGAAGT CCAGGAAATAATTCTGGCTCA 
GAPDH 52 GGGTTCCTATAAATACGGACT CCATTTTGTCTACGGGACGA 
*MXs-Oc4 39 GTGGTGGTACGGGAAATCAC TCTGAAGCCAGGTGTCCAG 
*MXs-X91 60 GTCGTGTCCAAGCCTTTACC CTCCACGGGGTCACATTTA 
*MXs-X25 49 CCAATGGGGCAATTAATGA CCCCATCAAGCATCTCTCC 
*MXs-Sox2 107 CGCCCAGTAGACTGCACA CAAGAAAGCTGGGTTTCACAT 
*MXs-C-myc 109 TCGAAACTCTGGTGCATAAGG TGACACCAGACCAACTGGTAA 
*MXs-Klf4 106 TGGTACGGGAAATCACAAGTT GACGCGAACGTGGAGAAG 
**CAG-POUV - CAGCTCCTGGGCAACGTGCTGG CTTCGGCCAGTAACGTTAGG 
**MXs-POUV - PBMN: GCTTGGATACACGCCGCCC - 
***NanogWT - Nanog genoF: TAACTCTTCTTTCTA 
TGATCTTTCCTTC 
Nanog geno R: GCATCTCAGT 
AGCAGACCCTT G 
***NanogGFP - IC200Rodda3F: GGGTCACCTTACAG 
CTTCTTTTGCATTA 
GFP geno R2: TCGTGCTGCTTC 
ATGTGGTC 
* primers used for screening of retroviral silencing in iPSC experiment 
** primers used for sequencing 
***primers used for Nanog-GFP genotyping (section 2.3.2), NanogWT primer set is used for detected 




Section 2.2 DNA/RNA manipulation techniques 
 
2.2.1 DNA isolation from bacteria 
 
Bacteria containing plasmids of interest were inoculated in LB broth at volume 4 mL 
and 100 mL for small-scale and large-scale amplifications, respectively. 100 µg/mL of 
ampicillin/carbenicllin and 50 µg/mL of kanamycin were added to LB broth, depending on 
the resistance gene presenting in the plasmids.  The bacterial culture was incubated for 
overnight at 37 oC with agitation at 225 rpm. 
 
After overnight incubation, the bacteria cells were harvested by centrifuging at 5000 
rpm for 10-20 minutes at 4 oC. Supernatant was discarded and plasmids were extracted using 
QIAGEN kits, following the manufacturer’s instruction. For small-scale plasmid preparation 
or “mini-prep” by QIAprep Spin Miniprep Kit, the DNA was eluted with 30 µL of nuclease 
free water. In addition, the plasmid extraction was carried out by IllustraTM PlasmidPrep 
Mini Spin Kit. For large-scale plasmid preparation or “maxi-prep” by the QIAGEN Plasmid 
Maxi kit, DNA pellet was re-suspended in 300 µL of nuclease-free water and incubated 
overnight at 4 oC and later stored in -20 oC.  
 
2.2.1 DNA isolation from mammalian cells 
 
- DNA isolation from embryonic stem cell or induced pluripotent stem cells 
 
Cells were grown in appropriate culture medium until 80% confluency (6-well 
plates), which contained approximately more than one million cells. Genomic DNA was 
extracted using the Qiagen-DNeasyTM Blood and Tissue Kit according to the 
manufacturer’s protocol. 
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- DNA isolation from mouse-tail for genotyping 
 
Tail samples were lysed with 100 µL of DirectPCR (Tail) Lysis Reagent (Viagen) 
supplement with 2.5 µL of proteinase K (20 mg/mL) and incubated overnight at 55 oC and 
then inactivated at 85 oC for 45 minutes. The samples were centrifuged briefly at 4000 rpm 
for 3 minutes and 1 µL of crude lysate was used directly for PCR. 
 
2.2.2 Polymerase chain reaction (PCR) 
   
All PCR reactions of cloning and genotyping were performed with Phusion® High-
Fidelity PCR Master Mix with HF Buffer (PhuHF). The primers were manually designed 
and optimised in Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/) to prevent the primer dimer 
and other complications. Primer annealing temperatures were calculated using NEB-web 
tool (http://tmcalculator.neb.com/). All primers were synthesised by Integrated DNA 
Technologies Company (IDT). 20-µl volumes of PCR reactions contained following recipe: 
10 µL of 2X PhuHF master mix (already containing dNTPs), 1 µL each of 10 µM forward 
and reverse primers, 1-100 ng of DNA template and nuclease-free water. All PCR reactions 
were performed as following steps in PCR machine: an initial denaturation step (30 seconds 
at 98 oC), followed by successive 34 cycles of denaturation (10 seconds at 98 oC), annealing 
(10 seconds at Ta calculated by NEB-web tool), and extension (1 minutes/kb to be amplified 
at 72 oC). In the end a final incubation at 72 oC 5-10 minutes took place. Some PCR primers 







2.2.3 Restriction enzyme digestion 
 
Restriction enzymes were used to generate compatible ends capable of joining PCR 
products containing DNA of interest into expression vectors or sub-cloning one gene from 
one vector to another vector or linearizing the DNA for further application. Briefly, 1 µg of 
purified DNA was digested in 50 µL volumes containing 5 µL of 10X NEB buffer, 0.5 µL of 
100X BSA (the addition of BSA depended on restriction enzymes), 10 units of restriction 
enzyme, and nuclease-free water. The DNA/solution mixture was incubated for 2 hours. For 
linearization of plasmid in the rescue experiment, 100 µg of purified plasmid DNA was 
digested in 200 µL volumes containing 20 µL of 10X NEB buffer, 1000 units of restriction 
enzyme, and nuclease-free water. The DNA/solution mixture was incubated overnight. 
Reactions were performed at optimal temperature depending on the enzyme being used.  
 
2.2.4 Dephosphorylation of DNA fragment ends 
 
To prevent self-ligation of vector and facilitating the success of cloning, 5’ end of 
linearised vector was removed by using 1 unit of Calf Intestinal Phosphatase (CIP) for 1 µg 
of digested DNA. The reactions were incubated at 37 oC for 30 minutes. 
 
2.2.5 DNA fragment ligation 
  
Digested PCR products or digested DNA fragments from other vectors (DNA 
inserts) were joined with destination vectors by using T4 DNA ligase. The amounts of DNA 
inserts and vectors were used at a molar ratio of 3:1. The calculations of ligation reaction 
were performed by http://nebiocalculator.neb.com/#!/ligation.  The 20-µL volume ligation 
reaction contains 2 µL of 10X T4 DNA ligase buffer, 1 µL of T4 DNA ligase, appropriate 
amount of DNA insert and DNA vector, and nuclease-free water. The reactions were carried 
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out at room temperature (cohesive ends) for 20 minutes or at 16 oC (blunt-ends) for 
overnight. After incubation, 1 µL of the ligation mixture was immediately added to 
competent cells for transformation. 
 
2.2.6 GeneArt Seamless cloning 
 
 The GeneArt Cloning is based on the homologous recombination to assemble 
adjacent DNA fragments sharing end-terminal homology. To generate the homology arms 
for assembly, DNA sequences of inserts containing gene of interest and vector were used for 
designing primers in web-based design tool (http://www.lifetechnologies.com/order/ 
oligoDesigner). The primers were synthesised by Integrated DNA Technologies. Phusion 
HF-based PCR were performed to generate DNA insert with 15 bp homology at each end. 
Generally, the DNA inserts were joined to linearised vector pUC19L supplied by the 
GeneArt Assembly kit. The amounts of DNA inserts were calculated following 
manufacturer’s instruction. The reactions were carried out in 20 µL-volume containing 100 
ng of insert, 100 ng of linear pUC19L vector, 4 µL of 5X Reaction buffer, 2 µL of 10X 
enzyme mix and nuclease-free water.  The reactions were incubated for 1 hour at room 
temperature and 1 µL of the reaction was used for transformation into appropriate competent 
cells.  
 
2.2.7 DNA electrophoresis  
 
 The PCR products or digested DNA fragments were run on 1% agarose gel in TAE 
buffer. To prepare the agarose gel, 1 g of agarose powder was mixed with 100 mL of TAE 
buffer, and dissolved in microwave. The DNA staining chemical, SyBr-Safe, was used for 
1:10 volume of agarose gel (e.g. 10 µL of SyBr-Safe in 100 mL gel) and was added directly 
into the gel before setting it on the apparatus. 50X TAE (Tris-Acetate-EDTA) buffer is stock 
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solution composed of 242 g of Tris base, 57.1 mL glacial acetic acid, and 100 mL of 500 
mM EDTA (pH8.0) in total volume of 1 L. For using as running buffer, the stock solution 
was diluted 50:1, thus 1X of TAE contained 40 mM Tris, 20 mM acetic acid and 1 mM 
EDTA. For running electrophoresis, the voltage was set at 100-110 V and running time was 
25-30 minutes. After this, the DNA was visualised under the UV or blue light for further 
imaging or gel excision/DNA purification.  
 
2.2.8 DNA clean-up from agarose gels 
 
DNA was extracted from gel using the Zymo Research-ZymocleanTM Gel DNA 
Recovery Kit. The weight of excised agarose gel containing DNA was firstly measured, and 
the gel was dissolved in dissolution buffer with 3X volume of gel and incubated at 50 oC for 
10-15 minutes. The dissolved gel was purified by column following manufacturer 
instruction. DNA was eluted with nuclease-free water. 
 
2.2.9 DNA clean-up from solutions by Zymo-Research DNA kit 
 
 The DNA was purified by Zymo-Research-DNA Clean and Concentrator kit. The 
volume of DNA mixture solution was adjusted to 100 µL and 3 volumes of the binding 
buffer was added. The reaction/buffer mixture was added to the column, and processed 
according to the manufacturer’s instruction. The DNA was eluted with nuclease-free water.  
 
2.2.10 DNA clean-up from solution by precipitation 
 
Firstly, DNA sample volume was adjusted to 200 µL with nuclease-free water. Next, 
22 µL of 3M sodium acetate at pH 5.2 and 470 µL of ice cold 96% ethanol were added and 
mixed well. To pellet the DNA, the mixture was centrifuged at max speed/4 oC for 30 
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minutes. Then the DNA pellet was washed twice with 1000 µL of ice cold 70% ethanol and 
centrifuged at max speed/4 oC for 10 minutes. Then the DNA pellet was air-dried for 10 
minutes under the laminar hood. The dried DNA pellet was re-suspended in 200 µL of PBS 
or nuclease-free water. 
 
2.2.11 DNA quantification 
 
 DNA quantification was performed using NanoDrop 2000 (Thermo Scientific). 1 µL 
of samples were used for the measurement. Absorbance ratios of 260/280 (A260/280) were 
observed to indicate the DNA purity. An A260/280 of approximately 1.8 is generally 
accepted for DNA with good purity (Sambrook and Russell, 2001). 
 
2.2.12 Bacterial transformation 
 
These bacterial strains were used for transformation. 
a) One Shot® Stbl3™ Chemically Competent E. coli (Invitrogen)  
Genotype: F-mcrB mrrhsdS20(rB-, mB-) recA13 supE44 ara-14 galK2 lacY1 proA2 
rpsL20(StrR) xyl-5 -leumtl-1 
b) One Shot® TOP10 Chemically Competent E. coli (Invitrogen) 
Genotype: F- mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15  lacX74 recA1 araD139 ( 
araleu)7697 galU galK rpsL (StrR) endA1 nupG 
c) MAX Efficiency® DH5α™ Competent Cells (Invitrogen)  
Genotype: F- 80lacZ M15 (lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, mk+) phoA 




Transformation: Approximately 1 µL of 100 ng/µL DNA was added to cold competent 
cells. The bacteria were then incubated on ice for 30 minutes, subjected to heat shock at     
42 oC for 30 seconds (Stbl3) or 45 seconds (TOP10 and DH5 ), followed by short 
incubation on ice. 250 µL of SOC medium was then added, followed by one hour incubation 
with agitation at 37 oC. 50-100 µL of the incubated culture was inoculated on LB agar (on 
Petri dish) and incubated overnight at 37 oC. 
 
2.2.13 DNA sequencing 
  
DNA sequencing was performed by GATC Biotech. Samples for sequencing were 
prepared by mixing 2.5 µL of 10 µM primers with 7.5 µL of DNA sample (300-600 ng). The 
results were analyzed by APE plasmid editor software.  
 
2.2.15 RNA isolation from mammalian cells 
 
For gene expression analysis, RNA from embryonic stem cells and induced 
pluripotent stem cells was isolated using either RNeasyTM Mini Kit or Trizol reagent 
(Qiagen) according to manufacturer’s instructions. Briefly, the cells were grown until 70-
80% confluency in 6-well plates. The cells were washed once with PBS to remove dead cells 
and culture medium. Then, 400 µL of lysis buffer or Trizol reagent was immediately added 
to the cells, and the cell lysate was transferred to eppendof tube for extraction as following: 
 
For RNA extraction by RNeasyTM Mini Kit, the lysate was loaded onto RNeasy 
MinElute Spin Columns for RNA capture, following by DNaseI treatment (Qiagen), washing 
step and elution step as described in the protocol. The RNA was eluted in 20 µL of RNase-
free water.  
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For RNA extraction by Trizol reagent, the lysate was mixed with 104 ul of 
chloroform and vortexed vigorously. The chloroform/lysate mixture was centrifuged at max 
speed/4 oC for 30 minutes. The upper aqueous layer containing RNA were collected and 
mixed with 0.6 ul of 15 mg/mL GlycoBlue. RNA then was isolated by isopropanol 
precipitation by adding 267 µL of isopropanol into the collected 200-µl aqueous solution. 
The mixture was then centrifuge at max speed for 10 minute at 4 oC. After this 
centrifugation, the RNA pellet (appeared blue from GlycoBlue) were wash twice with 550 µl 
of 75% EtOH, air dried and resuspended in 20 µL of RNase free water. To avoid the 
contaminated DNA in RNA samples, the RNA was treated with DNaseI (Qiagen) for 30 
minutes at 37 oC. The RNA from DNaseI treatment was re-extracted with Trizol reagent. 
 
2.2.16 RNA quantification and quality control 
 
RNA quantification was performed using NanoDrop 2000 spectrophotometer 
(Thermo Scientific). 1 µL of samples was used for the measurement. At absorbance (A) 
260/280 ratio, the value around 2.0 for RNA indicated that the RNA was not contaminated 
with organic compounds e.g. residual phenol from the extraction procedure.  
 
 For gene expression analysis by microarray, RNA quantification was performed 
firstly with NanoDrop and secondly with Bioanalyzer 2100 (Agilent). The Bioanalyzer 
provides the detail of RNA purity, quality, and concentration. The RNA was prepared and 
loaded onto RNA Chip according to manufacturer’s instruction. The analysis was based on 
the assay of Eukaryote Total RNA Nano Series II. Results of RNA concentration and RNA 
Integrity Number (RIN) were recorded. The best quality of RNA without degradation shows 




2.2.17 First strand cDNA synthesis 
  
For gene expression analysis by qRT-PCR, the cDNA were synthesised using 
SuperScript® III Reverse Transcriptase (Invitrogen) from high quality RNA.  Briefly, 1 µg 
of total RNA was mixed with 5 µL of 50 ng/µL random hexamers and 1 µL of 10 mM dNTP 
mix and incubated at 65 oC for 5 minutes, followed by short incubation on ice. Then 4 µL of 
5X First Strand (FS) buffer, 1 µL of 0.1 M DTT, 1 µL of 40,000 unit/mL RNaseOUT, and    
1 µL of Superscript III enzyme were added. For control, the addition of superscript III was 
omitted. The reactions were incubated at 50 oC for one hour, followed by 70 oC for 15 
minutes using PCR thermal cycler. The cDNA was diluted with nuclease-free water in ratio 


















Section 2.3 Manipulation of transgenic mice and embryos 
 
2.3.1 Transgenic mice  
 
Nanog-GFP mice were obtained from Ian Chambers laboratory, University of 
Edinburgh. Nanog-GFP mice carried one wild type Nanog allele (NanogWT) and one Nanog 
allele with eGFP IRES puromycin resistance gene cassette inserted after the start codon of 
Nanog allele (Nanog-GFP). Homozygous embryo of Nanog-GFP/Nanog-GFP is lethal at 
early stage of development. Only heterozygous transgenic line (Nanog-GFP/NanogWT) can 
be maintained and used for all experiments. To maintain the line, the transgenic mice were 
crossed with transgenic or wild type 129sv (Jackson Laboratory) mice. The mice were 
maintained, bred, and manipulated at University of Copenhagen, SUND transgenic core 




Genotyping was used to confirm Nanog-GFP allele and Nanog wild type (WT) allele 
of transgenic mice and embryos/MEF used for iPSC experiments. Tail samples were 
collected by SUND transgenic core facility. The DNA isolation for genotyping is described 
in section 2.2.1. To confirm the presence of Nanog-GFP allele, forward primer IC200 
Rodda3F and reverse primer GFP geno R2 were used in PhuHF-based PCR condition at an 
annealing temperature of 68 oC. To confirm NanogWT allele, forward primer Nanog geno F 
and reverse primer Nanog geno R were used in PhuHF-based PCR condition at an annealing 




2.3.3 Mouse embryonic fibroblast isolation 
 
Mouse embryonic fibroblasts (MEFs) used as feeders were derived from the 
C57BL/6NTac (Taconic) embryos at embryonic stage 13.5. MEFs for iPSC generation were 
derived from the embryo at embryonic stage 13.5. The embryos were from the cross of male 
Nanog-GFP mice with female 129S2/ScPasCrl (Charles Reiver). Embryos were dissected 
separately to avoid contamination of wild type ones. To screen the transgenic embryos, tail 
of each embryo was cut and place in eppendof tube for genotyping (see section 2.3.2). 
Briefly regarding the MEF isolation, the embryo head and internal organs were removed. 
The rest of embryo body was minced with scissor and incubated in 1X trypsin-EDTA for 30 
minutes at 37 oC. During the incubation, the trypsinised embryos were physically separated 
by pipetting (with 5 mL-volume pipette) every 10 minutes. The dissociated cell suspension 
was re-suspended in MEF medium and centrifuged at 1800 rpm for 5 minutes. The cell pellet 
was then re-suspended with appropriate volume of MEF medium. For obtaining frozen 
stock, 500 µL of 4-8 million cells/mL cell suspension was added into cryotubes containing 
500 µL of cold freezing medium composed of 20% of DMSO in FBS (see section 2.4B for 












Section 2.4 Cell culture 
 
All mammalian cells were cultured at 37°C, 5% CO2 and 90% humidity (BBD 6220 
incubators, Thermo Scientific), unless otherwise stated. All solutions were sterile and all cell 
manipulations were performed in a sterile laminar flow hood. The medium was warmed at 
37 oC prior to use. 
 
Section 2.4A Mouse embryonic stem cell culture 
 
2.4A.1 The maintenance of mouse ESCs 
 
Routinely, ESC were cultured in GMEM containing 0.1 mM non-essential amino-
acids, 2 mM L-glutamine, sodium pyruvate, 0.1 mM β –mercaptoethanol, 10% Fetal Bovine 
Serum (FBS) and LIF. The flasks/dishes (Corning) for ESC culture were coated with 0.1% 
gelatin in PBS for 5-10 minutes. The ESCs were grown until 80% confluency before 
passaging or further applications. For passaging, the cells were washed once with warm PBS 
and detached by 1X trypsin-EDTA with 3 minutes incubation at 37 oC. ESC medium was 
then added to a flask/dish and the cell suspension was pipetted several times to generate a 
single cell suspension (neutralization step, FBS in ESC medium blocks the trypsin activity). 
Cells were collected by centrifugation at 1300 rpm for 3 minutes. Cells were then re-
suspended in appropriate volumes of ESC medium. In general, 1:5 split ratio was used. 
 
2.4A.2 Mouse ESC colony picking and expansion 
 
 10 µL of 1X Trypsin-EDTA was added to V-bottom 96 well plates. Medium was 
aspirated from the culture dish (100 mm2) and cells were washed once with 10 mL of PBS. 
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12 mL of PBS was then added to the dish. The colonies were picked with a p10 pipette and 
transferred into trypsin solution and incubated for 5 minutes at room temperature. Then 200 
µL of ESC medium was added into each well using multi-channel pipette and vigorously 
pipetted to generate single cell suspension. The cell suspension was then transferred to 
gelatin-coated flat-bottom 96-well plate and incubated overnight. The medium was changed 
the next day. About two days after picking when the ESCs grew until around 80% 
confluency, they were passaged to 48-, then 12- and 6-well plate for cell expansion and 
freezing. The procedures were described following: 
Passaging from 96- to 48-well plate: washing with PBS (200 µL/well), cell 
detachment (10 µL of trypsin), neutralization/vigorous pipetting (100 µL of ESC medium) 
and transferring all cell suspension to gelatin-coated well containing 500 µL of ESC 
medium.  
Passaging from 48- to 12-well plate: washing with PBS (500 µL/well), cell 
detachment (50 µL of trypsin), neutralization/vigorous pipetting (500 µL of ESC medium) 
and transferring all cell suspension to gelatin-coated well containing 1 mL of ESC medium.  
Passaging from 12- to 6-well plate: washing with PBS (1 mL/well), cell detachment 
(100 µL of trypsin), neutralization/vigorous pipetting (1 mL of ESC medium) and 
transferring only 500 µL of cell suspension to gelatin-coated well containing 2 mL of ESC 
medium.  
Passaging from 6- to 6-well plate: washing with PBS (2 mL/well), cell detachment 
(500 µL of trypsin), neutralization/vigorous pipette (3 mL of ESC medium), centrifugation at 
1300 rpm for 3 minutes, and resuspension with 500 µL of ESC medium, (for passaging) 
transferring 100 µL of cell suspension to gelatin-coated well containing 2 mL of ESC 
medium, (for freezing) transferring 500 µL to cryotube containing 500 µL of ice cold ESC 




2.4A.3 Freezing mouse ESCs 
  
Freezing medium composed of 10% DMSO (v/v) in ESC medium was prepared 
fresh and stored on ice before use.  The cells were harvested after passaging. Cells were re-
suspended in cold freezing medium to obtain 2 million cells/mL and transferred to cryotube 
(1 mL per vial). The tubes were stored at -80 oC overnight. On the following day, the 
cryotubes were transferred to liquid nitrogen cell bank. 
 
2.4A.4 Thawing mouse ESCs 
 
Frozen cells from liquid nitrogen were quickly thawed at 37 oC. The defrosted cell 
suspension was transferred to 9 mL of warm ESC medium. The cells were collected by 
centrifugation at 1100 rpm for 5 minutes. The cell pellet was gently re-suspended with 
appropriate volume of ESC medium and transferred to appropriate gelatin-coated vessel. The 
medium was changed on the following day. 
 
2.4A.5 Transfection of mouse ESCs 
 
a) Transfection by liposomes 
 
Transfection was performed by using Lipofectamine® 2000 DNA transfection 
reagent (Invitrogen). Briefly, one million ESCs were seeded onto one well of gelatinised     
6-well plate, followed by one-hour incubation. During this incubation, 3 µg DNA and 3 µL 
lipofectamine were added to 250 µL OptiMEM medium or serum-free ESC medium (in 
polystyrene tubes) and incubated at room temperature for 30 minutes. After one hour, the 
DNA/transfection agent mixture was added in dropwise manner to the culture and the cells 
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were incubated overnight. Medium was changed on the following day. The cells were 
collected for further applications after two days of transfection.  
 
b) Transfection by electroporation 
 
Transfection by electroporation was done as following:  
 
1) The preparation of linearised plasmid  
 
100 µg of plasmid was linearised with restriction enzymes as described in section 
2.2.3. The linearised plasmids were then purified by DNA precipitation as described in 
section 2.2.10. The DNA pellet was air-dried and re-suspended in 200 µL PBS in a laminar 
flow hood.  
 
2) ESC preparation 
 
 ESCs were grown until 80% confluency in 75 cm2 flasks (containing around 20 
million cells/flask). The cells were harvested as described in 2.4A.1. The cells were counted 
and 10 million cells were transferred to a universal tube. The cells were collected by 
centrifugation at 1300 rpm for 3 minutes, washed once with 10 mL of warm PBS, collected 
by centrifugation again. The cell pellet were then re-suspended in 600 µL of warm PBS, 
mixed with 200 µL of DNA and allowed to stand at room temperature for 10 minutes. The 
DNA/cell suspension was transferred to a 4 mm electroporation cuvette (Biorad). The 
electroporation was carried out by electroporator BioRad at 0.8 kV and 10 µF. The 
successful electroporation gave time constant around 0.1. After electroporation, the cells 
were allowed to rest at room temperature for 10 minutes. The cells were then gently 
transferred to a universal containing 10 mL of ESC medium. One million cells were plated 
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on gelatin-coated 100 mm culture dish containing 10 mL of ESC medium. For rescue 
experiment, the medium was changed after two days of electroporation.  
 
Section 2.4B Mouse embryonic fibroblast cell culture 
 
2.4B.1: MEF cell culture 
 
Both MEF for feeder preparation and iPSC induction were cultured in MEF medium 
composed of DMEM (high glucose), 10% fetal bovine serum (FBS), 0.1 mM MEM non-
essential amino acids (NEAA), 2 mM L-glutamine, 0.1 mM β-mecaptoethanol, and 1% 
penicillin-streptomycin (Invitrogen). For passaging, the cells were washed once with warm 
PBS and dissociated by adding 1X trypsin-EDTA and incubating for 5 minutes. After 
incubation, the trypisinised cells were re-suspended with MEF medium in ratio 1:10 (1 mL 
of trysinised cells with 9 mL of MEF medium). The cell suspension was centrifuged at 1800 
rpm for 5 minutes. The cell pellet was then re-suspended in the appropriate volume of MEF 
medium.  
 
2.4B.2: Feeder preparation 
 
MEF cells from frozen stock were defrosted and expanded in MEF medium. The 
cells were cultured in 150 cm2 flask until 90% confluency. The cells were harvested as 
passaging procedure described in section 2.3.4 and expanded in ten of 150 cm2 flasks until 
90% confluency. To inactivate the cell division, the MEF cells were treated with mitomycin- 
C (Sigma) at 10 ug/mL final concentration for 2 hours. Alternatively, the MEFs were 
irradiated with gamma radiation treatment at 3000 rad for 30 minutes. After treatments, the 
cells were harvested for obtaining frozen stock. 500 µL of 4-8 million cells/mL cell 
suspension was prepared and added into cryotubes containing 500 µL of cold freezing 
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medium composed of 20% of DMSO in FBS. The cells were stored in 80 oC and transferred 
to liquid nitrogen cell bank on the following day. 
 
Section 2.4C Induced pluripotent stem cell culture 
 
2.4C.1:The maintenance of iPSCs 
 
Unless otherwise specified, all iPSCs were cultured on the irradiated feeders or 
mitomycin-treated feeders. The feeder preparation is described in section 2.4B.2. Two 
million of feeders were seeded onto gelatinised 6-well plate (around 300,000 cells/ well, 35 
mm2 surface area). The defined iPSC medium composed of 390 mL of DMEM high glucose, 
100 mL of knockoutTM serum replacement (KOSR), 5 mL of non-essential amino acid, 5 mL 
of L-glutamine, 500 µL of B-mercaptoethanol, and 550 µL of LIF, 1000 µL of 10 mg/mL 
Vitamin C (L-ascorbic acid), 25 µL of 10 µM Alk5 inhibitor. The defined medium was used 
for both iPSC induction and maintenance.  
 
2.4C.2: iPSC colony picking, expansion and freezing 
 
The process of iPSC colony picking was the same as ESC colony picking described 
in section 2.4A.2, except that iPSCs were seeded onto flask/dishes coated with feeders. In 
general, the feeders were seeded one or two days before colony picking and expansion. The 
freezing stock preparation was the same as to ESC described in section 2.4 A.3. The cell 
pellet for freezing was re-suspended in defined iPSC medium to obtain 2-4 million/mL. 500 
µL of cell suspension was added into cryotube containing cold freezing iPSC medium (20% 
DMSO in KOSR). The cells were stored at -80oC and transferred to liquid nitrogen cell bank 
on the following day. 
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Section 2.4D Retrovirus production 
 
The ecotropic retrovirus production was performed under GMO class I. The 
retrovirus strategy is illustrated in figure 2.1. 
 
2.4D.1 Packaging cell lines for retrovirus production  
 
293LTV (CellBioLab) cell line was used as packaging cell line for retrovirus 
production. The cells were maintained in the complete medium composed of DMEM (high 
glucose), 10% fetal bovine serum (FBS), 0.1 mM MEM non-essential amino acids (NEAA), 
2 mM L-glutamine, and 1% Pen-strep. The cells were passaged in the same way as ESCs 
section 2.4A.1. 
  
2.4D.2 Retroviral transfection 
 
To produce retrovirus particle, packaging cell lines were transiently transfected with 
two expression vectors: pMXs-vector carrying gene of interest and pCL-ECO containing 
modified gene encoding retroviral components. pCL-ECO packaging vector consists of three 
retroviral genes: gag, pol, and env which are essential to establish complete retroviral 
particles capable of infection. Types of envelop protein, gp70 encoding by env determine the 
host of infection. The retrovirus produced by this pCL-ECO is ecotropic (MoMuLV based), 
meaning that it can infect only mouse and rat cells, but not human cells. 
 
Transient transfection was performed using Lipofectamine LTX (Invitrogen). 
Briefly, the 293LTV cells were grown until 50% confluency. At the time of transfection, 50 
µg of retrovirus expression vector pMXs, 25 µg of packaging vector and PLUS reagent 
(supplied with Lipofectomine LTX) were mixed in 1.50 mL of OptiMEM I (Invitrogen) to 
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obtain the “mixture 1”. Then, 100 µL of Lipofectamine LTX was mix with 1.50 mL of 
OptiMEM I to obtain the “mixture 2”, which was incubated at room temperature for 5 
minutes. After the incubation, both mixtures were mixed together and incubated further for 
20 minutes. The mixture of DNA/Lipofectamine was then added in dropwise manner onto 
the cells cultured in 25 mL of the 293 LTV medium. The cells with transfection reagents 
were incubated at the normal cell culture conditions overnight. The medium was changed on 
the following day. Retroviral expression vector with dsRED gene (pMXs-dsRED) was used 
to roughly monitor the transfection efficiency, and the strong expression of dsRED could be 
noticed in 293LTV after 24 hours. The retrovirus from pMXs-dsRED transfection was also 
collected for testing infection efficiency at the later step.   
 
2.4D.3 Collection and concentrating of retrovirus   
 
Retrovirus supernatant or medium containing virus particles was harvested at day 2 
and day 3 after transfection to obtain two batches of retrovirus. The viral supernatant was 
filtered with WHATMAN 0.45 µM filter unit (made from cellulose acetate) to remove the 
contaminated 293LTV cells and debris. The retrovirus then was concentrated by Retro-
Concentrator (Clontech) solution in ratio 1:3 and incubated at 4 oC overnight. On the 
following day, the virus supernatant/concentrator mixture was centrifuged at 1500 g for 45 
minutes at 4 oC. The virus pellet was then re-suspended in small volume of MEF medium to 








2.4D.4 Measurement of retrovirus titer 
 
The titer of retrovirus was measure by Retro-X qRT-PCR Titration Kit (Clontech). 
Briefly, retroviral RNA were purified from fresh retrovirus with NucleoSpin RNA Virus Kit, 
following manufacturer instruction. The final elution was done with 50 µL of RNase-free 
water. To avoid the contamination of DNA from transient transfection of previous steps, the 
RNA samples were treated with DNase I (Clontech, 12.5 µL of RNA samples, 2.5 µL of 
DNaseI buffer, 4 µL of 5 units/ul DNase I, 6.0 µL of RNase-free water), and the 
RNA/DNaseI were incubated at 37 oC for 30 minutes and then at 70 oC for 5 minutes. The 
treated RNA was stored in -80 oC before the qRT-PCR step. The SyBrGreen-based qRT-
PCR was performed according to the manufacturer’s instruction (Clontech). Briefly, RNA 
samples were serially diluted in four concentrations: 1X, 0.1X, 0.01X and 0.001X. The RNA 
control template was serially diluted in five concentrations (copies/µL): 5X107, 5X106, 
5X105, 5X104, and 5X103. The qRT-PCR mastermix solution was composed of 5 µL of 2X 
Quant-X buffer, 0.2 µL of 10 µM retro-X forward primer, 0.2 µL of 10 µM retro-X reverse 
primer, 0.2 µL of Quant-XTM enzyme, 0.2 µL RT-Enzyme Mix, 2.2 µL of RNase-free water 
and 2 µL of serially diluted RNA. The qRT-PCR reactions were carried out in a 
LightCycler480 (Roche) with following conditions: reverse transcription (RT) reaction (42 
oC 5 minutes, 95 oC 10 seconds), 40 cycles of qPCR (95 oC 5 seconds, 60 oC 30 seconds), 
and dissociation curve (95 oC 15 seconds, 60 oC 30 seconds). The standard curve was 
constructed based on the serial diluted RNA template with known concentration of retroviral 
copies. The calculations of retrovirus RNA copy number were done in LightCycler480 






Figure 2.1 Retrovirus production for iPSC generation
see the description in section 2.4D
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ESC cells were seeded onto 8 well 15µ-Slide (Ibidi) at a density 20,000 cells/well. 
The cells were grown for two days. The cells were washed once with warm PBS, and fixed 
with 150 µL of 4% paraformaldehyde (PFA) for 15 minute at room temperature. The fixed 
cells were washed three times with PBS and were stored in PBS at 4 oC in case 
immunostaining was not immediately performed after the fixation. The cells were incubated 
in the blocking solution (200 µL of TritonX 100, 2 mL of serum and 1 mL of 7.5% BSA in 
100 mL of PBS) for one hour prior to the staining procedure. The types of serum used in the 
blocking solution were the same as the secondary antibodies’ host. The primary antibodies 
were diluted in the blocking solution as described in section 2.1.3. The primary antibody 
solution was added into the fixed cells, followed by an overnight incubation at 4 oC. On the 
following day, the stained cells were washed three times with PBS prior the staining with 
secondary antibodies. Secondary antibodies were diluted 1:800 in the blocking solution. The 
solution was then added onto the cells with one-hour incubation at room temperature in the 
dark. The cells were washed three times with PBS, stored in PBS and visualised under 
microscrope. All immunofluorescence-stained cells were imaged in Leica AP6000 








2.5.2 Flow cytometry and Fluorescence-activated cell sorting (FACS) 
 
 ESCs/iPSCs were collected as described in 2.4A.1 and 2.4C.1. The cells were 
stained with appropriate dilution or primary antibodies (as section 2.1.3) in FACS buffer 
(10% FBS in PBS) with 15-minute incubation at 4 oC (dark). The cells were washed three 
times with FACS buffer and re-suspended in cold FACS buffer containing DAPI (100 
ng/mL). If secondary antibodies were required, the cells were further stained with 
appropriate dilution of secondary antibodies for 15 minutes, washed three times with PBS, 
re-suspended in cold FACS buffer containing DAPI. If only one surface marker was 
examined, the primary and secondary antibodies were added at the same time for the 
staining. DAPI was used in all FACS analysis to exclude the dead cells. All experiments 
included unstained E14Tg2A ESCs as non-fluorescent control required for gating process. 
Flow cytometry analysis and cell sorting were carried out on a Fortessa (BD Bioscience), 
FACS Aria Cell Sorter II SORP (BD Bioscience). Flow cytometry data from Fortessa and 
FACS Aria were further analyzed in FCS Express (De Novo Software).  
  
The amounts of cells used for sorting depended on the percentage of required 
subpopulations. The cells were sorted into FACS buffer-coated FACS tubes. The sorted cells 
were collected by centrifugation at 500 g for 10 minute at 4 oC. The supernatant was 
carefully removed by aspirator. For RNA extraction, 350 µL of buffer RLT was directly 
added to the cell pellet in FACS tubes and transferred to eppendofs for further RNA 







2.5.3 Alkaline phosphatase staining 
 
The Leukocyte Alkaline phosphatse Kit (Sigma, 86R-1KT) was used for the 
staining, Before starting the procedure, cells were washed once in PBS and fixed for one 
minute with a fresh solution containing 25 mL of citrate solution, 8 mL 37% formaldehyde 
and 65 mL acetone. The fixed cells then were washed twice with tap water and stained with 
fresh AP solution. 400 µL of FRV alkaline phosphatase solution and 400 µL of sodium 
nitrate solution were firstly mixed and incubated in dark for 2 minutes. Then the mixture was 
added into 18 mL of water and mixed well. 400 µL of naphthol was lastly added to the 
mixture. 5 mL of the mixture was immediately added to the fixed cells, followed by 25-
minute incubation in dark at room temperature. After the incubation, the undifferentiated 
ESC colonies obtained red-violet colour. The stained cells were washed twice with tap water 
and air dried overnight. The photos of AP colonies were taken by microscope Leica-5500B 
(10X magnification). All AP images were then processed with FIJI, imaging processing 
software. The colonies were categorised into 3 classes: undifferentiated, mixed and 
differentiated colonies based on the intensity of AP staining. Undifferentiated colonies are 
AP positive containing less than 5% AP negative differentiated cells around periphery of the 
colony. Mixed colonies exhibit AP positive cells in the centre of the colony, but also contain 
from 10 to 80% of differentiated cells around periphery. Differentiated colonies show only 
faint AP staining and consist of at least 90% differentiated cells (figure 2.2). The rescue 
index was calculated by dividing (1) the number of rescued AP positive ES cell colonies 
obtained in the absence of endogenous Oct4 with  (2) the number of rescued AP positive 
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Figure 2.2 The classification of alkaline phosphatase (AP) stained ESC colonies 











ESCs/iPSCs were grown until 50-70% confluence. The cells were incubated with 
ESC/iPSC medium containing 0.1 μg/mL demelcocine (colcemid) at 37 oC for 40 minutes. 
Demecolcine depolymerises microtubules, leading to the cell arrest at metaphase. After 
incubation, the metaphase-arrested cells were collected and incubated in 2.5 mL of 
hypotonic solution (0.56% KCl) for further 6 minutes. Cells were fixed in 1 mL of fixative 
(3 methanol : 1 acetic acid) at 4 oC for 30 minutes. Cells in fixative were dropped onto a 
cleaned glass microscope slide and air-dried. The slides were then stained with either 10% 
Giemsa (pH 7.2) or DAPI (1:10,000) for 20 minutes. The stained chromosomes can be 


















Section 2.6 Gene expression analysis 
 
2.6.1 Quantitative RT-PCR (qRT-PCR) 
 
Quantitative RT-PCR was performed using Roche Universal ProbeLibrary (UPL) 
System. UPL primers were designed by using Roche Assay Design Centre 
(http://lifescience.roche.com/shop/CategoryDisplay?identifier=Universal+Probe+Library). 
The list of UPL primers and probes are noted in section 2.1.4. Reactions were performed 
using the LightCycler® 480 Probes Master Mix (Roche) and UPL Set, Mouse (Roche) 
according to manufacturer’s instructions. Briefly, 1 reaction of UPL qRT-PCR composed of 
5 µL of Probes Master Mix, 0.45 µL of 10 µM forward/left primer, 0.45 µL of 10 µM 
reverse/right primer, 0.1 µL of specific probe, 2 µL of diluted first strand cDNA, and 2 µL of 
RNase-free water. The RNA and cDNA preparations are described in 2.2.15 and 2.2.17. The 
stand curve for each gene assay was constructed based on the serial dilution of cDNA pool 
(the combination of cDNA from all samples). The concentration of transcripts of each gene 
was calculated in LightCycler software based on the cDNA pool-derived standard curve. The 
values of concentration from each gene of interest were normalised to that of housekeeping 










2.6.2 Agilent one-colour microarray  
 
Global transcriptomes of POUV-rescued lines and iPSC lines were obtained by 
using Agilent one-colour microarray-based gene expression analysis, following 
manufacturer’s instruction. Only samples with high quality RNA (RIN = 10) were used for 
the analysis to ensure the chance of successful and reliable outcomes. The RNA extraction 
and quality control are described in section 2.2.15 and 2.2.16. For both rescue and iPSC 
experiments, total RNA was labeled in Cyanine 3 CTP labeling reaction according to the 
manufacturer’s instruction and purified by Qiagen’s RNeasy Mini Spin Columns. The 
quantity of purified cRNA was measured by Nanodrop UV spectrophotometer. 600 ng of 
cRNA from each sample was used for fragmentation according to the manufacturer’s 
instruction. The fragmented cRNA was then added to the 8X60K Agilent slides containing 
probes specific for mouse genes (Grid_GenomicBuild: mm9:NCBI37:Jul2007), followed by 
17-hour hybridization step at 65 oC, and washing with Agilent wash buffer. The processed 
slides were scanned with Agilent Scanner (Agilent Technologies, G2600D SG12524268), 
following manufacturer’s instruction. The data were analyzed by NIA Array Tool Analysis 
(http://lgsun.grc.nia.nih.gov/ANOVA/bin/login.cgi) for comparative global transcriptome 
analysis. Overexpressed genes and underexpressed genes from pairwise comparison were 
extracted to analyze the enrichment of gene categories based on several features e.g. 
molecular functions, biological functions, cellular functions, protein domains (Gene-
annotation enrichment analysis or Gene ontology (GO) enrichment analysis). The GO 
analysis was done using NIA tools (http://lgsun.grc.nia.nih.gov/ANOVA/) and ExATLAS 
(http://lgsun.grc.nia.nih.gov/exatlas/), BINGO in Cytospace, and Panther 
(http://pantherdb.org). The lists of genes were also analyzed by GENEMANIA 
(http://www.genemania.org) to visualise the gene network. For GO analysis by BINGO, the 
parameters were including 1) Binomial statistical test 2) Bonferroni Family Wise Error Rate 
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(FWER) correction 3) significant level P<0.005 4) visualization by overrepresented 

























Section 2.7 ZHBTc4 rescue experiment  
 
ZHBTc4 cell line designed by Hitoshi Niwa (Niwa et al., 2000) was used for Oct4 
rescue experiment. The Oct4-null ESC rescue strategy is illustrated in figure 2.3B. In 
ZHBTc4 ESC cell line, both alleles of endogenous Oct4 are disrupted by homologous 
recombination and tetracycline-regulated Oct4 transgene is randomly integrated. Without 
adding tetracycline (Tc), Oct4 can be expressed from the transgene and the cell line can 
maintain its ESC self-renewal and pluripotency. In contrast, adding Tc blocks Oct4 
expression from the transgene, leading to its dramatic reduction of Oct4 protein in 12 hours 
(Niwa et al., 2000). ZHBTc4 with Tc quickly differentiates toward trophectodermal lineage 
in a few days. Thus, we can test the ability of other POUV proteins in rescuing Oct4-null 
ESC by their constitutive expression in the same time of adding Tc to remove mouse Oct4 
expression (figure 2.3A).  
 
The sources of POUV genes used for rescue assay are listed in section 2.1.2. POUV 
coding sequences were subcloned into plasmid pPCAG575-SiP between CAG promoter and 
IRES-Puromycin resistant gene (PAC). The pPCAG575-SiP-POUV plasmids were 
linearized according to section 2.4A.5 (without removing Origin of replication). The 10 
million of ZHBTc4 ESC cells were electroporated with 100 µg of linearised plasmids. One 
million of electroporated cells were then plated into gelatinised 100 mm culture dish 
containing 10 mL of ESC medium with and without tetracycline (Tc, 2 µg/mL). Thus, for 
each condition there were five plates with Tc and another five plates without Tc. In all 
experiments, 3XFlag mOct4 and empty vector were tested as the positive and negative 
control, respectively. At day 2 post electroporation, the medium was changed to ESC 
medium supplement with 1µg/mL puromycin (with and without Tc) to select the cells 
expressing transfected POUV genes. The medium was changed every two days. At day 9 
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post electroporation, the ESC colonies could be seen and were ready for alkaline 
phosphatase staining (section 2.5.3). At the same day of AP staining, 24 clones of POUV-
rescued clones were picked and 12 clones were further expanded for obtaining frozen stocks 
(section 2.4A.1, 2.4A.2 and 2.4A.3) and other applications including immunofluorescent 
staining (section 2.5.1), flow cytometry (section 2.5.2), qRT-PCR (section 2.6.1), 
microarray-based transcriptome analysis (section 2.6.2). During passaging and cell 
preparation for all investigations, POUV-rescued clones were maintained in ESC medium 
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Figure 2.3 Procedures for Oct4-null ESC rescue experiment
see the description in section 2.7 
Trophectodermal lineage
ESC colonies can 




Section 2.8 Procedure for the generation of iPSCs  
 
The iPSC strategy is illustrated in figure 2.4. Induced pluripotent cells (iPSC) were 
established by ecotropic retrovirus-based induction of Yamanaka transcription factors: 
mouse Oct4, Sox2, Klf4 and c-Myc. In this study, mouse Oct4 in retroviral expression vector 
was replaced by Xenopus Pou91 (Xlpou91, Pou5f3.1) and Xenopus Pou25 (Xlpou25, 
Pou5f3.2) in the murine cellular reprogramming. The detail of plasmids is described in 
section 2.1.2. The retroviral expression system was based on pMXs-vector, which was 
originally used by Shinya Yamanaka laboratory for the first iPSC induction (Takahashi and 
Yamanaka, 2006).  
 
The source of somatic cells for the reprogramming was Nanog-GFP mouse 
embryonic fibroblasts (Nanog-GFP MEFs), in which the cells carry green fluorescent protein 
(GFP) expression under the control of one Nanog promoter. The emergence of GFP 
indicated the Nanog expression, which was used to monitor the pluripotency acquisition and 
reprogramming behavior. The procedures for isolation and maintenance of Nanog-GFP 
MEFs are described in section 2.3.  
 
Regarding the induction, 100,000 MEF cells were seeded onto gelatin-coated 6-well 
plate in 2 mL of MEF medium per well, followed by overnight incubation. On the following 
day, MEF cells were observed under microscope to ensure that MEF cells were grown until 
approximately 50-60% confluency. For infection, the following amounts of retrovirus were 





(1) Negative control 1: no retrovirus added 
(2) Negative control 2 - “SKM only”:  
1X109 retrovirus copies of Sox2, Klf4 and c-Myc 
(3) Negative control 3 - “dsRED low SKM”:  
1X109 retrovirus copies of dsRED, Sox2, Klf4 and c-Myc 
(4) Negative control 4 - “dsRED high SKM”:  
5X109 retrovirus copies of dsRED and 1X109 retrovirus copies of Sox2, Klf4 and c-Myc  
(5) Positive control/ POUV testing 1 - “mOct4 low dose SKM”:  
1X109 retrovirus copies of mouse Oct4, Sox2, Klf4 and c-Myc 
(6) POUV testing 2 - “mOct4 high dose SKM”:  
5X109 retrovirus copies of mouse Oct4 and 1X109 retrovirus copies of Sox2, Klf4 and c-Myc 
(7) POUV testing 3- “Xlpou91 low dose SKM”:  
1X109 retrovirus copies of Xlpou91, Sox2, Klf4 and c-Myc  
(8) POUV testing 4- “Xlpou91 high dose SKM”:  
5X109 retrovirus copies of Xlpou91 and 1X109 retrovirus copies of Sox2, Klf4 and c-Myc 
(9) POUV testing 5- “Xlpou25 low dose SKM”:  
1X109 retrovirus copies of Xlpou25, Sox2, Klf4 and c-Myc 
(10) POUV testing 6- “Xlpou25 high dose SKM”:  
5X109 retrovirus copies of Xlpou25 and 1X109 retrovirus copies of Sox2, Klf4 and c-Myc 
 
The retrovirus were prepared immediately prior to the infection. To start infection, 
the medium on the MEF cultures was aspirated and immediately replaced by the medium 
containing retrovirus. The cells incubated overnight and the same procedure of infection was 
repeated on the following day. The day of the first infection was count as “Day 0”. At day 2, 
cell media was replaced for 2 mL of MEF medium. On day 3, MEF medium was replaced 
with defined iPSC medium (section 2.4C.1). On day 4, the cells were collected by 
trypsinization (section 2.4 B.1). The cells were counted by haematocytometer and were then 
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collected by centrifugation at 1800 rpm for 5 minutes. The cells were re-suspended with 
defined MEF medium to obtain 10,000 cells/mL and reseeded onto irradiated feeder (10,000 
cells/well). The cells were placed in the incubator without disturbing for two days. Medium 
was changed daily from day 6 to day 10 and every two-day from day 12-26. The 
experiments was stopped at day 27 post the first infection. On day 24-28, iPSC colonies 
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Figure 2.4 Procedure for iPSC generation and analysis
 see the description in section 2.8




Section 2.9 Phylogenetic analysis and the estimation of rate of protein 
evolution 
 
The procedure for phylogenetic analysis is illustrated in figure 2.5. The sources of 
POU5F1 and POU5F3 proteins used in this study are shown in table 2.2 and 2.3. Phylogeny 
of vertebrates was estimated based on a manually-curated POU protein alignment (only POU 
domains) under Bayesian phylogenetic framework by using BEAST 1.8.0. The best amino 
acid substitution model (JTT+G) determined by ProtTest 2.4 was applied. The procedure for 
BEAST analysis is illustrated in figure 2.5.  Parameters used for BEAUTi v1.8.1 set up as 
following: 
 
1) Substitution Model: JTT (Jones et al., 1992) 
2) Site heterogeneity Model: Gamma 
3) Number of Gamma Categories: 4 
4) Clock Model: Lognormal relaxed clock (Uncorrelated) 
5) Tree Prior shared by all tree models: Speciation/Yule Process 
6) MCMC: Length of chain:10,000,000, Echo state to screen every: 10,000, Log  
parameters every: 10,000 
7) Taxa and Tree Prior TMRCA was set as shown in Figure 2.6 and Table 2.4. 
 
The XML files with following parameters and input protein sequences were 
generated by BEAUTi and subjected to further process with BEAST. I used online platform 
CIPRES SCIENCE GATEWAY (https://www.phylo.org) for BEAST analysis (Miller et al., 
2010). Two outputs from BEAST analysis (.log and .tree file) were analyzed for statistical 
outcomes of the phylogenetic tree and constructed the phylogenetic tree by TreeAnnotator 
v.1.8.1 and visualised by FigTree (v.1.4.2). The rate of protein evolution was visualised as 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.2 Sources for POU5F1 protein sequences 
 
Species Genbank ID 
Latimeria chalumnae (Coelacanth) AFYH01090867 (17555-18199), 
BAHO01146254 (698-809, 2975-3105, 3982-
4143, 4560-4850) 
Ambystoma mexicanum (Axolotl or Mexican 
salamander) 
AY542376 
Python bivittatus (Burmese python) XP_007432810.1 
Anolis carolinensis (Green anole) XP_008120168.1 
Chrysemys picta bellii (Painted turtle) AHGY01526669 (432-995), AHGY01303135 
(1193-1082, 623-493), AHGY01303134 (178-
17), AHGY01303133 (2081-1811) 
Equus caballus (Horse) XP_001490158 
Ceratotherium simum simum (White rhinoceros) XP_004424441              
Odobenus rosmarus divergens (Walrus) XP_004409093 
Panthera tigris altaica (Siberian tiger) XP_007090678 
Myotis lucifugus (Little brown bat) XP_006104717 
Vicugna pacos (Alpaca) XP_006215371 
Sus scrofa (Wild pig) NP_001106531 
Bos Taurus (Cow) NP_777005                 
Balaenoptera acutorostrata scammoni (Minke whale) XP_007194049 
Lipotes vexillifer (Baiji-Chinese river dolphin) XP_007449241              
Sorex araneus (Common shrew) XP_004619648 
Erinaceus europaeus (European hedgehog) XP_007532379 
Homo sapiens (Human) isoform1, OCT4A NP_002692.2 
Callithrix jacchus (Common marmoset) NP_001252513              
Tarsius syrichta (Philippine tarsier) XP_008069928 
Otolemur garnettii (Northern greater galago) XP_003789042 
Tupaia chinensis (Treeshrew) XP_006172307 
Mus musculus (Mouse) ENSMUSG00000024406 
Peromyscus maniculatus bairdii (Prairie Deer Mouse) XP_006997372 
Jaculus jaculus (Lesser Egyptian Jerboa) XP_004671946 
Oryctolagus cuniculus (European rabbit) NP_001093427 
Orycteropus afer afer (Aardvark) XP_007949571 
Loxodonta Africana (African bush elephant) XP_003422494 
Dasypus novemcinctus (Nine-banded armadillo) XP_004457909 
Macropus eugenii (Tammar wallaby) FJ998419 
Ornithorhynchus anatinus (Platypus) NP_001229656              
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Table 2.3 Sources for POU5F3 protein sequences 
 
Species Genbank ID 
Latimeria chalumnae (Coelacanth) coelacanth POU5F3, JH126767 (739970-
739293, 735489-735378, 725094-724964, 
718795-718631, 713786-713511) 
Acipenser sinensis (Sturgeon) JN099311 
Lepisosteus oculatus (Spotted gar) XP_006640642.1 
Labeo rohita (Rohu) ADC96616.1 
Danio rerio (Zebrafish) NM_131112 
Astyanax mexicanus (Blind cave tetra) XP_007230899.1 
Cynoglossus semilaevis (Tongue sole) XP_008322749.1 
Oryzias latipes (Medaka fish; Japanese rice fish) NP_001098339.1 
Poecilla reticulate (Rainbow fish) XP_008422195.1 
Xiphophorus maculatus (Platyfish) XP_005799711.1 
Oreochromis niloticus (Nile tilapia) XP_005451421.1 
Neolamprologus brichardi (Cichlid) XP_006788794.1 
Larimichthys crocea (Yellow croaker) NP_001290294.1 
Stegastes partitus (Damselfish) XP_008302560.1 
Takifugu rubripes (Japanese puffer) XP_003965650.1 
Xenopus laevis (African clawed frog), Xlpou91 NP_001081342.1 
Xenopus laevis (African clawed frog), Xlpou25 ABH07383 
Ambystoma mexicanum (Axolotl or Mexican 
salamander) 
KF020689 
Chrysemys picta bellii (Painted turtle) AHGY01090879 (23030-23629, 30326-30440, 
31140-31270), AHGY01090878 (4146-4310), 
AHGY01090877 (649-903) 
Alligator sinensis (Alligator) XP_006022783              
Gallus gallus (Chicken) NP_001103648.1 
Melopsittacus undulates (Budgie) XP_005143614.1 
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(adapted from Hedges and Kumar 2009)
Figure 2.6 Timetree of vertebrates The figure is adapted from Hedges and Kamar 2009. The numbers in each node are refered to 
divergence time in table 2.4  Abbreviations: C (Carboniferous), Cm (Cambrian), CZ (Cenozoic), D (Devonian), J (Jurassic), K (Cretaceous), Np 

























Hagfish-lamprey 520/596-461 (1) 432/473-391 (9) 478/497-459 (9) not included 
not included 
Chondrichthyes-Osteichthyes 525/580-494 (1) 528/639-417 (8) 525/580-494




































Actinopterygii-Sarcopterygii 476/494-442 (1) 450/520-380 (8) 476/494-442
Lissamphibia-Amniota
Actinistia/Dipnoi-Tetrapods 430/438-421 (1) N/A N/A 430/438-421




282/356-250 337/353-321(11) (20) 294/319-271 (19)



































104.7/115-96 105.0/118-92 104.5/122-90(12) (8) (18)
103.3/114-95 (12) N/A N/A 103.3/114-95
104.7/115-96
77.8/86-70 (12) 89.0/104-75 (18)
75.1/83-67 (12) 80/96-67 (18)
73.0/81-65 (12) 85/100-71 (18)












97.4/106-90 (12) 92.0/95-89 (8) 92.5/105-81 (18) 97.4/106-90
91.0/99-84 (12) 90.8/95-87 (8) 85.5/98-76 (18) 91.0/99-84
89.1/97-82 (12) 89.1/97-8285.9/109-63 (8) 78.0/88-70 (18)
86.2/71-98 (12) N/A N/A 86.2/71-98
86.4/94-80 (12) 74.0/89-62 (18) 85.7/71-98 (7) 86.4/94-80
87.2/93-82 (12) 81.5/91-74 (18) N/A 87.2/93-82
84.6/80-90 (12) 83.0/91-75 (8) 78.0/85-72 (18) 84.6/80-90
84.2/89-79 (12) 74.0/85-63 (8) N/A 84.2/89-79
82.5/87-78 (12) N/A N/A
79.8/85-75 (12) 74.0/81-67 (18) N/A not included 
82.5/87-78
213/262-164 (10) 204/218-190 (3) 227/251-203 (3) 213/262-164
192/238-146 (17) 178.5/192-166 (3) 173.0/197-149 (5) 178.5/192-166
323/343-305 (16) 326/354-311 (1) N/A 326/354-311
276/383-169 (8) 285/296-274 (3) 289/302-276 (3) 276/383-169
268/278-256 (3) 275/292-258 (3) N/A not included 
225/238-205 (14) 265/278-252 (3) 273/291-255 (3) 225/238-205
222/325-119 (8) 214/259-169 (10) 259/282-236 (20) 222/325-119
407/376-446 (5) N/A N/A not included 
343/310-381 (5) 372/347-391 (4) N/A
327/295-366 (5) N/A N/A
343/310-381
not included 
312/279-351 (5) N/A N/A 312/279-351
307/371-215 (5) 230/264-200 (10) 278/314-241 (10) 278/314-241
170.5/153.1-187.9 (13) N/A N/A 170.5/153.1-187.9




N/A N/A N/A Prior default
Table 2.4  Divergence times of vertebrate lineages in million of years for BEAST analysis to estimate the rate 
of POUV protein evolution The nodes are referred to figure 2.6 timetree of vertebrates (adapted from Hedges & Kumar 2009). The second 
column is the description of lineage divergence, for example “Gnathostome-Cyclostome” means the divergence of Cyclostome lineage from 
Gnathostome ancestor occured around 652 million years ago. The third-fifth columns are time estimates of divergence event in million year unit and 
CL is the 95% confidential interval. The last column contains time estimates I used for BEAST analysis of POUV protein evolution. N/A stands for 
“not available age estimates”.  “Not included” means that there is no POUV protein/DNA sequence available for that specific lineages. References 
in brackets (1) Blair and Hedges 2005 (2) Hedges and Kumar 2009 (3) Hugall et al., 2007 (4) Hurley et al., 2007 (5) Ionue et al., 2003 (6) Ionue et 
al., 2005 (7) Janecka et al., 2007 (8) Kumar and Hedges 1998 (9) Kuraku and Kuratani 2006 (10) Mannen and Li 1999 (11) Marjanovic and Laurin 
2007 (12) Murphy et al., 2007 (13) Near et al., 2012 (14) Paton et al., 2002 (15) Peng et al., 2006 (16) Pereira 2006 (17) van Rheede 2005 














Pluripotency is the ability of cells to give rise to all somatic lineages including germ 
cells (the origin of sperm and oocyte). In mouse embryo, inner cell mass (ICM), epiblast, 
and primodial germ cells are pluripotent cells, they can be isolated and maintained in vitro as 
pluripotent stem cells called embryonic stem cells (ESCs), epiblast stem cells (EpiSCs), and 
embryonic germ cells (EGCs) respectively. Pluripotent stem cells can also be generated via 
the reprogramming of adult somatic cells through the exogenous expression of transcription 
factors normally expressed in ESCs, to make induced pluripotent cells (iPSCs).  
 
Pluripotency is regulated through a series of extrinsic signals that input into a 
complex network of transcription factors. A class V (POUV) transcription factor called 
Oct3/4 (here referred to Oct4) is an essential component of this network. The removal of 
Oct4 from the mouse blastocyst or the ESCs resulted in a failure to maintain pluripotent cell 
types and differentiation toward an extraembryonic tissue called trophectoderm, which is the 
origin of placenta (Nichols et al., 1998). Oct4 also regulates differentiation in dose-
dependent manner such that either up- or down-regulation of Oct4 can cause differentiation 
and Oct4 is therefore both a mediator of self-renewal and differentiation (Niwa et al., 2000). 
ESC-expression levels of Oct4 are required for both the maintenance of ESC self-renewal 
and efficient differentiation into all lineages (Radzisheuskaya et al., 2013). Oct4 is also a 
central player in reprogramming to generate iPSCs (Takahashi and Yamanaka, 2006). 
Moreover, while different cocktails of transcription factors can reprogram somatic cells to 
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iPSCs, Oct4 is required for most combinations (Kim et al., 2009; Li et al., 2011; 
Radzisheuskaya and Silva, 2013; Yuan et al., 2011).  
 
Recent advances in genome assembly technologies have enabled the completion of a 
vertebrate genome sequence database that includes almost all branches of vertebrate taxa. So 
far, more than 100 potential POUV gene sequences have become available in a range of 
vertebrate genomes, providing important information to help understand how this class of 
POU proteins originated and evolved.  What are the origins of the regulatory program driven 
by this master stem cell factor? To what extent are different POUV activities conserved 
functionally? Based on several pieces of evidence including conserved protein region called 
POU domains, exon-intron structure, and the conserved synteny, jawed vertebrate POUV 
genes likely share a common ancestor; hence it is logical to call all POUV genes in several 
jawed vertebrate taxa together as POUV/Oct4 homologs. 
 
The conserved synteny of POUV, which is preserved co-localization of POUV-
flanking genes in different species, leads to further classification of POUV genes into two 
subfamilies named POU5F1 and POU2/POU5F3 (In my thesis I refer to only POU5F3). It is 
believed that both classes of POUV originated from a single POUV gene through genome 
duplication, which occurred before the divergence of extant cartilaginous fish and bony fish.  
Hence, all vertebrate POU5F1 genes can be called technically together as POU5F1 
orthologs while all POU5F3 genes as POU5F3 orthologs. Based on the assumption that 
these two genes originated after duplication from a single gene, POU5F1 can be called as a 
paralog of POU5F3 (or POU5F3 paralog) and vice versa (Frankenberg and Renfree, 2013).   
 
 A significant number of extant vertebrate species have lost either POU5F1 or 
POU5F3 gene. The vertebrate taxa retaining only POU5F3 include cartilaginous fish, 
actinopterygians (e.g. sturgeon, zebrafish, medaka), birds, and crocodiles. The vertebrate 
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taxa retaining only POU5F1 include lizards, snakes, eutherians (e.g. mouse, human, 
elephant). Based on available expression profiles of POUV in some species, the only 
remaining POUV protein (either POU5F1 or POU5F3) is generally found and play roles in 
both epiblast and germ cells. In eutherian mammals, POU5F1 is additionally found in ICM, 
an evolutionary novel structure of that enables the early formation of both embryonic and 
extra-embryonic lineages (Nichols et al., 1998). It is noteworthy that germ cells/EGCs and 
ICM/ESCs share lot of gene expression and epigenetic status in common (Leitch et al., 
2013). Hence, this suggests that POUV protein activities can basically be categorised into 
two subfunctions: epiblast like activity and germ cell/ICM like activity. Interestingly, some 
species including some cartilaginous fish, coelacanths, axolotls, turtles, monotremes (e.g. 
platypus) and marsupials (e.g. tammar wallaby) retain both classes of POUV gene. 
Following the trend of some other duplicated genes, POUV subfunctions in these species 
seem to segregate into different POUV proteins, in that POU5F1 regulates pluripotency 
related to germ cells, while POU5F3 plays roles in the epiblast during gastrulation, as 
suggested by expression profile of both POUV proteins in tammar wallaby (Frankenberg et 
al., 2013).  How can this functional distinction between POU5F1 and POU5F3 be verified? 
How is this distinction related to cell potency, early development and germ cell 
specification? Do those species carrying both POUV forms show this functional 
segregation? These are unanswered questions I investigated in this chapter.  
 
At the beginning (section 3.1), I performed in silico analysis of vertebrate POUV 
proteins to understand the evolutionary relationships between POUV orthologs. Integrative 
knowledge of fossil records and molecular analysis enables many research groups to identify 
the divergence time among vertebrate taxa. Based on these divergence times and our 
combined POUV protein sequences from available online database, I illustrate how POUV 
proteins have evolved in each vertebrate lineage. Next, I investigated their biological 
functions to address the hypothesis that POU5F1 maintains pluripotency in early 
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embryo/ESC and germ lines while POU5F3 play roles during gastrulation. I replaced the 
endogenous Oct4 in mouse ESCs with either POU5F1 or POU5F3 genes from different 
species and analyzed the ability of these POUVs to regulate pluripotency and differentiation. 
I found that POU5F1 proteins have a greater capacity to maintain ESC self-renewal than 
POU5F3 proteins. Moreover, germ cell/ESC markers were consistently expressed at higher 
levels in cells rescued by POU5F1 proteins, while POU5F3-rescued ESC lines showed a 
higher degree of differentiation. The most striking difference in the ESC rescue activity of 
different POUV paralogs was observed between coelacanth POU5F1 and POU5F3 (section 
3.2-3.3). Global gene expression profiling of coelacanth POUV-rescued lines provided 
evidences that POU5F1 has conserved roles in regulating germ line level pluripotency while 
POU5F3 regulates more epiblast-related developmental programs including cell 
differentiation and cell adhesion (section 3.4-3.7).  
 
Lastly, I aimed to find the origin of POU5F1 and POU5F3 genes. As it is believed 
that genome duplication took place before gnathostome (jawed vertebrate) ancestor 
originated (Donoghue and Keating, 2014), the single POUV gene might present in extant 
vertebrates whose ancestor diverged before jawed vertebrates. The only closest extant 
vertebrates to gnathostomes belong to Cyclostomata including lamprey and hagfish. In the 
last section 3.8, I describe a POUV gene in the arctic/Japanese lamprey and show that also in 
this species the POUV gene is structured into 5 protein-coding exons. Interestingly, there is 
only one POUV gene in lamprey, which support that this might represent a bona fide 







Section 3.1 Evolutionary Model of POU5F1 and POU5F3 proteins 
 
Several studies have conveyed an in-depth phylogenetic analysis of a conserved 
protein region called POU domain. Based on these analyses, several proteins containing 
POU domains were identified across animal kingdom and categorised into the class I to class 
VI (Gold et al., 2014). Oct4 and its homologs (both POU5F1 and POU5F3) are classified 
into the same major group of class V POU proteins. In POUV protein, there are very 
divergent N- and C- terminal protein domains (NTD, CTD respectively) that flank the 
conserved domain. Inside the POU domains, there are two distinct conserved sequence 
regions: the first part joined to the NTD is the POU specific domain (POUS), and the second 
part joined to the CTD is the POU homeodomain (POUHD). These two POU subdomains are 
joined by a highly diverged protein linker sequence (Figure 3.1-3.4). 
 
 Based on the already characterised distinction between POU5F1 and POU5F3, all 
gnathostome POUV proteins were assumed to be either POU5F1 or POU5F3-like protein. 
However, in the NCBI database, most POU5F3 genes were misidentified as POU5F1 or 
POU5F1-like genes. Here I was be able to gather all vertebrate POUV genes/proteins 
available online and categorised them into the right subfamilies for further analysis. 
Originally, global phylogenetic analysis of both POU5F1 and POU5F3 was not enough to 
distinguish all POUV proteins into two distinct subclasses because some POUV proteins 
extremely diverged, in particular Xenopus POUV proteins and this led to the misconception 
that all vertebrate POUV genes were orthologous. Frankenberg and Renfree, 2013 has 
gathered both syntenic analysis and protein alignment sto identify unique amino acid 
composition of vertebrate POUV protein sequences, enabling the easier way to classify them 
into two subclasses and confirming that POU5F1 is a paralog of POU5F3. These unique 
sequences identified to distinguish POU5F1 from POU5F3 protein, include the region 
135
Cyclostome 









tandem gene duplication 
POU5F1 orthologues
POU5F3 orthologues
































NTD POUs POUHD CTDL
E1 E2 E3 E4 E5
NTD POUs POUHD CTDL
E1 E2 E3 E4 E5
E1 E2 E3 E4 E5




























Figure 3.1 Details of POUV homologues and unique protein sequences of POU5F1 and POU5F3. A) The 
simplified vertebrate tree depicts the evolution of duplicated POUV genes (POU5F1 and POU5F3) from a single POUV gene. Transparent lines 
in some branches of vertebrates illustrate that the elimination of POUV gene during evolution and marked as “eliminated”. The cartoons on the 
right side of the tree indicate the synteny of POUV genes marked in purple color for POU5F1 and green color for POU5F3. In frog lineage, 
tandem duplicated gene Pou91 (Pou5f3.1) and Pou60 (Pou5f3.3) are marked with purple and orange boxes indicating their predicted activities 
as POU5F1-like activity and diverged activity, respectively. The color boxes next to POUV genes mark the flanking genes which are used to 
confirm the identity of POUV homologues. B) Schematic illustration shows exon-intron structure of POUV genes and the corresponded protein 
domains. The letters of POUV protein cartoon indicate amino acids that are unique to either POU5F1 or POU5F3 protein or both. There are 
more consensus sequences common in both POUV proteins and those are shown in the alignments of POUV proteins in figure 3.2-3.4. 
Abbreviations; P1, POU5F1; P3, POU5F3; E1-E5,  exon1-exon5; P,  Proline; M,  Methionine; R, Arginine; T, Threonine; S, Serine;  Q, 









around the nuclear localization signal (NLS), which is located on N-terminal site of the 
POUHD and an amino acid adjacent to the N-terminal site of the linker region. The consensus 
sequence around the NLS for POU5F1 proteins is RKRKRTS, while the consensus sequence 
for POU5F3 proteins has one additional arginine residue (R) (RKRKRRTS). They also 
feature an aspartic acid (D) before the linker in POU5F1 that is always a glutamic acid (E) in 
POU5F3 (both amino acids are negatively charged), see figure 3.4. In addition, there is a 
small unique consensus sequence MAGH that can be found only in POU5F1 proteins 
(Figure 3.2).  
 
 I was able to find POUV proteins in almost all branches of vertebrate taxa, which 
enabled several phylogenetic analysis and evolutionary modeling to elucidate how these 
POUV proteins are related. Here I built a specific model for the change in both POU5F1 and 
POU5F3 proteins during the vertebrate evolution. I combined the knowledge of time-
constructed vertebrate phylogeny and POUV protein sequences to estimate when in 
vertebrate evolution specific changes occurred and which branches of vertebrate taxa 
contained the highest changes in amino acid composition for either POU5F1 or POU5F3 
protein. The changes in amino acid composition relative to the estimated time of each 
vertebrate divergence can infer to the rate of protein evolution. 
 
 I used the BEAST software package, which implements a family of Markov Chain 
Monte Carlo (MCMC) algorithms for Bayesian phylogenetic inference, divergence time 
dating and other related molecular evolutionary analyses (Drummond et al., 2012). The full 
methods and parameters used for BEAST analysis are described in chapter 2 section 2.9. 
Briefly, we used BEAST to estimate the rate of protein evolution by gathering two 
parameters: conserved sequences of POU5F1 or POU5F3 proteins (POU domains) sampled 
from several vertebrate lineages (NCBI database, GENBANK detail is listed in chapter 2) 






























































Figure 3.2 Protein sequence alignments of selected vertebrate POU5F1 orthologues 
The protein sequences were aligned using MUSCLE in Jalview. The colorscheme at the sequences is based on 
CLUSTAL X. The intensity of color is scaled by the degree of amino acid property conservation. Histograms under the 
sequence alignments represent amount of conserved amino acid composition with consensus sequence logo. The red 
box indicates conserved POU specific domain, the blue box indicates conserved POU homeodomain and the orange 
box indicates MAGH consensus sequence at the N-terminal domain.
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Figure 3.3 Protein sequence alignments of selected vertebrate POU5F3 orthologues 
The protein sequences were aligned using MUSCLE in Jalview. The colorscheme at the protein sequences is based on 
CLUSTAL X. The intensity of color is scaled by the degree of amino acid property conservation. Histograms under the 
sequence alignments represent amount of conserved amino acid composition with consensus sequence logo. The red 
box indicates conserved POU specific domain and the blue box indicates conserved POU homeodomain. 
human POU5F1
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Figure 3.4 Protein sequence alignments between POU domains of selected vertebrate 
POU5F1 and POU5F3 orthologues 
The protein sequences were aligned using MUSCLE in Jalview. The colorscheme at the sequences is based on 
CLUSTAL X. Histograms under the sequence alignments represent amount of conserved amino acid composition with 
consensus se uence logo.  helices define the protein tertiary structure corresponding to the underlying se uences.  
and B indicate the unique signatures between POU5F1 and POU5F3. NLS indicates nuclear localization signal 
(RKRKR). sterisk ( ) indicates Leusine which is the key amino acid on linker re uired for murine reprogramming, as 
reported by Esch D et al 2 13. 
POU specific domain
α1 α2 α3 α4







review (summarised in figure 3.5 and table 3.1). Calibration dates indicate the estimated 
timing of an evolutionary divergence event. BEAST analysis sets these calibration dates and 
DNA/protein sequences input as parameters to infer rates of protein changes or vice versa. 
 
 Figure 3.6 shows the result of BEAST analysis on POU5F1 protein evolution. Based 
on this analysis there are three major changes of the amino acid composition in POU 
domains over time: at the divergence of testudines (turtles) from squamata (snake and lizard) 
around 280 million years ago (MYA), the second one at the divergence of monotreme (e.g. 
platypus) from therians (marsupial and eutherians) around 200 MYA, and the third one at the 
divergence of afrotherians (e.g. elephant) from boreoeutherians (e.g. mouse and human) 
around 110 MYA. The latter shows the highest rate amongst the examined POU5F1 
proteins. Both afrotherian and boreoeutherian belong to eutherians, which developed a 
unique developmental program during early embryonic development, like an inner cell mass 
(ICM) and an enhanced implantation machinery (Hedges and Kumar, 2009; Warren et al., 
2008). The eutherian ICM (as shown mostly in mouse) is maintained by a complex 
regulatory pluripotency circuit, in which POU5F1 is one of the essential players (Chen et al., 
2008b; Chew et al., 2005; Ng and Surani, 2011; Nichols et al., 1998). Highly diverged 
POU5F1 around 110 MYA might be a part of this key evolutionary novelty. After 110 MYA 
timepoint, POUV proteins among eutherians stay highly conserved, despite the observation 
that mammals have undergone extreme species radiation and exhibit morphological changes 
specific to the environment conditions found at different geographical locations. This 
preservation indicates that gene regulatory networks involved in the early developmental 
programs of mammals were unaffected by those environment adaptations.  
 
There are only two eutherian branches showing a high rate of POU5F1 protein 
evolution, the Rodentia (mouse, rat, hamster) and Chiroptera (bats). All examined rodents 
including deermouse, Chinese hamster, golden hamster, southern vole and mouse exhibit a 
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(adapted from Hedges and Kumar 2009)
Figure 3.5 Timetree of vertebrates used as a reference for BEAST analysis The figure is adapted from Hedges and 
Kamar 2009. The numbers in each node are refered to divergence time in table 3.1  Abbreviations: C (Carboniferous), Cm (Cambrian), CZ 
(Cenozoic), D (Devonian), J (Jurassic), K (Cretaceous), Np (Neoproterozoic), O (Ordovician), P (Permian), Pg (Paleogene), PR (Proterozoic), S 

























Hagfish-lamprey 520/596-461 (1) 432/473-391 (9) 478/497-459 (9) not included 
not included 
Chondrichthyes-Osteichthyes 525/580-494 (1) 528/639-417 (8) 525/580-494




































Actinopterygii-Sarcopterygii 476/494-442 (1) 450/520-380 (8) 476/494-442
Lissamphibia-Amniota
Actinistia/Dipnoi-Tetrapods 430/438-421 (1) N/A N/A 430/438-421




282/356-250 337/353-321(11) (20) 294/319-271 (19)



































104.7/115-96 105.0/118-92 104.5/122-90(12) (8) (18)
103.3/114-95 (12) N/A N/A 103.3/114-95
104.7/115-96
77.8/86-70 (12) 89.0/104-75 (18)
75.1/83-67 (12) 80/96-67 (18)
73.0/81-65 (12) 85/100-71 (18)












97.4/106-90 (12) 92.0/95-89 (8) 92.5/105-81 (18) 97.4/106-90
91.0/99-84 (12) 90.8/95-87 (8) 85.5/98-76 (18) 91.0/99-84
89.1/97-82 (12) 89.1/97-8285.9/109-63 (8) 78.0/88-70 (18)
86.2/71-98 (12) N/A N/A 86.2/71-98
86.4/94-80 (12) 74.0/89-62 (18) 85.7/71-98 (7) 86.4/94-80
87.2/93-82 (12) 81.5/91-74 (18) N/A 87.2/93-82
84.6/80-90 (12) 83.0/91-75 (8) 78.0/85-72 (18) 84.6/80-90
84.2/89-79 (12) 74.0/85-63 (8) N/A 84.2/89-79
82.5/87-78 (12) N/A N/A
79.8/85-75 (12) 74.0/81-67 (18) N/A not included 
82.5/87-78
213/262-164 (10) 204/218-190 (3) 227/251-203 (3) 213/262-164
192/238-146 (17) 178.5/192-166 (3) 173.0/197-149 (5) 178.5/192-166
323/343-305 (16) 326/354-311 (1) N/A 326/354-311
276/383-169 (8) 285/296-274 (3) 289/302-276 (3) 276/383-169
268/278-256 (3) 275/292-258 (3) N/A not included 
225/238-205 (14) 265/278-252 (3) 273/291-255 (3) 225/238-205
222/325-119 (8) 214/259-169 (10) 259/282-236 (20) 222/325-119
407/376-446 (5) N/A N/A not included 
343/310-381 (5) 372/347-391 (4) N/A
327/295-366 (5) N/A N/A
343/310-381
not included 
312/279-351 (5) N/A N/A 312/279-351
307/371-215 (5) 230/264-200 (10) 278/314-241 (10) 278/314-241
170.5/153.1-187.9 (13) N/A N/A 170.5/153.1-187.9




N/A N/A N/A Prior default
N/A
N/A
Table 3.1  Divergence times of vertebrate lineages in million of years for BEAST analysis to estimate the rate 
of POUV protein evolution The nodes are referred to figure 3.5 timetree of vertebrates (adapted from Hedges & Kumar 2009). The second 
column is the description of lineage divergence, for example “Gnathostome-Cyclostome” means the divergence of Cyclostome lineage from 
Gnathostome ancestor occured around 652 million years ago. The third-fifth columns are time estimates of divergence event in million year unit and 
CL is the 95% confidential interval. The last column contains time estimates I used for BEAST analysis of POUV protein evolution. N/A stands for 
“not available age estimates”.  “Not included” means that there is no POUV protein/DNA sequence available for that specific lineages. References 
in brackets (1) Blair and Hedges 2005 (2) Hedges and Kumar 2009 (3) Hugall et al., 2007 (4) Hurley et al., 2007 (5) Ionue et al., 2003 (6) Ionue et 
al., 2005 (7) Janecka et al., 2007 (8) Kumar and Hedges 1998 (9) Kuraku and Kuratani 2006 (10) Mannen and Li 1999 (11) Marjanovic and Laurin 
2007 (12) Murphy et al., 2007 (13) Near et al., 2012 (14) Paton et al., 2002 (15) Peng et al., 2006 (16) Pereira 2006 (17) van Rheede 2005 
(18) Woodburne et al., 2003 (19) Zhang et al., 2008 (20) Zhang et al., 2005
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high rate of POU5F1 protein changes (Figure 3.6). What were the evolutionary forces 
leading to this dramatic divergence of rodent POU5F1 proteins? It is well known that rodent 
gastrulation produces unique cylinder-like shape epiblast while other eutherians have a disc-
like epiblast (Sheng, 2014). In addition, it has been shown that Oct4 regulates cell adhesion 
in ESCs (Livigni et al., 2013). The high changes of Oct4 during Rodentia evolution might 
affect to cell adhesion property and be responsible for distinctive epiblast morphology.  
 
 We also examined the rate of vertebrate POU5F3 protein evolution (Figure 3.7). 
From this analysis there appear two major changes of POU5F3 proteins: (1) at the origin of 
actinopterygians including the divergence of chondrostei (sturgeon) and holostei (spotted 
gar) from other teleost fish in Clupeocephala (e.g. zebrafish and medaka) around 380-280 
MYA and (2) along the evolution of the frog lineage around 250-130 MYA. The high rate of 
fish POU5F3 protein evolution fits well with previous findings that these proteins have both 
distinct and varied expression patterns among fish and very little potential to sustain and 
establish eutherian pluripotency (Morrison and Brickman, 2006; Tapia et al., 2012). 
Although there was a teleost specific genome duplication and rearrangement that occurred 
around 300 MYA (M et al., 2007), this event may not be responsible for these extreme 
changes in the POUV family. My observations suggest that the rapid evolution of POUV 
protein sequence occurred prior to the split between the teleosts and Chondrostei/Holostei 
around 380 MYA. Future work on testing the biological function of sturgeon Pou5f3 may 
provide an indication of whether the functional divergence of Pou5f3 observed in the 
zebrafish is specific to all actinopterygian Pou5f3 or whether only Pou5f3 in Cupleocephala 
have diverged in their functions.  
 
The second biggest divergence in the POU5F3 subfamily happened during frog 
evolution. In Xenopus, there are three paralogs of Xenopus Pou5f3: Xlpou91 (Pou5f3.1), 
Xlpou25 (Pou5f3.2) and Xlpou60 (Pou5f3.3). We included only Xlpou25 and Xlpou91 in 
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this analysis, because both these proteins have been shown to have distinct functions and are 
required for normal development. The function of the third, Xlpou60 is less clear. Based on 
functional studies, Xlpou25 is an epiblast specific protein, like POU5F3 proteins from other 
species (discussed in section 3.2-3.7); Xlpou91 is an early marker of primordial germ cells 
(Hinkley et al., 1992) and has some of the functional attributes of POU5F1 (shown in section 
3.2 and (Morrison and Brickman, 2006)). Although Xlpou91 belongs to the POU5F3 
subfamily, it has re-acquired some activities normally specific to POU5F1. Thus this 
completely functional segregation of these two homologs might relate to the high changes in 
their POU domains sequences. 
 
The software also produced two additional informative data: the Mean Rate of 
POUV protein evolution and a Coefficient of Variation. The Mean Rate represents the rate 
of protein evolution averaged over the whole POUV phylogenetic tree. The distribution of 
POU5F1 and POU5F3 rates around the mean are shown in figures 3.6B, and 3.7B 
respectively. We found that the POU5F1 subfamily has a slightly higher mean rate of protein 
evolution than the POU5F3 subfamily. The Coefficient of Variation represents the extent to 
which the rate of protein evolution varies from lineage to lineage. The Coefficient of 
Variation is also higher in POU5F1 than in POU5F3, meaning that POU5F1 coding 
sequence is more heterogeneous amongst different vertebrate lineages. Moreover, the lowest 
rate in both POU5F1 and POU5F3 protein evolution are those derived from the coelacanth. 
This result is consistent with the findings that protein-coding genes of coelacanth have not 
changed much in over 450 million years and its contemporary morphological characters 










































































































(rate of evolution averaged over the whole tree) 
mean: 4.002E-4




















coefficient of variation 
(how much the rate of evolution varies from 
lineage to lineage) 
mean: 1.5863
stderr of mean: 0.0115
Figure 3.6 Molecular rate of POU5F1 protein evolution The full length POU5F1 protein sequences were firstly 
MUSCLE-aligned in MEGA6 and only POU specific and POU homeodomain including linker were selected for further analysis. The 
selected POU sequences were analyzed in BEAUTi/BEAST platform to estimate the rate of protein evolution. The prior setting and 
calibration node (C)/ divergence times for BEAUTi set up are described in full detail in chapter 2. The result from BEAST were 
analyzed by TRACER to provide mean rate (B) and coefficient of variation (C). The BEAST result file were then annotated by TREE 
ANNOTATOR and used to construct the tree as shown in A. The number at each node represents divergence time in miilion years. 









Rate of POU5F3 protein evolution
low high 
Figure 3.7 Molecular rate of POU5F3 protein evolution The full length POU5F3 protein sequences were firstly 
MUSCLE-aligned in MEGA6 and only POU specific and POU homeodomain including linker were selected for further analysis. The 
selected POU sequences were analyzed in BEAUTi/BEAST platform to estimate the rate of protein evolution. The prior setting and 
calibration node (C)/ divergence times for BEAUTi set up are described in full detail in chapter 2. The result from BEAST were 
analyzed by TRACER to provide mean rate (B) and coefficient of variation (C). The BEAST result file were then annotated by TREE 
ANNOTATOR and used to construct the tree as shown in A. The number at each node represents divergence time in miilion year. 
Asterisk (*) indicates the Xenopus laevis protein Xlpou91 (X91) and Xlpou25 (X25). Boxes at the names of vertebrate indicate the 






















































































(rate of evolution averaged over the whole tree) 
mean: 3.681E-4
SE of mean: 2.263E-6
coefficient of variation 
(how much the rate of evolution varies from 
lineage to lineage) 
mean: 1.3152
SE of mean: 0.0381












































Section 3.2 The Functional Capacity of POU5F1 and POU5F3 proteins to 
rescue Oct4 mutant ESCs  
 
Oct4 rescue experiments were performed by using Oct4-suppressable ESC cell line 
(ZHBTc4). This is an excellent tool to address the conservation of biological functions of 
POU proteins, especially their abilities to support stem cell self-renewal. In the ZHBTc4 ES 
cell line, both alleles of endogenous Oct4 were disrupted by homologous recombination and 
a tetracycline-suppressable Oct4 transgene was stably integrated. In the absence of 
tetracycline (Tc), Oct4 is expressed from the transgene and the cell line is able to self-
renewal and to maintain its ESC phenotype. In contrast, adding Tc blocks Oct4 expression 
from the transgene, leading to reduction of Oct4 protein within 12 hours and ESC 
differentiation. Addition of Tc to ZHBTc4 ESCs leads to rapid differentiates toward 
trophectodermal lineage within a few days. The ability of other POUV proteins to support 
self-renewal in Oct4 null ESC can therefore be tested by transfecting ZHBTc4 ESCs with a 
vector expressing different POUV proteins at the same time of adding Tc to remove mouse 
Oct4 expression. 
 
Our laboratory has previously used this cell line to test the functional conservation 
of Xenopus Oct4 homologs, Xlpou91 (Pou5f3.1), Xlpou25 (Pou5f3.2) and Xlpou60 
(Pou5f3.3) (Morrison and Brickman, 2006). Three Xenopus POUV genes are believed to 
originate as a result of tandem gene duplication of single ancestral pou5f3 gene. Based on the 
syntenic analysis, three Xenopus POUV paralogs are all orthologous to POU5F3 of other 
species (Frankenberg and Renfree, 2013). Interestingly, these three paralogs exhibit 
differences in expression during early Xenopus embryogenesis. Xlpou91 is the only POUV 
protein expressed in the primordial germ cells of Xenopus embryo (Hinkley et al., 1992; 
Venkatarama et al., 2010) while Xlpou25 exhibits the highest expression during gastrulation 
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(Cao et al., 2008) and Xlpou60 has the highest level of maternal expression in the oocyte. 
We discovered that these expression profiles are well correlated with their abilities to rescue 
eutherian pluripotency network supported by Oct4. In particular, Xlpou91 is equivalent to 
mouse Oct4 itself in its capacity to rescue the null ESCs, whereas Xlpou25 is unable to 
support large numbers of ESC colonies or maintain clear undifferentiated phenotypes 
(Morrison and Brickman, 2006). Based on the capacity of Xlpou91 to support ESC self-
renewal, we hypothesised that POUV proteins expressed in germ cells might be more 
effective at supporting ESC self-renewal/pluripotency. This is in part based on the 
similarities of the germ cell network and ICM/ESC pluripotency network (Leitch et al., 
2013).  
 
The discovery of Frankenberg and colleagues also highlights a distinction between 
germ cell and epiblast expression in different POUV proteins. In this case they characterised 
the expression of POU5F1 and POU5F3 in tammar wallaby embryos.  POU5F1 is expressed 
specifically in the germ cells while POU5F3 protein is expressed in the nucleus of 
gastrulation-stage epiblast (Frankenberg et al., 2013).  This suggests, that perhaps in species 
with both paralogs, POU5F1 is a central player in germ cell potency, while POU5F3 protein 
mainly supports epiblast during gastrulation. Thus, I hypothesised that germ cell-related 
POU5F1 can support naïve pluripotency while POU5F3 cannot. However, in the species that 
lost either POU5F1 or POU5F3 protein in their lineage-specific evolution, the remaining 
POUV protein has to perform both germ cell and epiblast like functions. For example, 
eutherian mammals lost POU5F3 gene and therefore Oct4 protein encoded by Pou5f1 gene 
is expressed in both germ cells (also ICM) and epiblast. In case of Xenopus, its ancestor lost 
pou5f1 and remaining ancestral pou5f3 gene was then duplicated to enable 
subfunctionalization to be re-established, so that Xlpou91 underwent convergent evolution to 
specialise in germ cells, and performs Oct4/Pou5f1-like function.  
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 To test this hypothesis and determine the extent to which POU5F1 and POU5F3 
protein function in both naïve and primed pluripotency, I examined the activities of POUV 
in species that carry both paralogs, including coelacanth (Latimeria chalumnae), axolotl 
(Ambystoma mexicanum), turtle (Chrysemys picta bellii), and tammar wallaby (Macropus 
eugenii). We excluded species that carry only single POUV from these rescue experiments 
because these proteins might already adapt novel functions to compensate the loss of their 
paralogs. I included Xenopus Oct4 homologs in this functional study, as they have been 
characterised extensively and serve as an excellent control for the putative segregation of 
germ cell activity (Xlpou91) and epiblast-like activity (Xlpou25).  The coding sequences of 
POU5F1 and POU5F3 from tammar wallaby (Stephen Frankenberg) and axolotl (Tapia et al 
2013) were originally amplified from the embryos. The predicted POU5F1 and POU5F3 
coding sequences of coelacanth and turtle was based on the available genome data and 
generated by gene synthesis (Invitrogen). All POUV coding sequences were introduced into 
ESC expression vectors employing the CAG promoter and a triple flag-tag sequence (to 
assess protein expression) and a selection cassette within the POUV cistron that employs an 
Internal Ribosomal Entry Site (IRES) to produce the puromycin resistance gene (PAC), see 
figure 2.3B and 3.8A. The details of GENBANK accession numbers for POUV coding 
sequences are described in chapter 2 section 2.1.2. 
 
Rescue vectors were introduced into ZHBTc4 ESCs by electroporation and colonies 
expanded in the presence and absence of Tc (endogenous Oct4). Colonies were stained for 
the ESC Alkaline Phosphatase (AP) activity (ESC colonies with undifferentiated cells show 
red-violet appearance). The procedure for rescue experiment is described in chapter 2 section 
2.8 and figure 2.3B. The results of AP staining of POUV-rescued ZHBTc4 colonies are 
shown in figure 3.8B. In the absence of any POUV protein, ESCs differentiate and do not 
expand as AP positive colonies. When mouse Oct4 was used to rescue itself, normal AP 










































































Figure 3.8 Oct4-null ESC rescued by different POU5F1 and POU5F3 proteins
a) Diagram shows rescue of ZHBTc4 Oct4-null ESCs with different 3xflag-tagged POUV proteins. POUV proteins were introduced 
into these cells by electroporation of plasmid containing POUV cDNA under CAG promoter. The cells were culture under treatment 
of tetracycline to suppress Oct4 expression from the transgene. B) POUV-transfected Oct4-null ESC cells were at clonal density in 
the presence of puromycin and presence/absence of tetracycline, and the colonies were stained for alkaline phosphatase (AP; red) 
after  da s of gro th  cale bar   m ) escue index indicating the capacit  of different ct  homologs in support E  
self-renewal. The rescue index is calculated by dividing the number of AP positive ES cell colonies in the absence of Oct4 
(presence of tetracycline) by the number of AP positive ESC colonies present in the presence of Oct4 (absence of tetracycline). D) 
Quantification of clonal growth in ESCs supported by different Oct4 homologs in place of mouse Oct4. Colonies were scored as 
undifferentiated (green), mixed (blue), and differentiated (black). C)-D) Data represents the means values obtained from three 


















































































































proteins, I found that all POU5F1 proteins are able to rescue Oct4 null ESCs and the 
colonies rescued by them show undifferentiated ESC colony morphology. In contrast, all 
POU5F3 proteins, except Xlpou91, produce morphologically abnormal, although to varying 
extents AP positive colonies. They all contain some degree of undifferentiated centre 
surrounded by mixed AP positive/negative differentiated cells. As Oct4 overexpression can 
induce differentiation, some POU5F1 proteins induce differentiation when expressed in the 
presence of Oct4 (absence of Tc). In particular the turtle POU5F1 and mOct4-rescued 
colonies exhibit the most extreme over-expression phenotypes. The differentiated cells from 
this POUV overexpression are mostly Gata6 positive, defining primitive endoderm lineages. 
Thus, it suggests that POU5F1 might also share common role in inducing primitive 
endoderm at higher dose. However, this is out of the scope of this thesis and future careful 
examination is required to resolve this interesting question.   
 
The extent of ESC rescue can also be quantitated. The rescue index is the ratio of AP 
positive colonies obtained in the absence of Oct4 to the total colonies obtained in the 
absence of Tc (presence of Oct4). Oct4 has a rescue index of 1, and all the POU5F1 proteins 
show a higher rescue index than POU5F3 proteins (Figure 3.8C). The coelacanth POU5F1 
has a rescue index indistinguishable from Oct4’s, while its paralog was particularly 
ineffective at supporting self-renewal in the absence of Oct4. To quantitate Oct4 rescue in 
another way, I categorised the AP positive colonies into three classes: undifferentiated, 
mixed and differentiated colonies (figure 3.8D). Undifferentiated colonies are AP positive 
containing less than 5% differentiated cells around periphery of the colony. Mixed colonies 
exhibit AP positive cells in the centre of the colony, but also contain from 10 to 80% of 
differentiated cells around periphery. Differentiated colonies show only faint AP staining 
and consist of at least 90% differentiated cells (criteria for the classification of AP stained 
ESC colonies is shown in chapter 2 figure 2.2). Consistent with the rescue index, all 
POU5F1 proteins, except turtle POU5F1, produced high percentages of undifferentiated 
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colonies, while POU5F3 proteins produced the highest numbers of differentiated colonies. 
Using this double system of quantitation supports the notion that capacity to support naïve 
























Section 3.3 Phenotypic distinctions of ESCs supported by POU5F1 or 
POU5F3 
 
The rescue assay showed that all POU5F1 supported naïve pluripotency phenotype 
while all POU5F3 from different species produced various aberrant ESC colony 
morphologies. To further explore these differences, I aimed to better characterise the Oct4 
null ESC cells supported by different POUV proteins. Firstly, I generated stable ESC lines 
from these POU5F1 and POU5F3-rescued colonies. At day 9 after electroporation, 24 
colonies from each condition were picked and expanded in ESC culture medium containing 
puromycin and tetracycline (described in chapter 2, section 2.4A2 and 2.7). After several 
passages, almost all clones of POU5F1-rescued lines self-renewed and expanded better than 
those supported by POU5F3. In addition, the cell morphology of POU5F1 lines was identical 
to other ESC lines (e.g. E14Tg2a ESCs, ZHBTc4 ESCs without Tc), while that of POU5F3 
lines showed strong differentiation. To better elucidate the phenotypes of stable POUV-
rescued lines, three clones of each cell lines where characterised at passage 6. These cell 
lines were plated at clonal density onto gelatin-coated culture dishes for further 
characterization by immunofluorescent staining (figure 3.10), qRT-PCR (figure 3.9 and 
3.10) and flow cytometry (Figure 3.12). 
 
Before further in-depth phenotypic analysis, I aimed to verify that those rescued 
lines were solely maintained by transfected POUV genes and not influenced by endogenous 
Oct4 expression. The expression of different POUV proteins in the established cell lines was 
initially confirmed by immunofluorescence (figure 3.9A).  I used flag antibody to detect the 
presence and localization of 3Xflag POUV proteins. I observed clear nuclear localization 
from all tested POUV-rescued lines. Remarkably, coelacanth POU5F3 protein was expressed 




coelacanth P1 coelacanth P3 
turtle P1 turtle P3 
FLAG E-cadherin
axolotl P1 axolotl P3 
Xlpou91 Xlpou25 













































































































































































Figure 3.9 The detection of POUV proteins and  the measurement of POUV transcipt levels
A) Immunoflorescent staining of POUV-rescued ESC clonal lines with Flag antibody was done to confirms the POUV protein 
expression and its nuclear localization, and I used E-cadherin antibody to mark individual cells. B) qRT-PCR on the expres-
sion of mouse Oct4 was performed to confirm that POUV-rescued ESC clonal lines were maintained solely by transfected 
POUV constructs. C) qRT-PCR on the expression of puromycin-resistant gene was performed to indirectly measure the 
POUV transcript levels between different POUV-rescued clonal lines. Data represents in boxplot showing average values 
from three independent clonal lines. Abbreviations: P1, POU5F1; P3, POU5F3; Tc, tetracycline; Ir, IRES: PAC, puromycin 
resistance gene.
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qRT-PCR employed Oct4 primers that specifically recognised mouse Oct4, but not other 
POUV transcripts. This result confirmed that all established rescued lines were only 
maintained by transfected POUV constructs (figure 3.9B). Because POUV gene and PAC are 
expressed as one transcript separated by IRES, I could indirectly measure POUV transcript 
level by using primer recognizing PAC. I found that majority of clonal lines had similar 
levels of POUV transcripts, except higher level in those rescued by coelacanth POU5F3 and 
turtle POU5F3 (figure 3.9C). This suggests that POU5F3 from coelacanth and turtle 
probably require higher dose to partially support ESC potency.    
 
The immunofluorescent staining of some ESC/differentiation markers on the POUV-
rescued clonal cell lines is shown in figure 3.10. E-cadherin and p120 catenin were chosen as 
membrane-associated markers to observe cell morphology. Klf4 marks an undifferentiated 
naïve ESC population, Cdx2 marks trophectodermal lineage and Gata6 marks primitive 
endoderm. I found that all POU5F1-rescued Oct4 null ESC lines exhibited ESC cell 
morphology similar to mOct4-rescued lines, and showed no expression of the differentiation 
markers Gata6 and Cdx2. However, I did observe heterogeneity in Klf4 expression in 
coelacanth POU5F1 and turtle POU5F1-rescued lines while those rescued by mOct4 showed 
uniform expression. This indicates that there may be aspects of the naïve gene regulatory 
network that are not perfectly conserved. In contrast, all POU5F3-rescued lines exhibited 
different patterns of cell morphology. Coelacanth and axolotl POU5F3 produced Cdx2+ 
trophectoderm-like cells containing small Klf4+ clusters of cells growing on the top of them. 
Turtle and tammar POU5F3-lines exhibited a mix of Klf4, Cdx2 and Gata6 expressing cells.  
In ESC supported by Xlpou25, most of clones showed big clumps of cells (ball-shaped) 
expressing E-cadherin and Klf4 on the top of primitive endoderm-like cell layer expressing 
Gata6. In contrast, ESCs supported by Xlpou91 were almost identical to POU5F1-rescued 
lines exhibiting no differentiation. Taken together these experiments suggest that POU5F1-
rescues ESC lines are largely undifferentiated, naïve ESCs, while POU5F3-rescued cells 
156

































































Figure 3.10 Characterization of POUV-rescued ESC clonal lines by immunofluorescence
The scale bars represent 1  m. The images are the overlay of different fluorescence channels. 
bbreviations  P1, PO 5F1  P3, PO 5F3
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contain mixed populations of potentially primed pluripotent and differentiated cells. Thus in 
species where both POUV proteins were retained, POU5F3 proteins diverged from the 
support of naïve pluripotency and potentially become different lineage specific regulators of 
potency and differentiation. On the other hand, POU5F1 proteins retained the capacity to 
support the naïve pluripotent network. 
 
To better quantify degree to which different POUV proteins support naïve 
pluripotency or allow for differentiation, I performed qRT-PCR for the expression of Esrrb 
(ESC marker), Prdm14 (ESC/PGC marker), Gata6 and Cdx2 (differentiation markers). The 
results are shown in figure 3.11. Consistent with the immunofluorescence results, some 
clonal lines rescued by Xlpou25 and turtle POU5F3 exhibited higher level of Gata6 
expression. Similarly, Cdx2 expression level was higher in lines rescued by coelacanth 
POU5F3, axolotl POU5F3, turtle POU5F3, and tammar POU5F3. Coelacanth POU5F3 
showed the greatest variation in Cdx2 expression levels amongst clonal lines, some 
exhibiting levels approaching those produced in the absence of any Oct4 or POUV protein 
ZHBTc4+Tc. In general, with species carrying two POUV forms, POU5F1s were more 
effective at supporting Esrrb and Prdm14 expression than its paralog, but the levels of these 
gene expressions were varied among lines. Amongst all examined POU5F3, axolotl POU5F3 
was the best in rescuing Prdm14 expression. Prdm14 expression in these axolotl POU5F3 
supported lines was similar to that in Xlpou91-rescued ESCs. This suggests that in the case 
of the axolotl, its POU5F3 contains some capacity to activate the germ cell gene regulatory 
network, and this fits well with the expression pattern of the axolotl POU5F1 and POU5F3, 







































































































































































































































































































































































Figure 3.11 The analysis of gene expression among different POUV-rescued ESC 
clonal lines The relative expression of pluripotency markers (Esrrb and Prdm14) and differentiation markers 
(Gata6 and Cdx2) was quantified by qRT-PCR and calculated by normalization with a house keeping gene TBP. 
Each diamond symbol represents the average value of each individual clone. The horizontal bars between 
diamond symbols are the mean of average values of the transcript level in each POUV-rescued clones.
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Next I aimed to examine ESC phenotype of rescued lines by flow cytometry using 
previously identified surface markers (figure 3.12). Livigni et al 2013 previously found that 
Xlpou25, a key player during gastrulation of Xenopus embryogenesis, drove higher             
E-cadherin level than Xlpou91 in mouse Oct4 null ESCs. This leads to the hypothesis that 
epiblast specific POUV proteins might be bona fide regulator of gastrulation stage adhesion. 
In tammar wallaby POU5F3 protein is expressed specifically in nucleus of epiblast cells 
during gastrulation while the POU5F1 is retained in the cytoplasm. This suggests that 
probably the conserved roles in the regulation of adhesion by POUV protein belong to 
POU5F3 subfamily. To address this, I assessed the E-cadherin levels of some POU5F1 and 
POU5F3-rescued lines, alongside with Xlpou91 and Xlpou25-rescued lines as the controls. 
In addition, the expression of Pecam-1, which is an undifferentiated ESC and germ cell 
surface marker, was also analyzed together with E-cadherin  
 
Figure 3.12 shows flow cytometry exploring the expression of E-cadherin and 
Pecam-1 in rescued cell lines. I found that mOct4-rescued line exhibited similar E-cadherin 
and Pecam-1 level to ZHBTc4 (without Tc). Supporting the notion that POU5F1 has germ 
cell activity, tammar POU5F1 and Xlpou91 could drive higher levels of Pecam-1 expression 
than mouse Oct4, while E-cadherin levels of these cell lines remained similar to those 
rescued by mouse Oct4 and the ZHBTc4 ESC. Similar to what we found previously, 
Xlpou25 drove higher E-cadherin expression than Xlpou91. Moreover, tammar POU5F3-
rescued lines contained a population of cells expressing E-cadherin level similar to Xlpou25-
rescued line. I also investigated the E-cadherin level in the lines rescued by coelacanth 
POU5F1 and POU5F3. Similar to the observations made for the tammar wallaby, coelacanth 
POU5F3 also induced higher level of E-cadherin than the POU5F1 and mOct4, although the 
level was not as high as in the lines rescued by Xlpou25 and tammar POU5F3. Taken 
together these observations suggest that POU5F3 activity has been specialised in efficiently 
regulating adhesion and differentiation in gastrulation. 
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mOct4 Xlpou91 Xlpou25 unstained mOct4 tammar P1 tammar P3 unstained
ZHBTc4 unstained mOct4 unstained
Figure 3.12 Flow cytometry analysis on Pecam-1 and E-cadherin of POUV-rescued ESC lines
A)-B) POUV-rescued ESC lines were plated on gelatinized culture dishes and cultured under ESC self-renewal condition for 5 
passages after colony picking. The levels of pluripotency surface markers (Pecam-1 and E-cadherin) were assessed by flow 
cytometry and analysed by FCS EXPRESS software. A) Data represents the overlay on Pecam-1 against E-cadherin of different 
POUV-rescued ESC lines. B) Data represents the overlayed histograms on E-cadherin levels among different POUV-rescued lines. 
The counts were normalized by the peak value in FCS EXPRESS software. 
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Section 3.4 Global transcriptome analysis of coelacanth POUV-rescued 
ESC lines 
 
To evaluate the expression states supported by POU5F1 and POU5F3 in an unbiased 
way, I assessed the transcriptomes of a pair of POUV paralogs. For this analysis I chose the 
coelacanth POU5F1 and POU5F3, as this pair is both well conserved and appears to have the 
largest difference in the rescue index for the two proteins. Stable coelacanth POU5F1 and 
coelacanth POU5F3-rescued Oct4-null ESC lines also exhibited the most distinctive 
phenotypes. The lines exhibited ESC phenotypes similar to those obtained from Oct4 rescue, 
while POU5F3 supported lines exhibited high levels of differentiation. Thus in ESC rescue 
activity, these two proteins appear to have distinct activities. As coelacanth protein coding 
genes exhibit very slow substitution rates (Amemiya et al., 2013), the segregated protein 
activities of coelacanth POUV proteins might represent ancestral division of POUV function. 
As a result, gaining insight into gene expression supported by these different proteins might 
provide insight into the ancestral pluripotency network and how its activity is effectively 
partitioned.   
 
To explore the global gene network, we performed one-colour based microarray on 
two biological replicates of each coelacanth POU5F1-rescued line, coelacanth POU5F3-
rescued line and mouse Oct4-rescued line. The full detail of microarray procedure is 
described in chapter 2 section 2.6.2. Briefly, I collected RNA from passage 6 of the stable-
rescued lines. Only high quality RNA (RNA integration number (RIN) = 10) was used to 
generate Cyt3-labelled cRNAs, which were then hybridised to whole genome-
oligonucleotide microarray slides (Agilent Technologies). The hybridised slides were 
scanned to obtain global gene expression profiles. To perform statistical analysis on 
microarray expression data, the raw datasets of samples were combined and uploaded onto 
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the web-based software NIA Array Analysis (http://lgsun.grc.nia.nih.gov/ANOVA/) (Sharov 
et al., 2005). All inputs were normalised by the platform to equalise multiple quantiles of the 
probability distribution of gene expression and analyzed based on the ANalysis Of VAriance 
(ANOVA). The statistical significance was determined using False Discovery Rate (FDR) 
method. This global gene expression analysis were based on false discovery rate threshold 
(FDR) = 0.05 and fold-change threshold = 2.  From these criteria, I obtained 6374 significant 
genes different among 3 conditions: mOct4 versus coelacanth POU5F1, mOct4 versus 
coelacanth POU5F3, and coelancanth POU5F1 versus POU5F3-rescued ESC lines. I used 
GENE-E to hierarchically cluster gene expression based on mean Euclidean distance of most 
(FDR<0.05, totally 6374 genes). This clustering is visualised in the heat map shown in in 
Figure 3.13A, and show that the mOct4-rescued line clustered together with those rescued by 
coelacanth POU5F1, not coelacanth POU5F3. 
 
 I then investigated how global gene expression profiles are different between each 
rescued line by performing pair-wise comparisons (Figure 3.13B). The pairwise comparison 
of gene expression profiles between each pair of the rescued lines allowed the identification 
of genes that are differentially expressed at an significance level FDR < 0.05, in both 
overexpressed and underexpressed direction. Results of the pairwise comparisons of POUV-
rescued lines are shown as following: 
 
(a) Comparison of mouse Oct4 and coelacanth POU5F1 rescued line 
 (Figure 3.13B, left) 
The log–ratio plot illustrates that both mouse Oct4 and coelacanth POU5F1 rescued 
lines are quite similar and show relatively few differences in gene expression. There were 











Figure 3.13 Microarray analysis of Oct4-null ESC rescued by coelacanth Pou5f1 and Pou5f3 
proteins A) Hierarchical clustering of gene expression (FDR < 0.05) was constructed by GENE-E software. The relative 
expression level of each gene was shown in three-color format, in which red, white and blue mark high, medium and low level of 
that gene expression respectively. B) Log-ration plots showing genes overexpressed (in red) and underexpressed (in green) in 
pairwise comparison of coelacanth POU5F1 versus mOct4 (left), mOct4 versus coelacanth POU5F3 (middle), coelacanth 
POU5F1 versus coelacanth POU5F3 (right). C)  Overexpressed/underexpressed gene lists of mOct4 and coelacanth POU5F1 
against coelacanth POU5F3 (refer to middle and right log-ration plots in B) were used to produce Venn Diagrams to further 
identify common genes expressed in both mOct4 and coelacanth POU5F1 or specific to either mOct4 or coelacanth POU5F1 



















Overexpressed to coelacanth P3
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Underexpressed to coelacanth P3
See figure 3.14 for 
GO-term analysis
See figure 3.15 for 
GO-term analysis
(including only annotated genes)
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(b) Comparison of mouse Oct4 and coelacanth POU5F3 rescued line  
(Figure 3.13B, middle) 
The log-ratio plot illustrates that there were 1983 genes upregulated in mouse Oct4-
rescued line and 2008 upregulated in coelacanth POU5F3-rescued line.  
 
(c) Comparison of coelacanth POU5F1 and coelacanth POU5F3  
(Figure 3.13B, right) 
The log-ratio plot illustrates that there were 1383 genes upregulated in coelacanth 
POU5F1-rescued line and 2224 genes upregulated in coelacanth POU5F3-rescued line. 
 
From these pairwise comparisons, it is apparent that the pattern of up- and 
downregulated genes of mouse Oct4 line and coelacanth POU5F1 lines are very much 
similar. Thus, to decipher which up- and down-regulated genes are shared by both mouse 
Oct4 and coelacanth POU5F1 lines, I extracted the list of these genes from NIA Array tool, 
and analyzed them by web-based software to produce Venn diagram, which visualise shared 













Venn Diagram in figure 3.13C illustrates the results as following: 
 
(a) Overexpressed genes of mouse and coelacanth POU5F1 compared to coelacanth 
POU5F3 
In the Venn diagram, there are 732 genes shared by both mouse and coelacanth 
POU5F1. 839 genes are specific to mOct4 and 326 genes are specific to coelacanth POU5F1. 
 
(b) Underexpressed genes of mouse and coelacanth POU5F1 compared to coelacanth 
POU5F3 
In the Venn diagram, there are 1250 genes shared by both mouse and coelacanth 
POU5F1. 432 genes are specific to mOct4 and 609 genes are specific to coelacanth POU5F1. 
 
In section 3.5-3.6, I explored more on functional significance of these gene lists by 















Section 3.5 Gene ontology (GO)-term analysis and gene network 
comparison of coelacanth and mouse POUV-rescue ESC lines 
 
 To investigate the functional significance of genes regulated by POU5F1, POU5F3 
or both of them, GO enrichment analysis was performed using ExATLAS (NIA) and 
BINGO in CYTOSPACE platform. As described in section 3.4 and Figure 3.13C, lists of 
significant gene for GO term analysis were obtained from the Venn Diagrams: 732 genes 
overexpressed and 1250 genes underexpressed in both mOct4 and coelacanth POU5F1 
(compared to coelacanth POU5F3). These gene lists were then analyzed by those web-based 
GO analysis platform to obtain overview of clusters of the biological/ cellular/ molecular 
functions represented as GO term networks.  
 
 Firstly, as shown by both ExATLAS and BINGO analysis, the list of 732 genes 
overexpressed in both mOct4 and coelacanth POU5F1 was enriched in genes regulating (1) 
biological functions involving developmental process, stem cell maintenance and 
differentiation, and reproduction process, in particular spermatogenesis (2) cellular function 
involving cell proliferation and (3) metabolic process involving primary metabolic process 
and nucleic acid metabolism.  Stem cell maintenance genes included in the list were Sox2, 
Tcl1, Rif1, Esrrb, Kit, Klf4 and Fgf4 (figure 3.14). In addition, it was found that among 
reproduction genes upregulated by both mouse and coelacanth POU5F1, most were are 
related to basic germ cell development (including Prdm14, Nanos3 and Zfp42), 
spermatogenesis, while less genes were related to oogenesis, see appendix figure X. In 
addition, mouse Oct4 specific cluster (839 genes) upregulated only in mOct4 was also 
analyzed by the same analysis platform. Interestingly, there is another gene set of 
developmental process (including reproduction and cell differentiation) and nucleic 
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GO:0006644, phospholipid metabolic process 
GO:0048863, stem cell differentiation 
GO:0019827, stem cell maintenance 
GO:0030154, cell differentiation 
GO:0006909, phagocytosis 
GO:0007389, pattern specification process 
GO:0005518, collagen binding 
GO:0043565, sequence-specific DNA binding 
GO:0006461, protein complex assembly 
GO:0003682, chromatin binding 
GO:0042102, positive regulation of T cell proliferation 
GO:0046872, metal ion binding 
GO:0003690, double-stranded DNA binding 
GO:0005516, calmodulin binding 
GO:0035556, intracellular signal transduction 
GO:0043197, dendritic spine 
GO:0007275, multicellular organismal development 
GO:0007283, spermatogenesis 
GO:0007166, cell surface receptor signaling pathway 
GO:0003774, motor activity 
GO:0042127, regulation of cell proliferation 
GO:0005089, Rho guanyl-nucleotide exchange factor 
GO:0030027, lamellipodium 




see appendix 3 for gene list
Figure 3.14 Gene annotation (GO)-term analysis of genes overexpressed in both mOct4 and 
coelacanth POU5F1 compared to coelacanth POU5F3. Overexpressed genes (732 genes) shared by both 
mOct4 and coelacanth POU5F1 were analyzed by two GO-term analysis platforms: ExATLAS and BINGO. A) GO term 
analyzed by ExATLAS. The parameter is FDR<0.05. Gene lists of each GO cluster are shown in appendix table X. B) GO 
term analyzed by BINGO in CYTOSPACE software. The parameters were including 1) Binomial statistical test 2) Bonferroni 
Family Wise Error Rate (FWER) correction 3) significant level P< 0.005 4) visualization by overrepresented categories after 
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Stem cell maintenance: (corrected p-value: 2.8117E-3)
SOX2, TCL1, RIF1, ESRRB, KIT, KLF4, FGF4
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FBXO24, GLI1, GLI2, CLGN 
NEURL1A, SOCS2, SOX2 
TIAL1, FBXO5, GGT1, 
MORC1, TCP11, AZI1, NOS3 
NANOS3, FANCA, HMGA1 
NR0B1, HNF1A, SIRT1, ETV5 










overexpressed in both mOct4 and coelacanth P1 
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Among these mOct4 specific genes, most of reproduction genes were involved mostly in 
spermatogenesis, see appendix 1 and 2. Gene lists in each GO term are shown in appendix  
3-5.  
 
 Next, I also performed GO analysis with 1250 genes overexpressed specifically in 
coelacanth POU5F3. As shown in figure 3.15, highly significant GO term for this cluster 
was cell differentiation that included various differentiation programs including 
neurogenesis, cartilage development, bone development, blood vessel development, 
epithelial cell differentiation and striated muscle cell differentiation. Remarkably, GO term 
for cellular function was enriched in cell-adhesion, cellular component movement, 
cytoskeleton organization, cell migration, localization and transport. Surprisingly, both E-
cadherin (Cdh1) and N-cadherin (Cdh2) were more significantly upregulated in POU5F3 
than in POU5F1-rescued lines. We have previously shown that Xlpou25, which is the 
epiblast-specific POUV protein and adhesion-related regulator during Xenopus gastrulation, 
induces higher level of E-cadherin in the Oct4-null ESC cell compared to Xlpou91 and 
maintained high level of E-cadherin and p120 catenin during the forced induction of 
differentiation. The upregulation of Cdh1 gene in coelacanth POU5F3 from the microarray 
data is consistent with higher level of E-cadherin observed in flow cytometry, implying that 
POU5F3 might be adhesion-related regulator during coelacanth gastrulation, similar to 
Xlpou25. In general, Cdh2 encoding N-cadherin protein is downregulated once Cdh1 is 
upregulated as shown by ESC-EpiSC conversion, and N-cadherin is specifically found in 
EpiSC. The upregulation of Cdh2, together with Cdh1, in the POU5F3 line is surprising 
while suggests that ESC phenotypes induced by Pou5f3 maybe biased toward 
epiblast/EpiSC-like. Gene lists in each GO term (specific to coelacanth POU5F3) are shown 
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GO:0001725, stress fiber 
GO:0030335, positive regulation of cell migration 
GO:0070062, extracellular vesicular exosome 
GO:0005925, focal adhesion 
GO:0005178, integrin binding 
GO:0005515, protein binding 
GO:0030056, hemidesmosome 
GO:0035329, hippo signaling 
GO:0016460, myosin II complex 
GO:0048514, blood vessel morphogenesis 
GO:0008305, integrin complex 
GO:0005604, basement membrane 
GO:0030511, positive regulation of transforming 
GO:0008092, cytoskeletal protein binding 
GO:0042383, sarcolemma 
GO:0007155, cell adhesion 
GO:0009986, cell surface 
GO:0003779, actin binding 
GO:0045216, cell-cell junction organization 
GO:0031012, extracellular matrix 
GO:0005913, cell-cell adherens junction 
GO:0016477, cell migration 
GO:0019897, extrinsic to plasma membrane 
GO:0030054, cell junction 
GO:0042476, odontogenesis 
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see appendix 6 for gene list Z-value
















































































































































































































































































































































































































































































































































































































































































































































































cell morphogenesis involved in
differentiation
regulation of cellular biosynthetic process
e.g. ITGB1, TEAD4, NOTCH3, 
DLX2, TGFB2, TGFB1I1, PAX3, 
GATA3, PSEN1, GATA2, 
HOXC10 GLI3, GAP43, GDNF, 
ID2, GAS1 PPARG, NKX2-5, 
SOX6, WNT3 WNT4, NKX2-2, 
CDON, FGFR1
e.g. ITGB1, DDR1, CYFIP2,APP 
COL16A1, ITGB5, ITGB4, ILK
 LAMC2, PIK3CB, F11R, PVR 
HSPB11, WISP1, CYR61, CTGF 
LGALS1, CDH2, CDH1, DAG1 
FLOT2, ITGAV, ITGB6, SCARF2 
BVES
Figure 3.15 Gene annotation (GO)-term analysis of genes overexpressed in coelacanth 
POU5F3. Overexpressed genes (1250 genes) specific to coelacanth POU5F3 and downregulated in both mOct4 and 
coelacanth POU5F1 were analyzed by two GO-term analysis platforms: ExATLAS and BINGO. A) GO term analyzed by 
ExATLAS. The parameter is FDR<0.05. Gene lists of each GO cluster are shown in appendix table X. B) GO term analyzed 
by BINGO in CYTOSPACE software. The parameters were including 1) Binomial statistical test 2) Bonferroni Family Wise 
Error Rate (FWER) correction 3) significant level P< 0.005 4) visualization by overrepresented categories after correction 









Overexpressed specific in coelacanth P3 or 
underexpressed in both mOct4 and coelacanth 
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 To better assess the relationship between POU5F3 supported ESC lines and EpiSC, I 
compared the list of genes upregulated in POU5F1 (732 genes) and POU5F3 (1240 genes) to 
the top 100 most significant genes upregulated and downregulated in EpiSC compared to 
ESC (Hayashi et al 2013). Here I identified,   
 
(1) There are 31 genes shared by both EpiSC upregulated cluster and POU5F3- 
rescued line upregulated gene cluster (Figure 3.16, top panel). 
 
(2) There are 25 genes shared by both EpiSC downregulated gene cluster and 
mOct4/coelacanth POU5F1-rescued lines upregulated gene cluster (Figure 3.16, 
bottom panel). 
 
The significance of these comparisons is born out by the fact that only 1 gene in 
either the reciprocal POU5F1 or POU5F3 dependent gene lists is common to the EpiSC gene 
lists. To confirm that these genes were highly expressed in POU5F3 line or POU5F1 lines, I 
took these 31 and 25 genes to further analyze in NIA Array Analysis to obtain log-intensity 
representing the expression level from the microarray. The log-intensity values were plotted 
on the same histogram to illustrate the behavior of EpiSC genes in the POU5F1 and POU5F3 
rescued cell lines (Figure 3.16). Genes highly expressed in POU5F1 lines, and reduced in 
POU5F3 lines are mostly related to naïve pluripotency (e.g. Klf2, Klf4, Esrrb, Fbxo15, Fgf4, 
Kit, Nr0b1, Zfp42). In summary, the combination of differentiation specific genes, and 
EpiSC markers, suggests that POU5F3 supports a primed pluripotent state, while POU5F1 









































































Figure 3.16 Coelacanth POU5F3-mediated rescue of Oct4 null ESCs induces EpiSC-like 
gene expression. We took (1) 732 genes upregulated in both mouse and coelacanth POU5F1 (compared to 
coelacanth POU5F3) and  (2) 1240 genes upregulated specific to coelacanth POU5F3 (downregulated in both mOct4 and 
coelacanth POU5F1) and compared them to genes up- or downregulated in EpiSCs as compared to ESCs.  The overlap 
of these lists with the top 100 most significant genes up- or downregulated in EpiSC (Hayashi et al., 2013) are shown in 
the Venn diagrams. 31 genes were shared by both coelacanth POU5F3 rescued line and EpiSC while 25 genes were 
shared by both mOct4/coelacanth POU5F1 and ESC (downregulated in EpiSC). The log intensity obtained from NIA Array 


















































































































Section 3.6 Gene expression profiles of mouse and coelacanth POUV-
rescued lines 
 
In order to better understand biological nature of POUV-rescued lines, I investigated 
microarray-based expression pattern of some genes with known biological functions related 
to pluripotency and differentiation. I grouped genes with the same functions or from the 
same protein family to illustrate their expression levels, as shown in figure 3.17.  
 
Group of genes based on gene functions 
 
(1) Naïve pluripotency  
Embryonic stem cells exhibit naïve pluripotency, in which Oct4 is a well-known 
crucial player in maintaining this level of cell potency. Deletion of Oct4 demolishes 
pluripotency circuity and the ESCs spontaneously differentiates toward trophectoderm 
(Nichols and Smith, 2009; Nichols et al., 1998). I found that coelacanth POU5F1 could 
potentially support naïve pluripotency-related gene expression (Zfp42 (Rex1), Nr0b1, Fgf4, 
Nanog and Esrrb) as well as mouse Oct4. In contrast, coelacanth POU5F3-rescued lines 
expressed lower levels of these genes. 
 
(2) Trophectoderm 
In embryo and ESCs, the deletion of Oct4 leads to the upregulation of Cdx2 (one of 
key trophectoderm marker) and vice versa. The reciprocal transcriptional regulation of Oct4 
and Cdx2 is important for inner cell mass/trophectoderm lineage segregation and 
maintaining ESC potency (Chew et al., 2005; Nichols et al., 1998; Wu et al., 2010). The 
microarray analysis revealed that Cdx2 was one of the top significant genes upregulated in 


























































BASED ON PROTEIN FAMILY
Figure 3.17 Rescue of POU5F1 mutant ESCs shows a high degree of functional conservation 
between mouse POU5F1 and coelocanth POU5F1, but not coelocanth POU5F3. Normalized 
log-intensity value plots for selections of differentially expressed genes in Oct4/Pou5f1 conditional null ESCs (ZHBTc4) rescued 

































































































Krt8 and Gata3, Tead4 and Rab13 were also significantly higher in POU5F3. This indicates 
the conserved roles of POU5F1 in suppressing trophectoderm-related programs. Based on 
the fact that trophectoderm doesn’t exist in non-mammalian vertebrates, downregulated 
Cdx2 expression in coelacanth POU5F1 rescued line implies the existence of POUV-CDX 
network prior the emergence of sarcoptergians. As a number of trophoblast markers are also 
mesoderm and endoderm markers, this suggests that the evolution of trophoblast is based on 
an ancient gene regulatory network involved in germ layer specification. 
 
(3) Germ cells 
Several naïve pluripotency-related genes expressed in ESCs are shared with those 
from early specified PGC including PGC-derived EGCs (Hayashi et al., 2011; Leitch et al., 
2013; Saitou and Yamaji, 2010). Prdm14, one of tripartite regulators (Prdm1/Blimp1, 
Prdm14, Tcfap2c/AP2) essential for germ cell specification (Magnúsdóttir et al., 2013), was 
expressed at similar level in both mouse and coelacanth POU5F1 line. However, Prdm1 and 
Tcfap2c were not significantly different between three rescued lines.  In addition, other germ 
line markers (Fbxo5, Sirt1, Tial1, Nanos3) were also expressed at similar level to Prdm14; 
whereas, some (Dnmt3l, Sycp3, and Tcam1) were specifically expressed at higher level in 
mOct4 rescued line. This indicates that mOct4 might have additional link to germ cell 
network not present in coelacanth POU5F1. 
 
(4) Primed pluripotency 
Primed state of pluripotency is found in post-implantation epiblast and epiblast stem 
cells, where genes related to various differentiation programs (e.g. Sox9, T-Brachyury, 
Wnt3a, Wnt8, Sall3, Meis2, Pou3f1 (Oct6), Otx2, Fgf5, Cer-1, Lefty-1, Cdh2) are 
upregulated while those related to naïve state are downregulated (Buecker et al., 2014; 
Hayashi et al., 2011). I found that some of primed pluripotency–related genes (Fgf5, T-
Brachyury, Wnt3a, Wnt8) were expressed at low level and not significantly different between 
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three rescued lines.  Interestingly, these genes are primitive streak markers and other epiblast 
specific markers are upregulated such as Cdh1, Cdh2, Pou3f1 and Meis2 that are all 
expressed at higher levels in POU5F3 supported ESCs. 
 
(5) Epigenetic regulators 
Chromatin modifiers are known to be important for the maintenance of pluripotency 
and differentiation of ESCs (Boland et al., 2014; Kraushaar and Zhao, 2013). It has been 
shown by some studies that Oct4/POUV network is linked to these epigenetic regulators 
(Loh et al., 2006). From my microarray, most of the candidate epigenetic modifiers (e.g. 
Ring1a, Ring1b, Prc1, Chd7, Mbd3) were not significantly different between POUV-rescued 
lines.  
 
Group of genes based on protein family 
 
(1) SOX family 
 Transcription factors of SOX family regulate cell fates during development and are 
conserved among animals (Sarkar and Hochedlinger, 2013). Sox2, together with Oct4, are 
key players regulating self-renewal and pluripotency of embryonic stem cells (Rizzino, 
2009). Sox1/Sox3 (also Sox2) and Sox7/Sox17 regulate neural development and 
endoderm/primitive endoderm differentiation, respectively (Artus et al., 2011; Niimi et al., 
2004; Uchikawa et al., 2011). From the microarray, Sox2 was expressed at higher level than 
other examined Sox genes (Sox1, Sox3, Sox7 and Sox17). Coelacanth POU5F1 sustained 
ESC level of Sox2 expression, which could not be achieved by its paralogs. Other Sox genes 





(2) Krüppel like factor (KLF) family 
 Klf2, Klf4 and Klf5 regulate ESC pluripotency and are functionally redundant. The 
deletion of all three KLF leads to ESC differentiation (Jiang et al., 2008). In ESCs, Oct4 
primarily regulates Klf2 and Klf4 expression, with KLF4 expression also supported by 
LIF/STAT signaling. Both Klf2 and Klf4 are downregulated in epiblast stem cells and the 
induction of either of Klf2 or Klf4 expression can reactivate naïve pluripotency (Hall et al., 
2009). The microarray analysis showed that both Klf2 and Klf4 were upregulated in both 
mouse and coelacanth POU5F1 lines and downregulated in the POU5F3 supported lines, in 
contrast to Klf5 expression was unaffected by different POUV proteins. This result is in the 
line with previous findings and indicates the conserved POUV role is more linked to Klf2 
and Klf4 than to Klf5.  
 
(3) ID family 
 Id1, Id2, and Id3 play roles in ESC self-renewal, cell differentiation towards neural 
lineages, and in neural stem cell maintenance. In addition, Id2 is found in mouse chorionic 
trophoblast cells (Jen et al., 1997; Romero-Lanman et al., 2012). I found that Id1 and Id3 
were expressed in all rescued cells and did not appear to significantly vary. However, Id2, 
like other trophectoderm markers such as Cdx2, Krt8 and Gata3 was upregulated in POU5F3 
supported cells. This agrees well with the presence of trophoblast lineages in POU5F3 line.  
 
(4) Fibroblast growth factor (FGF) family 
 FGFs regulated pluripotency in both the naïve and primed state. The expression of 
Fgf4 and Fgf2/5/8 is characteristic of ESC and epiblast state, respectively (Nichols and 
Smith, 2009; Sumi et al., 2013). However, Fgf4 is a marker specific to the naïve state and 




(5) GATA family 
 Zinc finger transcription factor GATAs play roles in early lineage differentiation. 
Gata2 and Gata3 are found in trophoblast cells and important for placenta functions (Ma et 
al., 1997), while Gata4 and Gata6 are upregulated during primitive endoderm differentiation 
and later are also found in parietal endoderm (Cai et al., 2008). From the microarray, Gata2 
and Gata3 were expressed at the similar trend with Cdx2, upregulated in the POU5F3 line 
and more extensively downregulated in coelacanth POU5F1 supported cells. Other GATA 
genes were not significantly different among rescued lines, although we did observed Gata6 




















Section 3.7 The origin of POUV protein 
 
Class V POU proteins are found across vertebrates in two forms POU5F1 and 
POU5F3. I have provided insights to evolutionary rate and conserved activities of those 
proteins in section 3.1-3.6. In this section I explore the history of these two paralogs and 
attempt to identify a single ancestral protein. The candidate ancestor of POU5F1 and 
POU5F3, that I will refer to here as POU5F1/3, should be a five-exon gene encoding a 
protein similar to both POU5F1 and POU5F3. It has been shown recently that both POUV 
forms are also present in little skate (Leucoraja erinacea, one of chondrichthyes) 
(Frankenberg and Renfree, 2013). Thus, it seems that gene duplication leading to the 
emergence of POU5F1 and POU5F3 occurred at least as early as gnathostome ancestor.  
However, it is not clear how old this duplication is.  The lamprey, a jawless vertebrate split 
from the ancestor of the gnathostomes around 550-650 MYA (Blair and Hedges, 2005; 
Kumar and Hedges, 1998). Did the POUV duplication take place prior to this split? To 
address this, I attempted to identify a POUV-related gene in jawless vertebrate 
(cyclostomes). There are two subclasses of cyclostomata: hagfish and lamprey. However, 
only the genome for the lamprey is publically available. For lamprey there are two genomes 
that have been sequences from both the arctic lamprey (Lethenteron camtschaticum) and sea 
lamprey (Petromyzon marinus). Noteworthy, arctic lamprey has several synonyms including 
Lampetra camtschatica, Lampetra japonica, and Lethenteron japonicum. The arctic lamprey 
and Japanese lamprey are indeed the same species (Potter et al., 2014). 
 
In order to find the candidate POUV gene in jawless vertebrate, several gnathostome 
POU5F1 and POU5F3 DNA/protein sequences were used in BLAST searches against the 
available lamprey genome assembly database named LetJap7.0, which was derived from the 
testis of Japanese lamprey (Lampetra japonica). The BLAST search identified numerous 
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BLAST search using several POU domain 
DNA/protein sequences
Arctic/Japanese lamprey (Lethenteron 
camtschaticum or Lampetra japonica) 
genome database
GenBank: KE995613.1: Lethenteron camtschaticum unplaced genomic scaffold 01942, WGS sequence 
Genome assembly: LetJap1.0 GenBank assembly (GCA_000466285.1) 







Done by Stephen Frankenberg
Result 1: Construction of the frist predicted lamprey POUV sequence
Verification: 
 BLAST POUV containing genome 
sequence and predicted protein 






Unpublished Japanese lamprey 
transcriptome database
Unpublished sea lamprey 
transcriptome database
Genome assembly: LetJap1.0 GenBank assembly (GCA_000466285.1) 
GenBank: KE995613.1: 
contig:APJL01088491 contig:APJL01026050 
G G G G G G
E1A E1B E2 E3 E4 E5
start stop
POUV transcript
Lamprey POUV protein NTD POUs POUHD CTDL
E1B E2 E3 E4 E5
genomic scaffold
BLAST hits: from both japanese and sea lamprey transcriptomes 
Result 2: reconstruction of new predicted sequence
see figure 3.19
Figure 3.18 Work flow of lamprey POUV gene identification
Abbreviation: E, exon; NTD, N-terminal domain; POUs, POU specific domain; L, linker; POUHD, POU homeodomain; CTD, C-terminal 
domain; aa, amino acids; G, Gap region (unknown DNA sequence)
GG GGG G
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sequences with some similarity to vertebrate POU domains, but most of them are other 
homeodomain containing proteins and some are POU3 (POU3 genes contain only one exon). 
However, there is only one genomic region or contig named APJL01088491 containing 
some sequences similar to that of POU specific and homeodomain and importantly with 
five-exon structure, suggesting a potential class V POU protein. These extensive searches 
were originally done by Stephen Frankenberg (University of Melbourne). To clarify the 
identity of this region, we initiated collaborations with Fumiaki Sugahara (RIKEN institute, 
Japan) and Chris Amemiya (Benaroya Reseach Institute, Seattle), and searched the predicted 
POUV-carried genomic region against unpublished transcriptome databases of Japanese 
lamprey and sea lamprey. Both transcriptomes lead to the identification of partial transcripts 
that were useful in constructing a complete full-length lamprey transcript sequence, which 
was then used to construct exon-intron structure on the contig. This strategy of lamprey 
POUV identification is illustrated in figure 3.18.  
 
Indeed there are distinct five exons that encode the full-length protein. The 
alignment of these sequence tags to the lamprey contig is shown in Figure 3.19 and suggests 
the existence of an additional exon, which contain 5’ untranslated region (5’UTR), in 
another contig named APJL01026050. This additional exon is referred to here as exon 1A 
and the second exon containing start site is referred as exon 1B (E1B). Similar to jawed 
vertebrate POU5F1 and POU5F3 genes, the first exon (E1B) containing the start site encodes 
for only the N-terminal domain. Exon 2 to 4 encode for the POU domain.  Exon 5 contains 
coding sequence for C-terminal domain and 3’ untranslated region (3’UTR). In contig 
APJL01026050, there are also possible promoters located upstream of exon1A. Thus, 
lamprey POUV protein is encoded by 6 exons and appears the only gene present.  The exon-




Figure 3.19 Exon-intron structure of POUV gene in lamprey
Alignment of Japanese lamprey genomic regions contig:APJL01088491 with predicted lamprey POUV sequnces obtained from the 
transcriptomes (on the left) and predicted protein sequence (on the right) is shown. The alignment is visualized by JALVIEW. 




























































The complete full length of POUV transcript enables us to construct a predicted 
protein coding sequence. As in figure 3.20, coelacanth POU5F1 and POU5F3 are used as the 
representative of vertebrate POUVs. The length of POUs (75 amino acids) and POUHD (61 
amino acids) of lamprey POUV protein are exactly the same as those of vertebrate POUV 
proteins. Whereas, length of the linker, NTD and CTD in Lamprey are much longer than 
those observed in other vertebrates. Based on an alignment of the POU specific domain and 
POU homeodomain, the lamprey protein contains conserved sequence representative of 
neither POU5F1 or POU5F3, as the identifying sequences described in Figure 3.1-3.4 match 
neither protein. There is also a very large linker domain that does not exist in either POU5F1 
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Figure 3.20 Characteristics of predicted lamprey POU5F1/3 protein
A) Predicted lamprey POUV exon-intron structure and corresponded protein region is similar to both gnathostomePOU5F1 and 
POU5F3 genes and proteins. B) Detail of lamprey POUV protein compared to coelacanth POU5F1 and POU5F3 proteins. C) 
An alignment of POU domains of POUV proteins was done by using JALVIEW. Green box marks POU specific domain, blue 
box marks POU homeodomain and unmark region represents linker. Red box indicates the linker part of lamprey POUV protein 
which is not found in coelacanth POU5F1 and POU5F3 protein. Abbreviation, E, exon, NTD, N-terminal domain, POUs, POU 
specific domain, L, linker, POUHD, POU homeodomain, CTD, C-terminal domain, aa, amino acids 
Lamprey POU5F1/3 protein NTD POUs POUHD CTDL
E1B E2 E3 E4 E5
NTD POUs POUHD CTDL
E1 E2 E3 E4 E5
NTD POUs POUHD CTDL
E1 E2 E3 E4 E5
Vertebrate POUF1 protein Vertebrate POUF3 protein
conserved exon-intron patterns 
and protein domain
554aa 75aa 61aa 145aa56aa
NTD POUs POUHD CTD
linker
18aa75aa 61aa 79aa214aa
NTD POUs POUHD CTD
18aa75aa 61aa 74aa225aa







(See appendix 7) 
184
Section 3.8 Discussion 
 
In this chapter I have shown that the central pluripotency regulator Oct4 is 
conserved, both at the level of sequence and functionally.  I have characterised the rate of 
POUV protein evolution for both POU5F1 and POU5F3 and shown that this rate is 
particularly enhanced in lineages that have lost one of these paralogs.  In species retaining 
both POU5F1 and POU5F3, I found that the capacity of Oct4 to support the ESC gene 
regulatory network appeared particularly well conserved in the POU5F1 family and 
appeared to correlate with expression of this gene in the germ line.  POU5F3 genes appeared 
to support something closer to primed pluripotency and this may correlate with expression in 
the epiblast at gastrulation.  Finally, I present evidence for an ancestral POUV protein, a 
single gene in lamprey that does not fit in either class.  
 
Previous work on the capacity of POUV proteins to support murine ESCs suggests a 
varied degree of POUV capacity to rescue Oct4 phenotypes. Based on data in Xenopus, it 
has been suggested that this activity might correlate with expression pattern of different 
POUV proteins in embryonic development.  Thus, as shown in Morrison and Brickman, 
2006) Xlpou91, a germ specific POUV protein, is better at rescuing Oct4-null ESC cells than 
Xlpou25, which is an epiblast specific POUV protein. These initial observations lead us to 
the suggestion that there were two independent functions of Oct4, one that is specific to 
germ/naïve ESCs and the other is specific to adhesion in the epiblast (Livigni et al., 2013). In 
my thesis I have examined the capacity of wide range of POUV proteins to rescue Oct4-null 
murine ESCs and found in species that possess two POUV proteins, this sort of segregation 
of function is observed. While POU5F1 appears specific to naïve ESC culture and germ cell 
related pluripotency, the loss of POU5F1 and further duplication of POU5F3 allowed rapid 
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diversification and the evolution of a specialised germ cell function, as seen in the case of 
POU5F1-like Pou5f3 protein (Xenopus Pou91). 
 
Mouse Oct4 is expressed in the inner cell mass, the germ cells and epiblast during 
gastrulation. As a result, Oct4 appears to regulate different aspects of pluripotency. 
Interestingly, the Oct4 promoter actually contains distinct regulatory regions, one that 
controls expression in naïve/germ cell pluripotency, and the second, that regulates 
expression in the epiblast (Ovitt and Scholer, 1998). In a number of species that retain both 
paralogs that go back to the beginning of the jawed vertebrates, it is clear that this function 
remains segregated. This is particularly interesting as the mechanism that regulates naïve and 
primed (epiblast) pluripotency are different, although both involve Oct4. For example, naïve 
pluripotency depends on the inhibition of FGF/ERK signaling, while primed pluripotency 
requires it.  Primed pluripotency is dependent on Nodal-related TGF-β signaling, while naïve 
cells rely on LIF (Nichols and Smith, 2009). Perhaps a closer inspection of both POU5F1 
and POU5F3 paralogs will help resolve the aspects of the network downstream of Oct4 that 
is responsible for interacting with these signaling pathways.   
 
 The finding that POU domains have changed dramatically at the birth of eutherian 
radiation, I hypothesise further that POU5F1 in eutherian ancestor might have evolved to 
help specializing novel structure called inner cell mass as discussed above, where naïve 
ESCs can be derived. One interesting aspect of this study is the strong implication that 
POU5F1 proteins regulate germ cell specification and that this is related to naïve 
pluripotency. This suggests that the relatively new mechanism for pre-implantation 
development evolved from the gene regulatory network employed during primordial germ 
cell specification.  This idea is consistent with the observation that ESCs and EGCs share 
gene expression profile and epigenetic status in common and any gene expression 
differences between them reflect the culture conditions (Leitch et al., 2013).  
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 As there is evidence of POUV linked to germ cell network, how can we apply this 
POUV activity to the evolutionary model to the germ cell mode specification varied among 
vertebrate branches? First of all, there are two modes of germ cell specification: 
predetermined mode and or inductive mode. Predetermined modes of germ cell specification 
rely on the localization of maternally inherited determinants to drive germ cell specification. 
Inductive modes for germ cell specification employ integrative signaling from surrounding 
tissues for the specification of primordial germ cells during gastrulation (Extavour, 2003). In 
vertebrates, some cartilaginous fish, axolotls, turtles and mammals have inductive modes of 
germ cell specification. Other vertebrates like actinopterygian fish, frogs and archosaurs 
(birds and crocodiles) have predetermined mode of germ cell specification. While the 
inductive mode of germ cell specification is highly conserved and may have been the 
ancestral mechanism of germ cell specification, predetermination appears a secondary 
derived trait that exhibits a high level of variability (Bachvarova et al., 2009; Johnson et al., 
2003; Saito et al., 2014). All vertebrate taxa with predetermined mode have lost POU5F1 
during its evolution. My study here showed that there is a link between POU5F1 and the 
inductive germ cell/reproduction network, in particular Prdm14 and other downstream germ 
cell networks. When POU5F3 is lost, some level of primed pluripotency is presumable lost 
and gastrulation could become constrained, when POU5F1 is lost, naïve/germ cell 
pluripotency is lost, necessitating the re-acquisition of germ plasm and free organisms from 
the structural constraints of making germ cells during embryonic development. 
 
The expansion of genome by duplication clearly enables the diversification of 
protein function in evolution. There are several fates that the duplicated genes can 
experience including non-functionalization (loss of functionality), neofunctionalization 
(acquisition of new function) and subfunctionalization (partitioning of subfunctions into 
different duplicated genes) (Cañestro et al., 2007). From this study, I found that duplicated 
POUV genes (POU5F1 and POU5F3) appear to have undergone partitioning of 
187
subfunctions. Here I provide a model of what might happen during the evolution of 
vertebrate POUV activity. This model is summarised in figure 3.21. Based on the finding 
that there is only one POUV gene found in the lamprey genome with an exon-intron 
structure similar to that of jawed vertebrate genes POU5F1 and POU5F3, this suggests that 
the origin of duplication event giving rise to these genes from a single ancestral POUV gene 
might be occurred after the divergence of jawless vertebrate lineage from the jawed 
vertebrates around 550-600 million years ago. Studies on chordate evolution suggest that it 
involves at least two rounds of whole genome duplication (called 2R model). The first round 
(1R) occurred in a lineage of protochordates and maybe linked to the emergence of jawless 
vertebrates, and the second round (2R) occurred in an ancestral cyclostome lineage and 
maybe linked to the emergence of gnathostomes (Dores, 2011). The nature, timing and 
significance of this second round is still controversial. Our finding that there is only single 
POUV in an extant jawless vertebrate give the impression that this second round of WGD 
might probably occurred around the emergence of gnathostomes and might be responsible 
for the birth of POU5F1 and POU5F3. 
 
 In my model, these dual functions might already present in jawless vertebrate 
ancestor and later after duplication this dual functions has been segregated between POU5F1 
and POU5F3. It has been shown that Oct4 dose is sensitive to development, as shown in 
mouse (Radzisheuskaya et al., 2013). The dose of other vertebrate POU5F1 and POU5F3 
might also influence their development. This might be why most of vertebrates have lost 
either POU5F1 or POU5F3 gene or have undergone complete POUV functional segregation 
to remove redundancy, which might provide benefit for developmental programs. I would 
like to suggest that while gene duplication enables the diversification of regulatory networks, 
these networks are not so different that these POUV proteins can’t regain the capacity to 
regulate different stages in development. More recently, POU5F3 in axolotl or tammar 
shows some capacity to support Prdm14 expression and therefore is perhaps showing a 
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plasticity of function that maybe able to eventually compensate for potential gene loss. This 
loss of one POUV paralog appears to occur frequently in evolution, while the re-duplication 
of pou5f3 in frog, appears only once in to my knowledge. As a result, it would seem that 





































































































































































































































































































































































































































































































































































































































































CONSERVED ROLES OF GERM CELL SPECIFIC AND 




CONSERVED ROLES OF GERM CELL SPECIFIC AND EPIBLAST 




Pluripotency is the ability of cells to give rise to all somatic lineages including germ 
cells (the origin of sperm and oocyte). The mouse embryo contains pluripotent cells 
including inner cell mass (ICM) cells and Oct4-positive gastrulation-stage epiblast cells. 
They can be isolated and maintained as pluripotent stem cells in vitro, called embryonic stem 
cell (ESCs) and epiblast stem cells (EpiSCs) respectively. In the last decade, there have been 
successful attempts to reprogram differentiated, mature somatic cells to these pluripotent, 
embryonic states. The initial efforts in reprogramming were inspired by the success in 
generating tadpoles from differentiated intestinal epithelial cells (Gurdon et al., 1958) and 
later the success in nuclear transfer in mammalian cloning (Wilmut et al., 1997). As a result 
several laboratories attempted to reprogram somatic cells by transferring somatic nuclei to an 
oocyte or ESC (reviewed in (Hochedlinger and Jaenisch, 2006)). Later in 2006, Shinya 
Yamanaka and colleagues made another breakthrough by converting somatic cells to an ESC 
state through the introduction of embryonic transcription factors. They obtained so called 
induced pluripotent stem cells (iPSCs), by overexpression of a specific set of transcription 
factors that are normally expressed in ESCs. They examined several combinations of ESC-
related transcription factors, and found one combination with the best potential in iPSC 
generation, Oct4, Sox2, c-Myc and Klf4, which together are known as Yamanaka factors 
(here I refer to this combination as “Yamanaka factor” or “OSKM”) (Takahashi and 
Yamanaka, 2006). Although some combined pharmaceutical inhibitors can be used in 
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reprogramming instead of Sox2, Klf4 and c-Myc, Oct4 appears to be required and essential 
for reprogramming (reviewed in (Radzisheuskaya and Silva, 2013)).  
 
A form of reprogramming is also used in the generation of germ cells during 
development. During the formation of the germ cells, pluripotency is re-established as the 
rest of the embryo is progressing on in embryonic differentiation (Saitou and Yamaji, 2010). 
In vertebrates, there are two basic modes of germ cell specification: inductive (epigenesis) 
and predetermined (preformation). The inductive modes employ integrative signaling from 
surrounding tissues for specifying primodial germ cells (PGCs) during gastrulation. 
Predetermined modes of germ cell specification depend on the localization of maternally 
inherited determinants (Extavour, 2003; Johnson et al., 2003). In mouse embryos, the 
inductive mode of specification takes place in a small cluster of epiblast cells located in the 
posterior proximal region of the embryo. Cells in this region experience the highest level of 
BMP signaling in the epiblast and as a result are induced to become PGCs (Arnold and 
Robertson, 2009). In contrast, the germ cell program of African clawed frog (Xenopus 
laevis) is specified by maternal determinants and is therefore classed as predetermined mode 
(Kobayashi et al., 1998). Despite the differences in the modes of germ cell induction, both 
mouse and Xenopus embryos express Oct4 and its homolog in their germ cells (Hinkley et 
al., 1992; Sabour et al., 2010). Does this mean that Oct4 plays a similar role in 
predetermined or inductive germ cell specification? Based on studies of cellular 
reprogramming, it appears that Oct4 is one of the key factors driving the acquisition of 
pluripotency and that a number of vertebrate homologs of Oct4 have the capacity to support 
pluripotency in mouse. In particular, the Xenopus Oct4 homolog expressed in germ cells, 
Pou5f3.1 (also referred to here as Xlpou91) is as effective as mouse Oct4 in ESC 
complementation assays and can also substitute for Oct4 in murine and human 
reprogramming (Morrison and Brickman, 2006; Tapia et al., 2012).  
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In chapter 3, I have shown that Xlpou91 has the highest rescue index of Oct4 null 
ESC cells among POU5F3 proteins, similar to all POU5F1, whereas all other POU5F3 lack 
this capacity. There is another Oct4 homolog in Xenopus embryos that has a rescue activity 
similar to other POU5F3 proteins, Pou5f3.2 (Oct25 or referred to here as Xlpou25). In the 
Xenopus embryo, Xlpou25 is highly expressed in gastrula stage embryos (Hinkley et al., 
1992). (Livigni et al., 2013) has shown that Xlpou25 is a regulator of adhesion required for 
Xenopus gastrulation, and it has also been shown that Xlpou25 can induce enhanced 
expression of E-cadherin in Oct4-null lines. This suggests that one of the Oct4 roles in 
primed state pluripotent epiblast is the regulation of cell adhesion. As a result it appears that 
in Xenopus, where the pou5f3 gene was duplicated, two of these genes were specialised to 
perform specific subsets of Oct4 function. Thus, the two Oct4 homologs have distinct 
activities in germ cells/ naïve pluripotency and epiblast/primed pluripotency. In mouse, both 
of these functionalities are encoded in a single factor, Oct4, while in Xenopus these functions 
has been distributed between Xlpou91 and Xlpou25 during evolution. Thus, Xlpou91 is a 
germ cell regulator, while Xlpou25 is an epiblast regulator. In this chapter, I ask how the 
epiblast and germ cell activities of Oct4 influence the cellular reprogramming or induction of 
pluripotency, by exploiting the specialization that occurred in Xenopus.  
 
To address the relationship of developmental activity and reprogramming, I asked 
about the relative abilities of Xlpou91 or Xlpou25 to replace mouse Oct4 in the induction of 
pluripotency during reprogramming. Using Nanog-green fluorescent protein (GFP) mouse 
embryonic fibroblast cells (MEFs) in which GFP has been placed under the control of the 
Nanog promoter (Chambers et al., 2007), the acquisition of pluripotency and reprogramming 
dynamics could be monitored and scored. I found that similar doses of mOct4 and Xlpou91 
could induce pluripotency, whereas higher doses of Xlpou25 were required to achieve 
cellular reprogramming. I then further characterised iPSCs derived from these experiments. 
Based on the examination of other ESC/germ cell surface markers together with Nanog-
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GFP, I found that cells reprogrammed with Xlpou25 eventually reached an “iPSC-like,” 
state, but that it was much less stable than that achieved with either Xlpou91 or Oct4, and 
contained large numbers of differentiated cells. Based on the transcriptomes of the sorted 
iPSC sub-fraction of these cultures, I could confirm that all derived iPSC lines contained 
cells that exhibited naïve pluripotency, although there were some differences.  I found that 
iPSCs derived from Xlpou91 and mOct4 expressed genes related to reproduction that were 
reduced in Xlpou25 iPSCs. Consistent with these observations, I found that Xlpou91 and 
mOct4 induced pluripotency by similar routes, whereas Xlpou25 promoted reprogramming 
via the induction of developmental differentiation programs first. Taken together, my 
observations suggest that direct and efficient reprogramming to naïve pluripotency may be 

















Section 4.1 Optimization of induced pluripotent stem cells (iPSCs) 
generation 
 
There are several methodologies for the generation of iPSCs. These include the 
introduction of the four factors by retrovirus, transposon, episome, as well as the addition of 
small molecules that can improve the reprogramming process (Hou et al., 2013; Kaji et al., 
2009; Shi et al., 2008; Takahashi and Yamanaka, 2006; Yu et al., 2011). The transition from 
MEFs to iPSCs takes time from several days to weeks. In general, reprogramming 
efficiencies are low, approximately 0.01-0.001% of cells exposed to the four factors.  To 
achieve the best cellular reprogramming, we used several experimental strategies to increase 
the efficiency of induction before proceeding to examine different POUV homologs’ 
activities.  
 
(a) The choice of cell line to monitor the acquisition of reprogramming? 
 
To monitor the acquisition of pluripotency, different pluripotency-related markers 
have been used, in particular fluorescence-tagged Oct4 or Nanog, cell surface staining for 
SSEA-1, and alkaline phosphatase staining.  Single cell analysis of gene expression during 
reprogramming has revealed that endogenous Oct4 is also one of the early markers of the 
process, with its expression originating as soon as cells reach an early or partially 
reprogrammed state. Nanog comes up later in the reprogramming process and better marks 
fully reprogrammed cells (Buganim et al., 2012). Moreover, even within the Nanog positive 
population there is a range of Nanog expression (these can be sorted with the Nanog-GFP 
reporter) and not all Nanog positive cells are fully reprogrammed. However, with the 
addition of two further cell surface markers, a stable fully iPSC population can be identified 
based of the cell phenotyping as Nanog+ICAM+CD44- profile (O’Malley et al., 2013). 
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Hence, I used Nanog as the marker to monitor the reprogramming efficiency and did 
molecular analysis on the Nanog+ICAM+CD44- population. The detailed method for iPS 
generation I used is described in chapter 2 section 2.8.  Briefly, (Figure 4.1A) I used MEFs 
derived from mice carrying a Nanog-GFP reporter allele (Chambers et al., 2007).  Nanog-
GFP MEFs at passage 1 were used for transfection with retrovirus. The derivation of MEF 
lines is described in chapter 2. The induced cells were seeded onto irradiated feeders and 
cultured in defined iPSC medium for 24-27 days before iPSC colonies were picked and 
expanded. The acquisition of pluripotency was monitored and scored through the appearance 
of Nanog-GFP colonies. 
 
(b) The choice of retrovirus and their doses for reprogramming 
 
I chose to use a retrovirus-based strategy for the induction of reprogramming 
because we could easily manipulate the identity and dose of transcription factors used in 
reprogramming. Each transcription factor was encoded by a cDNA subcloned under the 
retroviral promoter of pMXs-expression system. The retrovirus were produced by 293LTV 
cell lines, and the doses of the retrovirus production were quantified by qRT-PCR using 
primers specifically detecting the retroviral RNA backbone. As shown in figure 4.1B, the 
retrovirus produced from different plasmids expressed different levels of transcription factor 
encoding message. Following quantification of the amount of transcription factor expression, 
I determined the optimal infection efficiency. Retrovirus carrying the dsRED gene was used 
to monitor infection. I found that retrovirus doses of 109 copies and 5X109 copies led to 
infection efficiency of >70% and >96% respectively, as judged by flow cytometry analysis 





Figure 4.1 Optimization of induced pluripotent stem cells (iPSCs) generation A) Schematic illustration 
of strategy of iPSC generation. Nanog-GFP mouse fibroblast cells at passage 1 was used as a source of somatic cells for 
cellular reprogramming.The exogenous expression of Oct4, Sox2, Klf4 and c-Myc was transduced by ecotropic retrovirus. The 
numbers indicate number of days after the first infection. B) Before infection, retrovirus doses were measured by qPCR. Data 
represents two independent retrovirus productions. C) Infection efficiency was confirmed by fluorescence microscopy to detect 
dsRED expression. After 48 hours, the dsRED infected MEF cells were harvested and analysed by flow cytometry. Low dose 
(low) and high dose (high) indicates the amounts of dsRED/Oct4 homologues-carrying retrovirus approximately 1XE9 copies 
and 5XE9 copies, respectively.  D) Nanog-GFP MEF cells were infected with different doses of Oct4 and constant dose of Sox2, 
Klf4 and c-Myc. After four days post the first infection, the induced cells were seeded onto feeders with two clonal densities: 
2000 cells/well and 4000 cells/well, and the induced cells were maintained in different iPSC induction mediums: “KOSR” means 
GMEM+KOSR+LIF and “KOSR+Alk5i+VitC” means GMEM+KOSR supplement with Alk5i inhibitor and Vitamin C (see section 
4.1c). The Nanog-GFP appearance can be detected from day 10 onward after the first infection. The numbers in color circles 
indicate the total number of Nanog-GFP appearance at day 15. 
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(c) The choice of culture medium for iPSC derivation 
 
Yamanaka and colleagues originally used ESC medium containing fetal 
bovine serum (FBS) supplemented with LIF for their reprogramming experiments 
(Takahashi and Yamanaka, 2006). We also tried this ESC condition and could not 
achieve reprogramming. This could be due to variation between FBS batches. As a 
result I tried a number of different media conditions for iPSC generation including:  
(a) ESC medium: GMEM + FBS + LIF 
(b) ESC medium: GMEM + FBS + LIF + Alk5 inhibitor + Vitamin C 
(c) DMEM high glucose + 20% KOSR + LIF 
(d) DMEM high glucose + 20% KOSR + LIF + Alk5 inhibitor + Vitamin C 
These conditions were originally examined by Kumiko A Iwabuchi, in Keisuke 
Kaji’s lab, University of Edinburgh and were based on the published data that the Alk5 
inhibitor and Vitamin C can improve the induction of pluripotency (Esteban et al., 2010; Li 
et al., 2009). I tested these conditions with my retroviruses and found that there were no 
Nanog positive colonies formed when the reprogramming was done in either (a) or (b) 
conditions, but with  (c) and (d) I observed the appearance of Nanog-GFP expression at day 
10-15 after the first infection (figure 4.1D).  Supplementing media with Alk5 inhibitor and 
Vitamin C improved the number of total Nanog-GFP colonies in both replicated 
experiments. I also observed that the number of GFP positive colonies was increased when 
higher Oct4 doses were used. From these colonies I was also able to generate stable clones 
of iPSC lines, which could maintain their Nanog-GFP during expansion. I concluded that the 
best condition for iPSC generation with my viruses and cell lines was DMEM high glucose 
with 20% KOSR supplemented with Alk5 inhibitor and Vitamin C. This was used for all 




Section 4.2 Generation of induced pluripotent stem cells by different 
doses of Xenopus POUV proteins 
 
After I optimised the conditions for iPSC generation (section 4.1). We analyzed the 
ability of different POUV proteins to induce pluripotency. Reprogramming experiments 
were performed with different doses of Oct4 and its homologs, alongside the same doses of 
Sox2, Klf4 and c-Myc. Thus, I tested the capacity of different doses of POUV protein 
alongside constant SKM dose by using the following parameters: 
 
1) 109 copies of Oct4/Xlpou91/Xlpou25 retrovirus as Oct4/Xlpou91/Xlpou25 low dose  
2) 5X109 copies of Oct4/Xlpou91/Xlpou25 retrovirus as Oct4/Xlpou91/Xlpou25 high dose 
3) 109 copies of each Sox2, c-Myc, and Klf4 retrovirus as a constant dose of SKM 
(The infection strategy is described in chapter 2, section 2.8) 
 
To verify that infected MEF expressed OSKM in expected doses, I collected 
infected cells at day 4 post the first infection and quantified the exogenous expression of 
these factors by qRT-PCR. Figure 4.2A shows that while there was some variation in levels 
of c-Myc, Sox2 and Klf4, these levels of variation are all within a tolerable range, less than 
2-fold. Oct4/Xlpou91/Xlpou25 expression levels were proportional to the amount of 
retrovirus used, although Oc4 expression was slightly lower (20%) than the two Xenopus 
genes.  
 
During the induction of iPSCs, I recorded the first appearance and number of 
Nanog-GFP colonies daily. I found that in all reprogramming experiments mOct4 high SKM 
always produced GFP positive colonies first at day 10-11 following the infection. Both Oct4 
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Figure 4.2 Generation of induced pluripotent stem cells (iPSCs) by different doses of Xenopus 
POUV proteins  After infection for 4 days, exogenous gene expression was confirmed by qPCR. Data represents technical 
replicates of one experiment. B) The transduced cells were monitored daily and number of Nanog-GFP colonies were recorded. C) 
Merged images of brightfield and Nanog-GFP present iPSC colonies at day 24 post first infection. D) iPSC clones from Oct4 low and 
Oct4 high doses were picked and expanded for 5 passages on feeders. E) Reprogramming efficiency is calculated by dividing the 
number of Nanog-GFP colonies by the number of reseeded cells. Data represents three independent experiments. 
D Oct4 low Oct4 high
passage 5
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with the activity of Xlpou25, which only produced Nanog positive colonies when infected at 
high levels and only at a later time point (day 16-21, see figure 4.2B).  Xlpou25 low SKM 
and Xlpou91 high SKM both generated a lot of iPSC-like colonies, although none of them 
became Nanog positive (figure 4.2C).  Moreover, while Oct4 high SKM was the most 
effective condition at inducing Nanog-GFP and could induce robustly GFP positive colonies 
(figure 4.2C), iPSCs formed with this dose of Oct4 were not stable, and could not maintain 
expression of the GFP over time in culture (Figure 4.2D). Consistent with the observations in 
ESCs that Oct4 overexpression can also induce differentiation, I also observed that while 
Oct4 high SKM induced Nanog expression at an early time (Figure 4C, D), this expression 
was unstable and Nanog expression was lost when these colonies were picked and expanded 
(Figure 4D). Taken together my observations show that there appears a correlation between 
POUV dose and reprogramming time, but establishing a stable reprogrammed line may be 
incompatible with high level POUV/Oct4 expression. 
 
The reprogramming efficiency for each POUV protein was calculated by dividing 
the total number of Nanog-GFP colonies by the number of originally seeded cells (figure 
4.2E). The most efficient was mOct4 high SKM (0.332%), although most Nanog-GFP 
colonies were not expandable as they did not maintain expression of the Nanog transgene. 
The reprogramming efficiency of mOct4 low SKM was about five fold lower (0.068%). 
Xlpou91 could also induce reprogramming at low dose, but the efficiency was significantly 
lower.  The reprogramming efficiency of Xlpou91 was slightly higher than that of high dose 
Xlpou25, but like the Oct4 lines, these could efficiently maintain Nanog during expansion 




Section 4.3 The derivation of clonal iPSC cell lines generated by 
different POUV proteins 
 
The derivation of iPSC was performed using only the following conditions: Oct4 
low dose, Xlpou91 low dose, and Xlpou25 high dose. In all text and figures, these will be 
referred as mOct4 iPSC, Xlpou91 iPSC, and Xlpou25 iPSC. These conditions were chosen 
based on the effective generation of Nanog positive colonies during reprogramming. 
 
 All Nanog-GFP colonies were picked and plated onto irradiated feeders and 
expanded until passage 6. Only clones retaining Nanog-GFP expression were kept for further 
analysis. At passage 6, I observed that colony morphology of most Xlpou91 clones showed 
less differentiation than the others. Most of Xlpou25 lines contained colonies with Nanog-
GFP centres surrounded by differentiated cells. Interestingly, iPSC generated by mouse Oct4 
low SKM produced a mix of both undifferentiated and differentiated clones in similar 
proportions (Figure 4.3A). I then assessed whether the established iPSC lines were 
maintained solely by endogenous Oct4. I screened for retroviral silencing by qRT-PCR on 
expanded clones at passage 6 and could not detect any residual expression of virally derived 
mOct4/Xlpou91/Xlpou25 in most clones, compared to the high level of those in day 4 
transduced cells. Most Nanog-GFP clones derived from Oct4-mediated reprogramming 
could maintain GFP expression for several passages. Although exogenous Xlpou25 and 91 
had been silenced, Xlpou91 induced clones had high proportions of Nanog positive, while 
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Figure 4.3 Derivation of iPSC clonal cell lines generated by Xlpou91 or Xlpou25 
and karyotyping. A) Data shows the merged images of brightfield and GFP marking Nanog expres-
sion. All iPSC clonal lines shown here were derived from two independent experiments and expanded until 
passage 6 for imaging. B) Karyotyping was done for all derived clones (5 clones each) before further 
analysis. The chromosomes were stained with DAPI and at least 10 cells were imaged. Data shows only 
the result of clones used for global gene expression analysis by microarray. 




 During the retrovirus-based iPSC generation, the retrovirus integrate their reverse 
transcribed genome carrying an exogenous gene construct into the host (MEF) cell 
chromosomes. The high amount of retrovirus used for induction might potentially cause 
chromosome breaks. Moreover, the generation of iPSCs is a selective process and this 
process can also select for abnormal, growth advantaged, karyotypes. Thus, all established 
iPSC lines were karyotyped before further characterization (Figure 4.3B).  I found that most 
of the screened cells from Xlpou91 and mOct4 iPSC lines had a correct karyotype (40 
chromosomes) whereas some Xlpou25 derived lines contained a significant proportion of 
cells with an abnormal karyotype, consisting of an increase in the number of chromosomes 
(around 42-44). In total 50% of the Xlpou25 derived lines had an abnormal karyotype and 
they were excluded from further analysis.  
 
 Most defined, stable, pluripotent cell lines can now be grown under defined 
conditions without feeders.  To test the robust nature of the reprogramming by different 
POUV proteins, I next aimed to examine whether POUV derived iPSC lines could be 
passaged on gelatin coated plates in the absence of feeders. After two passages, the Nanog-
GFP expression in each clone was assessed by flow cytometry. Based on testing three 
clones, I observed that two of the clones induced by either Oct4 or Xlpou91 maintained 
robust expression of Nanog-GFP in the absence of feeders, while one clone lost expression. 
All clones derived from Xlpou25 failed to maintain significant levels of Nanog-GFP 
expression (Figure 4.4).  Taken together this suggests that only Xlpou91, not Xlpou25, is 














































































Figure 4.4 Adaptability of iPSC clonal lines to grow on gelatin-coated culture 
dishes All iPSC clones were picked and cultured on feeders in iPSC medium for 6 passages. The cells 
were then counted and reseeded onto gelatin-coated culture dishes for two passages. The percentage of 
Nanog-GFP expressing cells were assessed by flow cytometry. 
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To determine whether this was a property of the culture or the reprogramming 
process, I isolated the GFP+ subpopulation and expanded it with the goal of assessing 
whether the reprogrammed population induced by Xlpou25 was fundamentally different. To 
do this I used flow cytometry to sort the Nanog-GFP positive population from Xlpou25 iPSC 
line alongside a similar population from a mOct4 control. The sorted cells were then 
expanded on feeders for three passages. Using this strategy, I could establish Xlpou25 iPSC 
lines capable of growing independent of feeders, suggesting that the initial culture system 
established by Xlpou25 was unstable, but once isolated it was able to grow efficiently. As 
shown in figure 4.5, all three clonal lines of Xlpou25 iPSCs could potentially grow on 
gelatin after removing all Nanog negative cells, and their expression of ESC markers was 
similar to that of mOct4 iPSC lines, as judged by immunofluorescence and qRT-PCR. 
During expansion of these gelatin adapted iPSC lines, I also replaced the iPSC medium with 
ESC medium and found that both mOct4 and Xlpou25 iPSC derived iPSCs exhibited a 
decrease in Nanog-GFP expression over time, while those in iPSC induction medium 
maintained the Nanog expression at high level.  
 
Thus, this result suggests that Xlpou91 is capable of restoring the pluripotency gene 
network similar to mouse Oct4 and that the network probably resembles that of embryonic 
stem cells, while Xlpou25 also has this capacity, but is less effective at establishing this 
network stably.  Xlpou25 reprogrammed cells appear more sensitive to the differentiated 

































































Figure 4.5 The generation of stable Xlpou25 iPSC clonal lines on gelation by serial cell sorting
A) Xlpou25 iPSC growing on feeders showed high differentiation and could not adapt well on gelatin, this might be due to the overgrowth of 
differentiated cells or partial reprogrammed cells; thus we performed serial cell sorting for three passages to select only Nanog positive popula-
tion for expansion. After four passages, gelatin-adapted iPSC were stained for immunofluorescence. Both mOct4 and Xlpou25 iPSC showed 
positive for Oct4 (O4), E-cadherin (EC) and SSEA1 (SA). B) At this passage 4, we also collected cells for qRT-PCR to quantify Oct4, Nanog, 
Cdh1 (E-cadherin) and Cdh2 (N-cadherin) transcript level . C) All of iPSC clones in A) and B) were maintained in iPSC medium containing 
Knockout Replacement Serum (KOSR) similar to the iPSC induction. We tested the culture of these iPSC lines in conventional ESC medium 















Section 4.4 Characterization of iPSC clonal lines 
 
Induced pluripotent lines generated by different POUV proteins exhibited ESC-like 
colony morphology with varied degree of differentiation. To better understand the degree to 
which they represent true reprogramming, I characterised the ESC-like subpopulation that I 
have established. I further investigated the expression of naïve pluripotency markers by 
immunofluorescence, flow cytometry/cell sorting and qRT-PCR.   
 
Immunofluorescence with ESC markers 
 
Immunofluorescent staining of all iPSC lines was performed using antibodies 
detecting Oct4 and SSEA-1. During reprogramming, iPSCs switch to endogenous Oct4 and 
are independent from exogenous expression of Oct4 expressed from the retrovirus that 
becomes silent in the pluripotent state. All clones assessed here were previously screened to 
confirm that the exogenous Oct4 had been silenced. Stable expression of the endogenous 
Oct4 is a sign of complete reprogramming. The result of immunofluorescent staining is 
shown in Figure 4.6 and demonstrates that all iPSC lines expressed endogenous Oct4. I also 
observed the expression of Oct4 and Nanog were reversely correlated. In particular, Xlpou91 
iPSC clone 2 and 3 exhibited low levels of Oct4 but high levels of Nanog expression, while 
Xlpou91 iPSC clone 1 exhibited high levels of Oct4 but low levels of Nanog expression. 
This is consistent with published reprogramming experiments on the role of Oct4 dose, that 
show low levels of Oct4 are required to establish high levels of Nanog expression 
(Radzisheuskaya et al., 2013). In addition, all iPSC lines were also stained with SSEA-1 
antibody, which is an ESC/germ cell surface marker. Interestingly, SSEA-1 was present only 
in some Xlpou91 and mOct4 induced iPSCs, not those generated with Xlpou25. SSEA-1 

























































Figure 4.6 Characterization of Xenopus POUV-derived iPSC clonal lines by immunofluorescence
iPSC clonal lines at passage 6 were seeded onto feeders and cultured for two days before fixing with 4%PFA. The fixed cells were stained 
with mouse Oct4 and SSE -1 antibodies. ll imaging and image processes were performed at the same time. Scale bar  25  m.
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Flow cytometry with iPSC/ESC markers 
 
James O’Malley and colleagues have identified protein surface markers, which can 
be used to follow murine reprogramming behavior. During reprogramming, they observed a 
unique pattern of ICAM-1 and CD-44 cell phenotypes as assessed by flow cytometry. In the 
final state, iPSC exhibiting a fully reprogrammed state (similar to ESC) are ICAM1 positive 
and CD44 negative in both Nanog positive and negative populations (O’Malley et al., 2013), 
see chapter 1 figure 1.6. To better characterise the phenotype of iPSCs derived from different 
POUV factors, I used flow cytometry to characterise the expression of Nanog-GFP, ICAM1 
and CD44 in four clonal lines of mOct4 iPSCs, X91 iPSCs and X25 iPSCs. The control was 
the TNG-B line, an ESC line carrying GFP expression driven by the Nanog promoter (ESCs 
used to generate the mice from which the Nanog-GFP MEFs were derived (Chambers et al., 
2007)).  
 
The results of flow cytometry are shown in figure 4.7 and 4.8. The Nanog positive 
and negative populations from the control ESCs, TNG-B, exhibited an ICAM-1 positive and 
CD44 negative profile, confirming the expected cellular phenotype. In newly established 
iPSC lines, all Nanog positive cells (with the exception of those from Xlpou25 iPSC clone 
1.5.1) were ICAM1+/CD44-, consistent with this population exhibiting complete 
reprogramming. However, unlike ESCs, Nanog negative cells of iPSC clones contained two 
major subpopulations: ICAM1+/CD44- and ICAM+/CD44+. The latter subpopulation marks 
differentiated cells including feeders. As feeders were seeded before culturing iPSCs and 
were mitotically inactivated, each culture should contain a constant quantity of feeders, and 
variations in the ICAM+CD44+ populations should reflect the overall levels of differentiation 




(a) mOct4 iPSC lines: there were three clones with high amounts of ICAM1+CD44-  
and three clones with high amounts of ICAM1+CD44+ cells (Figure 4.7). 
 
(b) Xlpou91 iPSC lines: there were three clones with high amounts of ICAM1+CD44- and 
two clones with high amounts of ICAM1+CD44+ cells (Figure 4.8). 
 
(c) Xlpou25 iPSC lines: there was one clone with high amounts of ICAM1+CD44-  
and four clones with high amounts of ICAM+CD44+ cells (Figure 4.8). 
 
From the observation of phenotypes in the Nanog negative population, we could 
confirm that Xlpou25 iPSCs had the highest number of differentiated cells, while Xlpou91 
iPSCs had the lowest amount of differentiation. However, despite the presence of these 
differentiated cells, all clones had ICAM1+CD44- populations of fully reprogrammed cells, 
although the balance between these populations and differentiated cells was different in the 
different iPSCs.  
 
A second set of cell phenotyping tools available are the surface markers Pecam-1 
and c-Kit regularly used for characterization of the naïve pluripotency, germ cell phenotypes 
and final states of iPSC generation (De Felici et al., 2005; Polo et al., 2012).  As a result, I 
assessed the expression of these markers in different clones derived from either Xlpou25 or 
Xlpou91. Figure 4.9 shows flow cytometry for these two markers in different iPSC lines. 
While Xlpou25 derived iPSCs showed expression of both markers, there was a more 
significant negative population than that observed in either Xlpou91 or mOct4. Interestingly, 
with the exception of one clone, Xlpou91 induced cells appeared to have both the highest 
percentage of Pecam-1+ and c-Kit+ cells and the highest mean level of expression (Figure 
4.9).   
212

































































































































































Figure 4.7  Characterization of ESC phenotype in iPSC clonal lines by flow cytometry
All iPSC clonal lines from two independent experiments were expanded to passage 10 and the ESC phenotype assessed 
by flow cytometry. ESCs and fully reprogrammed cells exhibit ICAM1+CD44-  .
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Figure 4.8  Characterization of ESC phenotype in Xlpou91 and Xlpou25-derived iPSC 






















Figure 4.9 Characterization of iPSC clonal lines by flow cytometry with some ESC/germ 
cell specific markers. Four clones of each iPSC line were analysed by flow cytometry with cell surface marker 
Pecam-1 or c-Kit alongside with GFP expression driven by Nanog promoter. 
Nanog-GFP Pecam-1 c-Kit
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To determine whether the different POUV proteins have truly produced a 
completely reprogrammed stable population of cells, I decided to perform molecular analysis 
on the population of cells that expresses both Nanog-GFP and c-Kit as this is thought to 
better represent homogeneously reprogrammed cell populations, since that both markers are 
expressed in naïve ESCs.  Figure 4.10 represents this data in terms of double and single 
positive populations. Consistent with all the previous analysis, I observed similar levels of 
this double positive population in Oct4 and Xlpou91 induced iPSCs, and this was reduced in 
the majority of Xlpou25 induced cell lines.  
 
Gene expression analysis of ESC-like population in the iPSC lines by qRT-PCR 
  
To assess whether these populations were the same or different, in cell lines derived 
from different POUV proteins, the Nanog+ c-Kit+population was sorted and RNA made from 
these samples for qRT-PCR. Figure 4.11 shows the results of this qRT-PCR for the 
expression of Prdm14, Esrrb and Klf4.  While the overall levels of these genes in the culture 
(total population of live cells purified by flow cytometry) were different, the expression of 
these genes was similar in the sorted populations derived from the different iPSCs. This 
observation suggests that in all cases full reprogramming is obtained in a portion of the 
culture, but the extent to which this population is maintained dynamically over time is 
influenced by the starting POUV protein. 
 
Why should the reprogrammed population in one culture be more stable than 
another?  Why should Xlpou25 induce the same state, but a state that appears more prone to 
differentiate? To address these questions, I sorted the Nanog+c-Kit+ positive population from 
different iPSCs and determined the transcriptome established during reprogramming within 
this pluripotent sub-fraction.  These results of transcriptome  analysis are shown in section 
4.5.  
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Gating strategy for selecting live cells and double positive of c-Kit/Nanog-GFP subpopulation
Live cells (LIVE) 






















Figure 4.10 FACS sorting strategy and analysis of selected iPSC clonal lines for microarray 
analysis There is some degree of correlation of Nanog and c-Kit expression, as shown in figure 4.9. Thus, I used c-Kit 
and Nanog as markers to sort naïve ESC-like population in the iPSC clonal lines for further characterizing global gene 
expression profile (figure 4.12). The gating strategy to collect double positive (abbreviation, “+”) of c-Kit and Nanog 
subpopulation and live cells (abbreviation, “LIVE”) are shown in A. B) four clones of each iPSC lines and two duplicates of 
TNG-B were FACS-sorted as strategy in A. Gene expression of “+” and “LIVE” subpopulations were preliminarily analyzed 






Figure 4.11 Characterizarion of c-Kit+/Nanog-GFP+ subpopulation of iPSC clonal line 
by qPCR. IPSC cells at passage 12 were FACS-sorted, see figure 4.10. Live cells (LIVE) and c-Kit/Nanog 
double positive cells (+) were collected for RNA extraction and analyzed by qRT-PCR. The transcript levels of 
genes of interest were normalized to house keeping gene TBP. The numbers on the bar chart show the percent-
age of sorted c-Kit/Nanog-GFP subpopulation, according to Figure 4.10.  MEF1 and MEF2 are Nanog-GFP MEF 
cell lines used to establish iPSCs. Data represents technical replicates. 
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Section 4.5 Microarray-based global gene expression profile of iPSC 
clonal line generated by different Oct4 homologues 
 
To determine global gene expression differences between iPSC lines, we carried out 
one-colour based microarray on two biological replicates of each iPSC line. The biological 
replicates were selected based on the following criteria: (1) similar ESC phenotypes (ICAM-
1/CD44 profile), (2) correct karyotype, and (3) similar ESC/germ cell-related gene 
expression profile of sorted double Nanog/c-Kit double positive population.  Full details of 
the microarray strategy is described in chapter 2. Briefly, we used high quality RNA (RNA 
integration number (RIN) = 10) to generate Cyt3-labelled cRNAs, which were then 
hybridised to whole genome-oligonucleotide microarray slides (Agilent Technologies). The 
hybridised slides were scanned to obtain global gene expression profiles. The raw datasets of 
samples were combined and uploaded to the online analysis platform, NIA Array Analysis 
(http://lgsun.grc.nia.nih.gov/ANOVA/). All inputs were normalised by the platform to 
equalise multiple quantiles of the probability distribution of gene expression. Global gene 
analysis was based on 1) false discovery rate threshold (FDR) ≤ 0.05 2) fold-change 
threshold ≥ 2. 
 
First, I investigated how global gene expression profiles are different between each 
iPSC line by performing pair-wise comparison (Figure 4.12). The pairwise comparison of 
gene expression profiles between each pair of the iPSC lines allowed the identification of 
genes that are differentially expressed at a significance level FDR < 0.05, in both 
overexpressed and underexpressed directions. Results of the pairwise comparisons of sorted 
iPSC lines indicate very little difference between the purified fractions from either line.  
Intriguingly, the largest difference was observed between mOct4 and Xlpou91 iPSCs (127 
overexpressed and 230 underexpressed). The smallest differences in gene expression were 
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mOct4 iPSC versus Xlpou25 iPSC
mOct4 iPSC versus Xlpou91 iPSC












Figure 4.12 DNA microarray-based global gene expression analysis of c-kit+Nanog-GFP+ 
subpopulation of iPSC clonal lines generated by different Xenopus POUV proteins 
Pairwise comparison of gene expression profiles were assessed by NIA array online tool. The data represents two 
biological replicates 
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observed between Xlpou25 iPSCs and mOct4, with whole genome expression that exhibited 
very few greater than 2-fold differences (only 6 genes were differentially expressed).  Taken 
together, these comparisons suggest all these cultures contain very similar populations of 
reprogrammed cells.  
  
In order to perform more sensitive tests for understanding differential gene 
expression, I thought to compare all three iPSCs expression profiles to ESCs. As gene 
expression differences between different iPSCs might be masked by the 2-fold cut off, I 
thought that perhaps the differences between these iPSCs and ESCs might produce different 
lists of genes that could point to subtle differences between these reprogrammed cells. As a 
result I compared global gene expression profiles of iPSC lines to E14Tg2a ESC by pairwise 
comparison (Figure 4.13-4.15). Genes differentially expressed in iPSC lines in comparison 
to the ESCs were extracted and subjected to GO enrichment analysis in ExATLAS (NIA 
webtool). As these comparisons produced significant differences (even for Oct4 the number 
of gene expression changes was around 5,000, Figure 4.13A), I could ask whether there were 
differences in specific GO terms. The GO clusters enriched in both Xlpou91 and mOct4 
induced Nanog+c-kit+ populations showed significant enrichment in several germ cell 
categories relative to ESCs, whereas Xlpou25 did not.  These catagories are highlighted in 
red in figures 4.13-4.15.  The term reminiscent of germ cells identified in Xlpou25 induced 
cells was meiosis. 
 
In addition, the expression of some pluripotency and differentiation genes was 
compared between sorted iPSC lines, ESC and EpiSC (Figure 4.16). Several naïve 
pluripotency genes (e.g. Sox2, Klf2, Klf4, Klf5, Esrrb, Pecam-1, Icam-1, Zfp42) that are 
downregulated in EpiSC were not significantly different between sorted iPSC lines and the 
ESCs. Among differentiation markers, the sorted iPSCs expressed lower levels of epiblast 
genes  (e.g Fgf5, Brachyury, Wnt3) and trophoblast genes (e.g. Cdx2, Krt18) than the ESCs. 
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This result reveals that the c-Kit and Nanog double positive population resembles naïve 
ESCs and my choice to use these two markers to compare iPSC lines was a valid one.  
 
Taken together, my results so far have pointed to subtle differences in the levels of 
germ cell markers expressed within the reprogrammed cells induced by either Oct4 or 
Xlpou91. This is revealed both through the Pecam staining and pairwise comparisons.  Are 
these changes sufficient to explain the differences in stability of these populations in terms of 
differentiation? Or is there something different about the route by which these cells are 
established that leads to a less stable pluripotent state that is more prone to dynamically 
differentiate?  To address these questions, I compared the set of genes induced during the 




































Figure 4.13 Gene annotation enrichment analysis of mouse Oct4 iPSC overexpressed genes 
compared to ESCs. A) Gene expression of double positive c-Kit/ Nanog subpopulation of mOct4 iPSCs were used to 
compare to E14 ESCs in NIA Array Tool Analysis. There are 2905 genes overexpressed in mOct4 iPSCs to the ESCs. B) The 
list of 2905 genes were further analyzed for the GO enrichment in ExATLAS, NIA webtool. The red block indicate the genes 
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Figure 4.14 Gene annotation enrichment analysis of Xlpou91 iPSC overexpressed genes 
compared to ESCs. A) Gene expression of double positive c-Kit/ Nanog subpopulation of mOct4 iPSCs were used to 
compare to E14 ESCs in NIA Array Tool Analysis. There are 2267 genes overexpressed in mOct4 iPSCs to the ESCs. B) The 
list of 2267 genes were further analyzed for the GO enrichment in ExATLAS, NIA webtool. The red block indicate the genes 
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Figure 4.15 Gene annotation enrichment analysis of Xlpou25 iPSC overexpressed genes 
compared to ESCs. A) Gene expression of double positive c-Kit/ Nanog subpopulation of mOct4 iPSC were used to 
compare to E14 ESCs in NIA Array Tool Analysis. There are 2057 genes overexpressed in mOct4 iPSCs to the ESCs. B) The 
list of 2057 genes were further analyzed for the GO enrichment in ExATLAS, NIA webtool. The red block indicate the genes 
related to germ cell development and reproduction. C) List of genes from GO clusters related to germ cell development are 
shown.
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Figure 4.16 Microarray-based expression profiles of some selected genes involving in 
germ cell specification, iPSC generation and ESC/EpiSC pluripotency. ESC-like subpopula-
tion of sorted iPSCs (c-Kit+Nanog+) were compared to unsorted ESCs and EpiSCs. Graphs show mean-log intensity 
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Section 4.6 Mechanisms of cellular reprogramming driven by different 
Oct4/POUV homologs 
 
As shown in previous sections, Xlpou91 and mouse Oct4 have the potential to 
overcome the barrier to reprogramming with similar kinetics and based on response to a 
similar dose of POUV protein. Xlpou25 is required at a higher level, had slower 
reprogramming kinetics and produces a less stable pluripotent population. To assess the 
basis for these differences I performed a time course on reprogramming by these factors 
using qRT-PCR.  
 
The effects of different doses of POUV homologs on early embryonic gene 
expression were analyzed at day 4 to day 9 of reprogramming. This time period was chosen 
because I would like to monitor the effects of exogenous POUV expression to the 
reprogramming process as it is expressed early and just prior to the emergence of 
endogenous Oct4 expression around days 10-13 (based on the induction by mouse Oct4).   
 
In the first experiment, I assessed the immediate early effects of all three POUV 
proteins. I collected RNA for qRT-PCR from day 4 post the first infection, which was the 
day of reseeding induced MEF cells onto the irradiated feeders. I analyzed the expression of 
genes that have been associated with reprogramming in other studies. In particular, 
embryonic ectodermal genes, mesodermal genes and EMT/MET related genes were 
examined. I observed no expression of pluripotency genes (e.g. Prdm14 and Nanog) at day 4 
post infection. In figure 4.17A, I found that different transcriptional levels of POUV 
homologs affected the expression of these markers differently. Interestingly, the high dose of 
Xlpou25 (which can generate iPSCs) induced high level of Lhx5, an ectodermal gene 
marker, regulator of adhesion and direct Oct4 target that is conserved in Xenopus gastulation 
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(Livigni et al., 2013). High doses of Xlpou25 also induced the highest level of N-cadherin 
(Cdh2), a mesenchymal/mesodermal and primed pluripotency marker, and the primitive 
endoderm marker Sox7. The ectodermal marker Dix3 was also induced by Xlpou25, but     
E-cadherin appeared to respond best to low doses of all three POUV proteins.   
 
Based on these intriguing observations indicating gastrulation stage gene expression 
downstream of Xlpou25, I investigated its activity in reprogramming more closely, using 
Oct4 as a positive control.  Here I explored the expression of early embryonic genes at day 4 
and 9. I found that expression of a second primitive endoderm marker Gata6 was 
preferentially induced by Xlpou25, as well as the primitive endoderm and epiblast marker 
Fgf5 (figure 4.17B). Strikingly, Xlpou25 indeed induced higher level of Gata6 than mOct4 
and the transcript level of Gata6 increased during reprogramming. In particular, high dose 
Xlpou25 induces the higher level of Gata6 than the low dose. It has been shown that 
primitive endoderm markers like Gata6, Gata3 and Sox7 are potent in replacing mouse Oct4 
in murine cellular reprogramming (Shu et al., 2013). Thus it is possible that the underlying 
gene regulatory network responding to reprogramming could be different in Xlpou25 
induced cells, and that these cells progress into reprogramming with the help of primitive 
endoderm transcription factors. If these factors remain expressed throughout the 
reprogramming process, this would explain the potential instability of the pluriptotent 
populations induced by Xlpou25. These experiments are only preliminary and require 
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Figure 4.17 Mechanism of cellular reprogramming induced by different POUV homologs A) gene 
expression analysis by qRT-PCR of POUV-SKM induced MEF cells at day 4 post transduction. L, H and SKM stands for low 
Oct4/POUV dose, high Oct4/POUV dose, and Sox2-Klf4-c-Myc, respectively. B) time-course gene expression profile of Gata6 
and Fgf5 from Oct4 and Xlpou25 SKM-induced MEFs collected at day 4, 6 and 9 post transduction. 
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Section 4.7 Discussions 
 
In this chapter, I have shown that the roles of POUV proteins in the induction of 
pluriptoency are conserved. I showed that two different Pou5f3 proteins, with different ESC 
rescue activity, could both induce iPSCs. While these proteins induced very similar iPSC 
populations, the stability of these populations to differentiation did correlate with the ability 
of these proteins to support ESCs.  I also showed that this stability might be explained by 
differences in the sequence of factors induced by POUV proteins during reprogramming.   
 
Based on the rescue assay shown in Morrison and Brickman, 2006 and this study, 
Xenopus Pou91 is a germ cell specific Pou5f3 protein with Pou5f1-like activities. Low levels 
of Pou91 were capable of reprogramming murine somatic cells towards a naïve pluripotent 
state. This can be compared to the other Xenopus homolog with more obvious Pou5f3 like 
activities in gastrulation, Xlpou25. Higher levels of Xlpou25 expression were required for 
reprogramming of somatic cells towards pluripotent states. Xlpou25 represents a primed 
state/epiblast specific POUV protein, regulating gastrulation in Xenopus and required for cell 
integrity during the epiboly process (Livigni et al., 2013). The discovery that high doses of 
Pou25 could achieve reprogramming implies that both naïve/germ cell and primed/epiblast-
like activity of vertebrate POUV are able to induce pluripotency. As shown in chapter 3, 
Xlpou25 rescue phenotypes are similar to those of all POU5F3-rescued lines. Are all 
POU5F3 required at the high dose to achieve reprogramming? I have shown that coelacanth 
POU5F3 and turtle POU5F3 are required at higher levels to maintain partial ESC self-
renewal. Perhaps these cells have lower affinity for naïve ESC targets. Future work in 
reprogramming of mouse somatic cells with these POU5F3s and a comparison to their 
binding affinities on a few key target genes might explain some of these differences.  
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Tapia et al 2012 has shown that conserved POUV activities in reprogramming varied 
amongst different POU5F1 and POU5F3 encoded factors. However, they performed iPSC 
generation at a constant dose of different POUV proteins and found that the fish POUVs 
(POU5F3s) were very poor in reprogramming. However, based on my data, it is likely that 
these proteins could all reprogram at a sufficient dose.  
 
 The final states of reprogramming induced by different POUV homologs was very 
similar, in that they all contain a population of ICAM1+CD44- (O’Malley et al., 2013), 
Nanog positive cells.  Analysis of the sorted Nanog+c-Kit+ subpopulation suggests that these 
populations are very similar in the different iPSC lines, however cell lines derived from 
Xlpou25 appeared more prone to differentiate and contained higher levels of differentiated 
cells in their cultures.  Is this related to the stability of the pluripotency network in these 
iPSCs ? Transcriptomics indicates only subtle differences, but perhaps the Xlpou25 route to 
induce reprogramming is more prone to drive differentiation. Expression of Xlpou25 is 
required at high levels early in reprogramming and these levels are sufficient to induce 
expression of endoderm genes such as Sox7 and Gata6, and endoderm/epiblast genes Fgf5 
and N-cadherin.  Perhaps the robust induction of these genes can induce the pluripotency 
network but at the same time promote endoderm differentiation, so that sub-fractions of the 
cultures produced by Xlpou25 contain a mixture of pluripotent cells and differentiatied cells.  
 
The one subtle difference between the fully reprogrammed population of     
Nanog+c-Kit+ is the increase in GO terms associated with germ cells in the Xlpou91- and 
Oct4-induced iPSCs when compared to ESCs. While mOct4 has both germ cell and epiblast 
like function based on its expression profile, the duplication of pou5f3 in Xenopus created an 
opportunity for specialization and Xlpou91 exhibits early germ cell expression, but is not 
observed in Xlpou25. While this list of GO terms is not a striking observation, perhaps when 
combined with the enhanced stability of Xlpou91 induced pluripotent cells, and the data in 
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Chapter 3, it makes a strong case for functional specialization. After all, I showed that 
Xlopou91 appears unique in the POU5F3 family as having Oct4-like activity in ESC rescue 
assays and this correlates well with its capacity to induce germ cell specific markers.  Taken 
together this suggests that after duplication in Anuran amphibians, Pou5f3 underwent revised 
specialization and regained germ cell activity similar to that present in its lost Pou5f1 
paralog.  
Is the reprogramming capacity of POUV genes related to their embryonic 
localization? Does the POUV gene expressed in germ cells always have the best 
reprogramming capacity? However, this specialization observed in Xenopus might be 
uniquely due to the fact that only Xlpou91 is expressed in PGCs.  In the axolotl, both 
POU5F1 and POU5F3 are expressed in germ cells. Interestingly, axolotl OCT4/POU5F1 
was as potent in maintaining ESCs as Xlpou91, but is not as effective at reprogramming as 
Xlpou91 and is actually slightly less efficient in iPSC generation than axolotl POU5F3 
(Tapia et al., 2012). Based on the fact that some form of reactivation of the germ line 
program similar to reprogramming is a key event of germ cell development, the co-
expression of both axolotl POU5F1 and POU5F3 in germ cells might have led to further sub-
specialization of the germ cell network, such that the net activity is the same, but each 
protein only encodes partial regulatory activity. Future work on the combinatorial activities 
of axolotl POU5F1 and POU5F3 might provide the clue as to whether they act 
synergistically to induce pluripotency and why it is an advantage to promote this level of 
sub-specialization. Clearly in Xenopus, while there is some co-expression of these two 
proteins, Xlpou91 appears to need no contribution from Xlpou25 primed activity to 








CHAPTER 5: FINAL DISCUSSION 
 
 
In this thesis, I investigated the functional conservation and divergence of vertebrate 
class V POU proteins. Two forms of POUV genes called POU5F1 and POU5F3 have been 
identified among jawed vertebrates (gnathostomes) (Frankenberg and Renfree, 2013). My 
study showed that there is only one POUV gene in lamprey (agnathan), suggesting that both 
POU5F1 and POU5F3 may have originated from a genome duplication event that occurred 
after the divergence of agnathan and gnathostome lineages. We can further group 
gnathostomes into three categories based on presence/absence of POU5F1 and POU5F3: the 
presence of only POU5F1 (e.g. mammals, squamates), only POU5F3 (actinopterygian fish, 
birds), or both POUV forms (coelacanths, turtles, axolotls, marsupials). Through literature 
review and the analysis in this thesis, I can classify conserved and diverged POUV activities 
into four different levels.  
a) Roles at organ or tissue level: 
Species carrying a single POUV gene express it in two embryonic cell types: 
epiblast cells and germ cells (Fuhrmann et al., 1999; Lavial et al., 2007; Pelton et al., 2002; 
Sabour et al., 2010; Sánchez-Sánchez et al., 2009; Stebler et al., 2004). In addition, 
eutherians, which have lost POU5F3 during evolution, show POU5F1 expression in another 
unique structure called the inner cell mass (ICM) of the mammalian blastocyst, from which 
ESCs can be isolated (Nichols et al., 1998). The ICM shares expression of a large group of 
genes with the germs cells, so called naïve pluripotency (Leitch et al., 2013). Human ESCs 
and EpiSCs express genes more characteristic of later stages of development and exhibit a 
gene expression state referred to as primed pluripotency (Brons et al., 2007; Nichols and 
Smith, 2009; Rossant, 2008; Tesar et al., 2007). In species carrying more than one paralogs, 
POUV proteins are expressed at different tissues, as evidences in Xenopus and tammar 
wallaby embryos (Frankenberg et al., 2013; Morrison and Brickman, 2006; Venkatarama et 
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al., 2010). What are the distinct roles of POU5F1 and POU5F3 in embryos?   Recently, there 
is no in vivo experiment to delineate the distinct roles of POUV paralogs at tissue level, due 
to the limitation of embryonic manipulation (e.g. tammar wallaby and turtle embryos) and 
unavailability of samples (e.g. coelacanth embryo). In this thesis, I harboured mouse 
embryonic stem cells as an in vitro tool to delineate the functional roles of different POUV 
homologs, and here I presented evidence that POU5F1 homologs in several vertebrate taxa 
play conserved roles related to a naïve or germ cell-like pluripotency, while POU5F3 
homologs are more relevant to establishment and maintenance of a primed pluripotent state 
as found in the gastrulation stage epiblast. The extent to which POUV proteins exhibit 
different activities with respect to germ cell versus epiblast-related pluripotency varies from 
taxon to taxon, and likely depends on the actual expression sites.  
b) Genetic functions and gene regulatory network: 
Global transcriptome analysis showed that rescue of Pou5f1-null ESCs with 
coelacanth POU5F1 produces similar expression profiles to rescue with mouse Oct4. Several 
genes related to reproduction, stem cell maintenance and differentiation were specific to the 
POU5F1 lines. In contrast, rescue with coelacanth POU5F3 showed upregulation of genes 
involved in various cell differentiation programs, including cell integrity, thus representing 
the properties of the primed state. This clearly shows that POU5F1 and POU5F3 can induce 
different gene networks; however, some pluripotency genes are upregulated by both POUV 
paralogs, suggesting some degree of functional conservation. Future works on mass 
spectrometry analysis and ChIP-seq of POUV rescued ESC lines might unravel the pattern 
of transcriptional network cooperated with both POUVs or either POU5F1 or POU5F3. In 
addition, future work on global transcriptome on Oct4-null ESCs rescued by POUV from 
other species e.g. turtle and tammar wallaby might give higher resolution of how POUV 




c) Cellular functions: 
Based on the gene annotation analysis from microarray-based global transcriptome, 
coelacanth POU5F1 induces the expression of genes related to cell proliferation, chromatin 
binding, regulation of cell shape, stem cell differentiation, stem cell maintenance, cell 
differentiation, metal ion binding etc. Whereas, the POU5F3 induce expression of genes 
mostly related to cell adhesion, cell-cell adherens junction, extracellular matrix, basement 
membrane, integrin complex, cell migration etc. In addition, It is suggested by gene target 
analysis of Xenopus POUV, mouse and human ESCs that POUV network shared by both 
mammalian and non-mammalian species are cell adhesion, cell migration, cell proliferation 
and transcriptional regulation (Livigni et al., 2013). Based on this observation, it is 
interesting that species retaining only one POUV homologs seem to have both sets of POUV 
activities while species retaining both paralogs have segregated POUV proteins to perform 
functions at distinct cellular levels. 
d) Molecular functions: 
What could be the driving force behind the functional segregation of POUV 
proteins? One possibility is variations in the affinity of these proteins for DNA and its 
partners (Aksoy et al., 2013; Esch et al., 2013; Pardo et al., 2010; Remenyi, 2003). Thus 
variability in the expression level required to regulate a specific set of target genes enables a 
specific level of Oct4/Pou5f1 to support self-renewal with driving differentiation (Karwacki-
Neisius et al., 2013; Radzisheuskaya et al., 2013). This is consistent with observations that 
comparisons of Oct4 fusion proteins with a greater capacity to activate transcription can 
maintain ESCs at lower levels (Hammachi et al., 2012). Below a threshold level of 
Oct4/Pou5f1 expression required to activate its targets, ESCs differentiate towards 
trophectoderm and mesoderm/primitive endoderm, respectively (Nichols et al., 1998; Niwa 
et al., 2000; Radzisheuskaya et al., 2013). In addition, the functional distinction of POUV 
paralogs might be due to differences in miRNA-related mRNA degradation and protein 
turnover rate.  
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Evolutionary trends of POUV activities  
 
The genome duplication event that underlies POUV divergence has also produced 
homologs of several other transcription factor families, and animals have evolved several 
strategies to cope with the resulting functional redundancy. As the rate of evolution in the 
coelacanth protein-coding genes is very slow (Amemiya et al., 2013), the functional 
segregation observed here might probably be close to that achieved with the initial 
duplication event. Taken together, these observations suggest that the functional segregation 
of POU5F1 and POU5F3 may be an ancient trait that coincided with the birth of POUV 
paralogs when the gnathostome lineage first evolved. As POU5F1 and POU5F3 show a high 
degree of similarity in their conserved domains, it is plausible that functional segregation has 
become blurred over time in some vertebrate lineages. Thus, POU5F3 could be expected to 
regain partial germ cell function, while POU5F1 could regain some epiblast activity, 
depending on the species. Here I summarize the evolutionary trends of POUV activity into 
five patterns as follows: (summarised in figure 5.1) 
Trend 1: Vertebrate ancestors might experience a phenomenon called “POUV 
subfunctionalization” after genome duplication, in which the ancient roles of a single POUV 
protein have been segregated into separated roles for POU5F1 and POU5F3, creating distinct 
temporal and spatial expression patterns of these POUV proteins during embryonic 
development, to reduce pressure created as a consequence of excess POUV expression from 
two alleles. Subsequently, the ancestral POUV targets have segregated, so that each protein 
regulates its own network. In this case, the germ cell network is regulated by POU5F1 and 
the epiblast by POU5F3. Several living vertebrate taxa display this trend of POUV activity, 
including coelacanth (predited), turtle (predicted), and tammar wallaby.  
Trend 2:  Axolotl POUV expression in the early embryo is intriguing in that both 
POUV proteins are expressed in its germ cells and epiblast (Tapia et al., 2012). My results 
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revealed that axolotl POU5F1 was more efficient at rescuing naïve ESCs than its paralog, 
POU5F3. This observation is still in line with the functional segregation between POU5F1 
and POU5F3 described in trend 1. If complete functional segregation of POUV proteins 
(trend 1) is an ancient trait, the emergence of POU5F3 in axolotl germ cells could be a 
secondary derived trait. Perhaps this is the reason that axolotl POU5F3 induces Prdm14 
(germ cell marker) at a higher level than do other POU5F3s, thus corroborating the notion 
that axolotl POU5F3 regains at least some control over the germ cell network.  
Trend 3 and 4: Most vertebrate taxa eliminate the redundancy by losing one of the 
POUV paralog. In species that have lost either POU5F1 or POU5F3 during evolution, the 
remaining POUV protein has to regulate the complete set of genes to support both levels of 
pluripotency. For example, mouse Oct4 (a POU5F1) is expressed in both naïve 
ESC/ICM/germ cells and primed epiblast/EpiSC (Fuhrmann et al., 1999; Nichols et al., 
1998; Pelton et al., 2002; Sabour et al., 2010), and chicken POUV (a POU5F3) is expressed 
in both gastrulating epiblast and germ cells (Lavial et al., 2007).    
Trend 5: A special case of POUV evolution occurred in the frog lineage. Frogs have 
lost pou5f1 and retain only pou5f3, but further duplication events have led to the emergence 
of three pou5f3 paralogs in these species. This vertebrate lineage has also coped with POUV 
redundancy through functional segregation, creating distinct spatial and temporal expression 
patterns of the three Pou5f3 proteins. These Pou5f3s are called Xlpou91 (Pou5f3.1), 
Xlpou25 (Pou5f3.2) and Xlpou60 (Pou5f3.3). Xlpou60 is expressed predominantly prior 
mid-blastula transition (Hinkley et al., 1992). Xlpou25 is expressed predominantly during 
gastrulation, but later also in neural specification and in the posterior neural tube (Cao, 
2004). Xlpou25 has also been shown to be an important regulator of gastrulation (Livigni et 
al., 2013), while Xlpou91 is expressed in similar embryonic region to Xlpou25, but has an 
additional domain of expression in the germ cells, suggesting its role as germ cell regulator 
(Hinkley et al., 1992). The rescue assay showed that Xlpou25 has a similar ESC phenotype 
to other POU5F3s, while Xlpou91 has a similar capacity to Oct4 and other POU5F1 protein 
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to support ESC self-renewal. I also found that the naïve ESC-like populations in iPSCs 
derived with different Xenopus POUVs are very similar, but exhibit two striking differences. 
First Xlpou91 and mOct4 induce more genes associated with reproduction than does 
Xlpou25. Second, the Xlpou91 and mOct4 derived iPSCs contain an ESC-like fraction that 
is more stable and less differentiated. The Oct4-like function of Xlpou91 constitutes a clear 
example of convergent evolution, a rare evolutionary event that took place in POUV history. 
 
Taken together, these evolutionary trends in POUV activity (functional segregation, 
respecialization, and reduction of POUV activities based on redundancy level) emphasise 
that POUV proteins are flexible in switching between two modes of activity: “Germ cell 
activity” and “Epiblast activity”. This flexibility is likely managed through cooperative 
binding, so that minor amino acid changes alter the set of partners preferred by a particular 
POU protein, but no so drastically that it is no longer able to see the remaining set. In 
support of this is the notion that the tested POU5F1 and POU5F3 proteins are mostly able to 
activate transcription from Luciferase reporters driven by different promoter sequences 
defined based on Oct4 targets (Hammachi et al., 2012; Morrison and Brickman, 2006; Niwa 
et al., 2000), suggesting that affinity differences that distinguish POU5F1 and POU5F3 are 
subtle.  However, these subtle and easy to engineer changes in POUV proteins might have 
had a key influence on shaping the pattern of vertebrate embryonic development, supporting 
their success in species radiation. Interestingly, vertebrate taxa that have lost POU5F1 switch 
from an ancient inductive mode of germ cell specification towards a predetermined mode. 
Are these events related? I have shown that POU5F1 induces more reproduction-related 
genes than its paralog, and many of those reproduction-related genes (e.g Prdm14, Nanos3) 
are involved in the initiation of germ cell programs induced through paracrine signaling in 
the epiblast. The loss of POU5F1 may affect the competency of epiblast cells to respond to 
these signals, which could have provided an evolutionary force to drive animals without 
POU5F1 to acquire another source of germ cell network induction.   
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Figure 5.1 Modes of vertebrate POUV activities and the plasticity of POUV network
Vertebrate ancestors might experience a phenomenon called “POUV subfunctionalization” after genome duplication, in which the ancient 
roles of a single POUV protein have been segregated into separated roles for POU5F1 and POU5F3 proteins. In this thesis, I have 
presented the evidences that in species carrying both POUV forms, POU5F1 roles are related to germ cell network and reproduction 
while POU5F3 roles are more related to cell adhesion and integrity of gastrulation-stage epiblast (Trend 1). As POU5F1 and POU5F3 
show a high degree of similarity in their conserved domains, it is plausible that functional segregation has become blurred over time in 
some vertebrate lineages. For example, axolotl embryo expresses POU5F1 and POU5F3 in both germ cells and epiblast (Trend 2). In 
the species carrying only single POUV form, their POUV proteins regain the conserved activity of the lost paralog and perform both germ 
cell and epiblast like activities (Trend 3 and 4). In eutherians (using mouse as a model), pluripotent stem cells isolated from inner cell 
mass and germ cells share similar gene expression profile and epigenetic status and both tissues express Pou5f1/Oct4. This leads to 
the idea that conserved germ cell network regulated by Pou5f1 might evolve to be a part of the transcriptional network regulating inner 
cell mass/ESC pluripotency (Trend 4). There is an exceptional trend of POUV activities in frog lineage (using Xenopus laevis as a 
model). In Xenopus, there are three Pou5f3 genes which probably originated through tandem gene duplication from a single Pou5f3 
gene. Frog Pou5f3 proteins have underwent further subfunctionalization, in that Xlpou91 (Pou5f3.1) and Xlpou25 (Pou5f3.2) have 
distinct roles in germ cells and epiblast, respectively (Trend 5). The re-emergence of POU5F1 roles in Xenopus Pou91 (through 
neofunctionalization) represents an example of convergent evolution. 
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Appendix 1 Comparative reproduction gene network between mOct4 and coelacanth 
POU5F1-rescued ESC lines. Overexpressed genes shared by both mOct4 and coelacanth Pou5f1 and only 
specific to mOct4 were analyzed by BINGO, as described in figure 3.13. From BINGO, only genes in GO: developmen-
tal process were analyzed further by Genemania, which is online software predicting gene network. Network A is 
developmental gene network from mOct4 specific cluster overexpressed to coelacanth POU5F3. Network B is 
developmental gene network shared by both mOct4 and coelacanth POU5F1 cluster overexpressed to coelacanth 
POU5F3. In both network A and B, genes involving in reproduction processes (e.g. gonad development, oogenesis, 
spernatogenesis etc) were marked in color. Then I selected only reproduction genes from each network to further 
analyse by Genemania. Most genes of reproduction process in network A are related to spermantogenesis while 
reproduction genes in network B are related to spermatogenesis and basic germ cell specification network (e.g. 
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GO:0006334, nucleosome assembly 
GO:0060041, retina development in camera-type eye 
GO:0000790, nuclear chromatin 
GO:0043524, negative regulation of neuron apoptotic process 
GO:0007399, nervous system development 
GO:0045893, positive regulation of transcription, DNA-templated 
GO:0030425, dendrite 
GO:0031625, ubiquitin protein ligase binding 
GO:0048471, perinuclear region of cytoplasm 




Appendix 2 Gene annotation (GO)-term analysis of genes overexpressed in mOct4 or coelacanth 
POU5F1 compared to coelacanth POU5F3 Overexpressed genes in mOct4 specific cluster or coelacanth POU5F1 
specific cluster were analyzed for gene ontology in web-based analysis tool ExATLAS. The parameter is FDR<0.05.
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GO:0000794, condensed nuclear chromosome 
GO:0007189, adenylate cyclase-activating G-protein coupled receptor signaling pathway 
GO:0048863, stem cell differentiation 
GO:0007126, meiosis 
GO:0071320, cellular response to cAMP 
GO:0055072, iron ion homeostasis 
GO:0001944, vasculature development 
GO:0030426, growth cone 
GO:0006749, glutathione metabolic process 
GO:0019233, sensory perception of pain 
GO:0000122, negative regulation of transcription from RNA polymerase II promoter 
GO:0050885, neuromuscular process controlling balance 
GO:0006814, sodium ion transport 
GO:0006813, potassium ion transport 
GO:0007224, smoothened signaling pathway 
GO:0019827, stem cell maintenance 
GO:0008360, regulation of cell shape 
GO:0003779, actin binding 
GO:0005216, ion channel activity 
GO:0005925, focal adhesion 
GO:0071805, potassium ion transmembrane transport 
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Appendix 3 
GO-term analysis of 732 overexpressed genes shared by both mouse 
Oct4 and coelacanth POU5F1 (related to figure 3.14)  
FE, fold enrichment and NG, number of genes 
 
Title z-value FDR FE NG 
GO:0006644, phospholipid metabolic process 5.5415 0 6.7964 6 
Acp6,Aspg,Oc90,Pla2g1b,Pla2g2c,Pla2g5 
GO:0048863, stem cell differentiation 5.2789 0 6.3277 6 
Etv4,Jarid2,Kit,Mtf2,Sox2,Zscan10 
GO:0019827, stem cell maintenance 4.8474 0 4.6164 8 
Esrrb,Fgf4,Klf4,Mtf2,Rif1,Sox2,Tcl1,Tet1 





GO:0006909, phagocytosis 3.753 0.0002 4.4976 5 
Cebpe,Coro1a,Hck,Myo7a,Tub 
GO:0007389, pattern specification process 3.2304 0.0012 2.9128 8 
Foxd3,Foxn4,Foxo6,Gli2,Mfng,Ptch1,Rax,Zic3 
GO:0005518, collagen binding 3.2171 0.0013 3.7297 5 
Dpp4,Itga9,Map1a,Pcolce2,Vwf 




GO:0006461, protein complex assembly 3.0854 0.002 3.2194 6 
Capn3,Clgn,Dlgap3,Mdm4,Nupr1,Tfap4 
GO:0003682, chromatin binding 2.9991 0.0027 1.8725 21 
Cdc5l,Gabpa,Gli1,Gli2,Hells,Jarid2,Jdp2,Meox1,Mkrn1,Msh6,Mybl2, 
Nupr1,Phc1,Pola1,Prkcb,Rcor2,Sall1,Shmt2,Sox2,Ticrr,Ube2t 
GO:0042102, positive regulation of T cell proliferation 2.9614 0.0031 3.3982 5 
Cd80,Coro1a,Itgal,Jak3,Zp3 












GO:0003690, double-stranded DNA binding 2.5595 0.0105 2.2562 9 
Foxd3,Foxn4,Hnf1a,Jdp2,Klf4,Msh6,Nr0b1,Nr5a2,Pola1 
GO:0005516, calmodulin binding 2.3719 0.0177 2.0526 10 
Cacna1a,Camk2b,Camkv,Itpka,Kcnn2,Myh3,Myo1f,Myo1g,Myo7a,Nos3 
GO:0035556, intracellular signal transduction 2.3344 0.0196 1.6991 18 
Arhgef2,Dab1,Dgke,Inpp5d,Jak3,Kit,Mcf2l,Pdk1,Prkcb,Rasa3,Rasa4,Rasgrp2,Shc2,Socs2,Stk10, 
Syk,Zap70,Zp3 
GO:0043197, dendritic spine 2.3143 0.0207 2.302 7 
Asic1,Dlgap3,Fbxo2,Gabbr1,Itpka,Kcnn2,Neurl1a 




GO:0007283, spermatogenesis 2.2281 0.0259 1.711 16 
Ak7,Azi1,Clgn,Ggt1,Gli1,Hmga1,Kit,M1ap,Mei4,Morc1,Mtl5,Nanos3,Nr0b1,Sirt1,Tcp11,Tex40 
GO:0007166, cell surface receptor signaling pathway 2.2275 0.0259 2.0389 9 
Bai1,Cd79b,Cd97,Celsr3,Gpr133,Itgal,Ncam1,Pdk1,Syk 
GO:0003774, motor activity 2.1265 0.0335 2.4664 5 
Dnaic2,Myh3,Myo1f,Myo1g,Myo7a 
GO:0042127, regulation of cell proliferation 2.1097 0.0349 1.9661 9 
Atf5,Cdca7,Fanca,Foxo6,Jarid2,Klf4,Nr5a2,Ptch1,Sirt1 
GO:0005089, Rho guanyl-nucleotide exchange factor activity 2.0864 0.0369 2.4273 5 
Arhgef10l,Arhgef2,Fgd1,Mcf2l,Plekhg5 
GO:0030027, lamellipodium 2.0461 0.0407 2.0989 7 
Coro1a,Dpp4,Enah,Fgd1,Mcf2l,Plekhg5,Wasf3 
GO:0008360, regulation of cell shape 2.0181 0.0436 2.0785 7 
Brwd1,Coro1a,Fblim1,Fgd1,Hck,Kit,Wasf3 
GO:0001843, neural tube closure 2.0006 0.0454 2.1846 6 
Cecr2,Cobl,Enah,Ptch1,Sall1,Sfrp1 
GO:0045666, positive regulation of neuron differentiation 2.0006 0.0454 2.1846 6 
Dab1,Etv5,Gli2,Sall1,Socs2,Sox2 












Appendix 4  
GO-term analysis of 839 overexpressed genes specific in mouse Oct4, 
compared to coelacanth POU5F3 (related to appendix 2)  
FE, fold enrichment and NG, number of genes 
 
Title z-value FDR FE NG 
GO:0000794, condensed nuclear chromosome 4.1719 0 4.5678 6 
Dmc1,Dnmt3l,Hormad1,Smc1b,Sycp3,Ttn 
GO:0007189, adenylate cyclase-activating G-protein coupled 
receptor signaling pathway 3.9928 0.0001 4.3209 6 
Adcy5,Adm2,Adora2b,Adrb3,Calca,Ptgir 
GO:0048863, stem cell differentiation 3.8248 0.0001 4.594 5 
A2m,Nanog,Phf19,Pou5f1,Zscan4c 
GO:0007126, meiosis 3.5803 0.0003 3.0355 9 
2410076I21Rik,Dmc1,Hormad1,Mei1,Piwil2,Rsph1,Smc1b,Stra8,Sycp3 
GO:0071320, cellular response to cAMP 3.5366 0.0004 4.1633 5 
Akap7,Egr4,Gpd1,Itpr3,Rapgef3 
GO:0055072, iron ion homeostasis 3.5366 0.0004 4.1633 5 
Bdh2,Hfe2,Mfi2,Sfxn4,Trf 
GO:0001944, vasculature development 3.4483 0.0006 4.0372 5 
Calca,Frzb,Sfrp4,Sox18,Vegfa 
GO:0030426, growth cone 3.2032 0.0014 2.7251 9 
Arhgap4,Hap1,Inpp5j,Npcd,Otx2,Prex1,Trpv4,Tsc1,Twf2 
GO:0006749, glutathione metabolic process 3.2029 0.0014 3.7007 5 
Ggt6,Gstt1,Gstt2,Mgst1,Txnrd3 
GO:0019233, sensory perception of pain 2.8885 0.0039 2.7838 7 
Cnr2,Ephx2,Kcnip3,Nipsnap1,Ntrk1,P2ry1,Uchl1 
GO:0000122, negative regulation of transcription from RNA 




GO:0050885, neuromuscular process controlling balance 2.6948 0.007 2.8048 6 
Aars,Adcy5,Grin2c,Hexa,Jph3,Shank3 
GO:0006814, sodium ion transport 2.5911 0.0096 2.184 10 
Asic2,Asic4,Atp1a3,Atp1b2,Fxyd2,Hcn3,Slc20a2,Slc38a8,Slc5a2,Slc9b2 




GO:0007224, smoothened signaling pathway 2.3273 0.0199 2.6645 5 
Evc2,Gpc2,Hes5,Ift172,Tmem231 
GO:0019827, stem cell maintenance 2.1792 0.0293 2.5137 5 
Dppa2,Eomes,Nanog,Phf19,Pou5f1 
GO:0008360, regulation of cell shape 2.1494 0.0316 2.0695 8 
F2,Fgr,Gas2,Gas7,Icam1,Sema4a,Vegfa,Vil1 
GO:0003779, actin binding 2.0316 0.0422 1.5674 19 
Actn3,Actr3b,Cotl1,Hdac6,Hpca,Klhl1,Mib2,Mybpc3,Myh13,Myh6,Myh7b,Myh8, 
Mypn,Parvb,Tln2,Trpv4,Twf2,Vil1,Wasf1 
GO:0005216, ion channel activity 2.0212 0.0433 1.7981 11 
Asic2,Clcnkb,Fxyd2,Grin2c,Hcn3,Itpr3,Kcnc4,Kcnq2,Mlc1,Ryr3,Trpv4 
GO:0005925, focal adhesion 2.0041 0.0451 1.9737 8 
Arhgap4,Cidec,Ephx2,Myh6,Myh8,Parvb,Tln2,Trpv4 











GO-term analysis of 326 overexpressed genes in coelacanth POU5F1  
(related to appendix 2) FE, fold enrichment and NG, number of genes 
 
Title z-value FDR FE NG 
GO:0006334, nucleosome assembly 4.7748 0 6.3245 5 
H2afx,Hist1h1a,Hist1h1b,Hist1h1t,Tspyl4 
GO:0060041, retina development in camera-type eye 4.5552 0 5.9098 5 
Cacna1f,Clcn2,Lama1,Pax6,Pvrl1 
GO:0000790, nuclear chromatin 3.8624 0.0001 4.2 6 
H2afx,Hist1h1a,Hist1h1b,Pax6,Pou4f1,Rara 
GO:0043524, negative regulation of neuron apoptotic process 2.3865 0.017 2.7519 5 
Mdk,Ngfr,Pou4f1,Six1,Six4 
GO:0007399, nervous system development 2.2302 0.0257 2.047 9 
Disc1,Dpf1,Islr2,Ngfr,Ntrk3,Pou4f1,Pura,Sema4g,Sema5b 
GO:0045893, positive regulation of transcription, DNA-templated 2.1727 0.0298 1.7887 13 
Atf7ip,Bcl3,Brca2,Cd38,Egf,Mdk,Nolc1,Nos1,Pax6,Rara,Six1,Six4,Taf8 
GO:0030425, dendrite 2.0238 0.043 1.9958 8 
Camk2n1,Clcn2,Cpne6,Nos1,Pura,Rara,Rbm3,Tnk2 











GO-term analysis of 1250 underexpressed genes shared by both mouse 
Oct4 and coelacanth POU5F1 or overexpressed genes specific in 
coelacanth POU5F3. FDR<0.05, top 100 lists, from total 339 GO-terms 
found. (Related to figure 3.15) 
FE, fold enrichment and NG, number of genes 
 
Title z-value FDR FE NG 
GO:0001725, stress fiber 9.5306 0 5.861 21 
Acta1,Amot,Anxa2,Cnn2,Daam1,Dst,Flnb,Ilk,Lima1,Myh10,Myh9,Myl12a,Myl12b,Myl9,Nox4,Palld,P
dlim7,Sorbs1,Tpm4,Vcl,Zyx 
GO:0030335, positive regulation of cell migration 8.1757 0 3.6657 32 
Bcar1,Creb3,Csf1,Cxcl12,Cxcl16,Cyr61,Dab2,Edn1,Egfr,Epha1,Ets1,Fam110c,Flt1,Furin,Ilk,Irs1,Irs2,It
gav,Itgb1,Lamb1,Mmp14,Myo1c,Pdgfb,Pdpn,Podxl,Rras2,S1pr1,Smad3,Tfap2a,Tgfb2,Thbs1,Zfp703 
GO:0070062, extracellular vesicular exosome 8.024 0 4.5027 22 
Acta1,Anxa1,Anxa2,Anxa5,Anxa6,Cd274,Cd47,Flna,Gsn,Hspg2,Lama4,Lamb1,Ltbp2,Msn,Mvp,Myh9,
Myo1c,Myof,Rbmx,Stxbp2,Thbs1,Tln1 
GO:0005925, focal adhesion 7.8073 0 3.8375 27 
Arpc2,Bcar1,Cdh1,Dag1,Dst,Fhl2,Flnb,Ilk,Irf2,Itgb1,Itgb5,Lasp1,Lima1,Lpp,Msn,Nox4,Pak1,Parva,Pdl
im7,Plec,Sdc1,Sdc4,Sorbs1,Tgfb1i1,Tln1,Vcl,Zyx 
GO:0005178, integrin binding 7.8038 0 4.4771 21 
Col16a1,Ctgf,Cyr61,Dab2,Egfr,Emp2,Ilk,Itga6,Itgb1,Itgb5,Itgb6,Lama5,Lamb1,Lamb2,Mmp14,Npnt,P
pap2b,Thbs1,Thy1,Timp2,Tln1 


























GO:0030056, hemidesmosome 7.3139 0 10.2334 6 
Actr3,Dst,Itga6,Itgb1,Itgb4,Plec 
GO:0035329, hippo signaling 7.0513 0 7.6751 8 
Amot,Amotl1,Amotl2,Lats2,Mob1b,Tead3,Tead4,Wwtr1 
GO:0016460, myosin II complex 6.9605 0 10.9644 5 
Myh10,Myh9,Myl12a,Myl12b,Myl9 
GO:0048514, blood vessel morphogenesis 6.8608 0 5.8225 11 
Ahr,Amot,Cdh2,Edn1,Efnb2,Fgfr1,Flt1,Nr2f2,Pdgfb,Shb,Thbs1 
GO:0008305, integrin complex 6.7889 0 6.1401 10 
Itga11,Itga3,Itga6,Itga8,Itgav,Itgb1,Itgb4,Itgb5,Itgb6,Myh9 
GO:0005604, basement membrane 6.6524 0 3.5926 22 
Adamts1,Anxa2,Ccdc80,Col2a1,Col4a2,Dag1,Fras1,Gsto1,Hspg2,Itga6,Itgb1,Itgb4,Lama4,Lama5,Lam
b1,Lamb2,Lamc2,Npnt,Runx1,Tgfb2,Timp2,Timp3 
GO:0030511, positive regulation of transforming growth 
factor beta receptor signaling pathway 
6.5409 0 6.2796 9 
Cdkn1c,Cdkn2b,Dab2,Furin,Itga8,Npnt,Tgfb1i1,Tgfbr3,Thbs1 
GO:0008092, cytoskeletal protein binding 6.5345 0 4.4279 15 
Anxa2,Capn2,Cryab,Dynll2,Epb4.1l3,Farp1,Farp2,Flnc,Gabarapl1,Msn,Pdlim3,Plec,Sdc1,Sdc2,Sdc4 
GO:0042383, sarcolemma 6.5053 0 3.6988 20 
Adcy6,Adrb2,Alox5,Anxa1,Anxa2,Anxa5,Bsg,Car4,Ctsb,Dag1,Dst,Dysf,Flnc,Flot1,Itgb1,Krt19,Krt8, 
Plec,Sync,Vcl 
















GO:0045216, cell-cell junction organization 6.0713 0 6.1401 8 
Crb3,Heg1,Marveld2,Marveld3,Ocln,Smad3,Tgfb2,Tgfb3 




GO:0005913, cell-cell adherens junction 6.0253 0 4.6051 12 
Cdh1,Cdh2,Dag1,Dsc2,Itga6,Lmo7,Myh9,Ndrg1,Shroom2,Sorbs1,Vcl,Zyx 
GO:0016477, cell migration 5.8504 0 2.9294 25 
Atn1,Bcar1,Cd151,Cd24a,Cd47,Cdh2,Ctgf,Flt1,Fndc3b,Itgav,Itgb1,Lama5,Lamb1,Mmp14,Nck2,Nfatc2
,Pax3,Podxl,Pvr,Shroom2,St14,Tgfb2,Thbs1,Tnfaip1,Wwc1 
GO:0019897, extrinsic to plasma membrane 5.8102 0 5.3135 9 
Anxa2,Eea1,Ppl,Prss8,Rab13,S100a10,St14,Sytl1,Sytl2 






GO:0042476, odontogenesis 5.5683 0 5.9695 7 
Bcor,Csf1,Gas1,Lamb1,Msx2,Pitx2,Wnt10a 
GO:0005923, tight junction 5.5634 0 3.0411 21 
Amot,Amotl1,Amotl2,Bves,Cgn,Cldn4,Cldn6,Cldn7,Crb3,F11r,Inadl,Magi3,Marveld2,Marveld3,Mpp7,
Ocln,Pard6b,Pard6g,Pmp22,Rab13,Shroom2 
GO:0005911, cell-cell junction 5.5481 0 2.9623 22 
9430020K01Rik,Ahnak,Cdh1,Cdh2,Dsp,Epb4.1l3,F11r,Heg1,Ilk,Iqgap1,Itgb1,Krt8,Magi3,Myo1e,Ocln,
Pak1,Pcdh1,Pkp2,Prkcd,Rab13,Shroom2,Vcl 
GO:0003700, sequence-specific DNA binding transcription 
factor activity 








GO:0042127, regulation of cell proliferation 5.4591 0 2.7411 25 
Anxa1,Cd81,Cebpa,Cnn2,Creb3,Dusp22,Egfr,Esrra,Fas,Fgfr1,Gli3,Kctd11,Lama5,Mbd2,Nr3c1,Pbx1,Pi
as1,Pitx2,Pla2g4a,Ptgs2,Sat1,Serpine1,Tes,Tnfsf9,Wnt7a 




GO:0014704, intercalated disc 5.3839 0 4.2213 11 
Anxa5,Camk2d,Capzb,Cdh2,Dsp,Dst,Itgb1,Pak1,Pkp2,Scn1b,Vcl 
GO:0051496, positive regulation of stress fiber assembly 5.3547 0 4.7638 9 
Ctgf,Epha1,Kiss1r,Nox4,Pak1,Pfn1,Sdc4,Smad3,Wnt4 
GO:0051216, cartilage development 5.2766 0 3.319 16 
Bmp1,Bmp8a,Bmp8b,Chrdl2,Col2a1,Creb3l2,Dlx2,Edn1,Esrra,Gnas,Hoxa3,Msx2,Satb2,Scx,Sox6, 
Wnt7a 
GO:0001726, ruffle 5.2745 0 3.4366 15 
Amot,Anxa2,Bcar1,Eps8l2,Gsn,Myh9,Pak1,Palld,Pdlim7,Pdpn,Podxl,S100a11,S100a6,Tln1,Tnfrsf12a 
GO:0015629, actin cytoskeleton 5.2743 0 2.6085 26 
Acta1,Acta2,Cdc42ep1,Cdh1,Cfl2,Csrp1,Cttnbp2nl,Dennd2a,Dst,Dstn,Espn,Fam101b,Fhl2,Flna,Flnc,Gs
n,Lima1,Myh9,Nfatc2,Nxf7,Parva,Pdlim3,Pdlim7,Tln1,Vcl,Wdr1 
GO:0031668, cellular response to extracellular stimulus 5.2572 0 6.1401 6 
Axl,Cdkn1a,Cdkn2b,Fos,Itga6,Nr4a2 
GO:0031362, anchored to external side of plasma membrane 5.2572 0 6.1401 6 
Car4,Cd24a,Efna5,Hyal2,Thy1,Tnfrsf23 
GO:0000904, cell morphogenesis involved in differentiation 5.2347 0 6.9773 5 
Dab2,Dkk1,Krt8,Lamb2,Myh9 
GO:0000982, RNA polymerase II core promoter proximal 
region sequence-specific DNA binding transcription factor 
activity 
5.2347 0 6.9773 5 
Arntl2,Ddn,Egr1,Msx2,Tfap2a 
GO:0005544, calcium-dependent phospholipid binding 5.2166 0 4.6051 9 
Anxa1,Anxa2,Anxa3,Anxa4,Anxa5,Anxa6,Dysf,Pla2g4a,Syt1 


















GO:0048598, embryonic morphogenesis 5.0244 0 5.7563 6 
Bmp8b,Cdon,Flt1,Gas1,Gli3,Zeb2 







GO:0030027, lamellipodium 4.9709 0 2.8593 19 
Actr3,Amot,Amotl1,Arhgap31,Arhgef6,Arpc5,Bcar1,Capzb,Cdh2,Dag1,Dysf,Gsn,Ilk,Parva,Pdpn,Podxl,
Ptpn13,Rab13,Stxbp2 
GO:0017048, Rho GTPase binding 4.9578 0 4.3172 9 
Arhgef16,Daam1,Flna,Iqgap1,Lrrk2,Pak3,Pfn1,Rock2,Vcl 
GO:0071285, cellular response to lithium ion 4.9358 0 6.3959 5 
Cdh1,Cebpa,Fas,Id2,Pparg 
GO:0050860, negative regulation of T cell receptor 
signaling pathway 
4.9358 0 6.3959 5 
Dusp3,Elf1,Pawr,Prnp,Thy1 
GO:0045893, positive regulation of transcription, DNA-
templated 






GO:0043236, laminin binding 4.8104 0 5.4177 6 
Ecm1,Itga6,Itgb1,Lgals1,Thbs1,Tinagl1 
GO:0043034, costamere 4.8104 0 5.4177 6 
Dag1,Ilk,Krt19,Krt8,Sdc4,Vcl 
 
GO:0035914, skeletal muscle cell differentiation 4.7642 0 3.4755 12 
Ankrd1,Atf3,Btg2,Egr1,Egr2,Fos,Maff,Mef2d,Nr4a1,Pax3,Rb1,Scx 
GO:0001656, metanephros development 4.7329 0 4.3858 8 
Gdnf,Gli3,Id2,Itga8,Rdh10,Six2,Wnt4,Wt1 
GO:0051402, neuron apoptotic process 4.7194 0 4.0633 9 
Apaf1,App,Atn1,Bcl2l1,Bok,Fas,Psen1,Rb1,Trp63 











GO:0048704, embryonic skeletal system morphogenesis 4.6841 0 3.4111 12 
Dscaml1,Gli3,Hoxa3,Hoxb4,Hoxc9,Hoxd9,Hspg2,Mdfi,Satb2,Six2,Tbx15,Wnt9a 
GO:0051146, striated muscle cell differentiation 4.6691 0 5.9039 5 
Akt1,Bnip2,Cdh2,Cdon,Rb1 
GO:0017017, MAP kinase tyrosine/serine/threonine 
phosphatase activity 
4.6691 0 5.9039 5 
Dusp1,Dusp10,Dusp14,Dusp5,Dusp8 
GO:0046697, decidualization 4.6691 0 5.9039 5 
Ctsb,Ctsl,Junb,Pla2g4a,Ptgs2 














GO:0010718, positive regulation of epithelial to 
mesenchymal transition 
4.4996 0 4.4771 7 
Dab2,Smad3,Tgfb1i1,Tgfb2,Tgfb3,Wwtr1,Zfp703 
GO:0019838, growth factor binding 4.4987 0 3.8375 9 
Cyr61,Fgfbp1,Fgfbp3,Flt1,Ghr,Igfbp3,Igfbp6,Ltbp2,Osmr 
GO:0031175, neuron projection development 4.4728 0 2.6568 18 
App,Areg,Bloc1s2,Btg2,Capzb,Cd24a,Ehd1,Fgfr1,Gdnf,Itgb1,Lamb1,Lamb2,Micall1,Myh10, 
Palld,Rab13,Rb1,Ryk 
GO:0045669, positive regulation of osteoblast 
differentiation 
4.4545 0 3.2316 12 
Cebpa,Clic1,Cyr61,Gli3,Gnas,Ilk,Msx2,Npnt,Pdlim7,Trp63,Wnt4,Zhx3 
GO:0002020, protease binding 4.4442 0 2.8782 15 
Cast,Cstb,Ecm1,F3,Furin,Hspa1a,Itgb1,Mbp,Serpinb6a,Serpinb9,Serpine1,Sri,Tnfaip3,Tnfrsf1a,Ubc 
GO:0001968, fibronectin binding 4.4293 0 4.8474 6 
Ccdc80,Ctgf,Igfbp3,Itgb1,Sdc4,Thbs1 
GO:0030111, regulation of Wnt signaling pathway 4.4288 0 5.4822 5 
Dkk1,Mdfi,Mdfic,Ppap2b,Tax1bp3 
GO:0005160, transforming growth factor beta receptor 
binding 
4.4288 0 5.4822 5 
Gdnf,Smad3,Tgfb2,Tgfb3,Tgfbr3 
GO:0043410, positive regulation of MAPK cascade 4.3874 0 2.8426 15 
Adrb2,Bnip2,Cdh2,Cdon,Fgfr1,Flt1,Igfbp3,Ilk,Itgav,Itgb1,Pdgfb,Prkcd,Ryk,Timp2,Wwc1 
GO:0006469, negative regulation of protein kinase activity 4.3813 0 3.1759 12 
Akt1,Dbndd2,Epha1,Gadd45b,Gadd45g,Ilk,Itprip,Psen1,Rb1,Sh3bp5,Thy1,Wwtr1 
GO:0043406, positive regulation of MAP kinase activity 4.3629 0 3.4887 10 
Cd24a,Edn1,Egfr,Fgfr1,Flt1,Ilk,Nox4,Pdgfb,Prkcd,Psen1 
GO:0030018, Z disc 4.2889 0 2.6989 16 
Anxa5,Capzb,Cryab,Dst,Fhl2,Krt19,Krt8,Myl12a,Myl12b,Myl9,Pak1,Pdlim3,Psen1,Sri,Sync,Vcl 
GO:0016459, myosin complex 4.2836 0 3.2472 11 
Cgn,Dynll2,Myh10,Myh9,Myl12b,Myl6,Myl9,Myo1c,Myo1d,Myo1e,Myo5b 
282
GO:0007050, cell cycle arrest 4.2764 0 2.7741 15 
Cdkn1a,Cdkn1c,Cdkn2b,Cgref1,Cgrrf1,Dst,Gas1,Ilk,Irf6,Pmp22,Rassf1,Rb1,Smad3,Tgfb2,Thbs1 




GO:0005198, structural molecule activity 4.2413 0 2.329 22 
Anxa1,Bves,Cldn4,Cldn6,Cldn7,Dsp,Epb4.1l3,Evpl,Krt18,Krt19,Krt20,Krt42,Krt7,Krt8,Krt81,Krt85,L
mna,Nefl,Ocln,Sync,Tln1,Vcl 
GO:0009925, basal plasma membrane 4.2409 0 3.8375 8 
Cldn4,Itga6,Itgb4,Ldlrap1,Myo1c,Plec,Slco3a1,Tacstd2 
GO:0034446, substrate adhesion-dependent cell spreading 4.2409 0 3.8375 8 
Axl,Bves,Epha1,Fndc3b,Ilk,Lama5,Lamb1,Parva 
GO:0007411, axon guidance 4.2336 0 2.4716 19 
Artn,Efna5,Efnb1,Flot1,Flrt3,Gap43,Gas1,Gata3,Gli3,Lamb2,Lhx2,Myh10,Ryk,Scn1b,Sema3c,Sema6a,
Tgfb2,Unc5b,Wnt3 
GO:0004190, aspartic-type endopeptidase activity 4.2197 0 4.1327 7 
Bace1,Ctsd,H13,Nrip3,Psen1,Ren1,Ren2 
GO:0030667, secretory granule membrane 4.2105 0 5.1167 5 
Car4,Msn,Pam,Rab27b,Vgf 
GO:0006693, prostaglandin metabolic process 4.2105 0 5.1167 5 
Hpgd,Pdpn,Ptges,Ptgs2,Tnfrsf1a 
GO:0071347, cellular response to interleukin-1 4.2105 0 5.1167 5 
Ankrd1,Hyal1,Hyal2,Rbmx,Rela 
GO:0030036, actin cytoskeleton organization 4.1913 0 2.3985 20 
Amot,Arhgef5,Bcar1,Capzb,Csrp1,Daam1,Fam101b,Flna,Iqsec1,Myh10,Pak1,Pak3,Parva,Pdgfb,Pdlim7
,Pfn1,Pfn2,Rhou,Rock2,Tmsb4x 
GO:0007179, transforming growth factor beta receptor 
signaling pathway 
4.171 0 3.0197 12 
Bmp8a,Bmp8b,Cited1,Dusp22,Fos,Gdnf,Hpgd,Jun,Smad3,Tgfb2,Tgfb3,Tgfbr3 





GO:0030173, integral to Golgi membrane 4.1303 0 3.7213 8 
Acer3,Qsox1,Sgms1,Sgms2,St3gal1,St3gal5,St3gal6,St8sia4 









GO:0016328, lateral plasma membrane 4.1011 0 3.4538 9 
Bves,Cdh1,Cldn4,Cldn7,Iqgap1,Myh9,Myo1c,Rab13,Tacstd2 
GO:0043408, regulation of MAPK cascade 4.098 0 4.3858 6 
Bmp8b,Cd24a,Id1,Ren1,Rnf41,Timp2 
GO:0005912, adherens junction 4.0901 0 3.9797 7 
Cdh1,Cdh2,Itgb1,Mpp7,Myo1e,Pkp2,Vcl 





GO:0045944, positive regulation of transcription from RNA 
































































Appendix 7  Alignment of mouse Pou5f1/Oct4 mRNA with genomic region containing Pou5f1 gene. 
The alignment show five extron structure. The corresponded exon is plotted against the POUV protein 
domain (on the right). The letters are amino acid, the color of each amino acid is corresponded to the 
POUV protein region (NTD, N-terminal domain; POUs, POU specific domain;linker; POUhd, POU 
homeodomain; CTD, C-terminal domain) Underlying the amino acid sequences are the exon structures 
as shown on the left. This figure is used with figure 3.19 and 3.20 to understand the extron-intron 
structure/protein coding region of lamprey POU5F1/3
